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General introducti on
8Chapter 1
Surveillance is a core function of public health. It serves a range of public health needs, 
such as detecting unusual disease patterns, targeting interventions, evaluating preven-
tion and control measures, and facilitating planning. Data derived from the electronic 
medical records (EMRs) of general practitioners (GPs) might be a valuable source for 
surveillance, because this data provide an indication of the health status of the general 
population. Furthermore, the approach is effi cient since this data is already collected. 
Despite these advantages, currently there is no national, continuous surveillance system 
based on data from EMRs of general practices in the Netherlands. Why not? In contrast 
to the myth that data from EMRs is readily available by just pushing a button, complicated 
procedures are necessary to disclose and use data from EMRs for research purposes. 
In this thesis, we developed a strategy for continuous surveillance of health problems in 
general practice, based on data from EMRs of a national general practice database.
 In this introductory chapter, we provide background information on epidemiologic 
surveillance and describe the history of surveillance. Then, we focus on surveillance 
based on EMRs in Dutch general practice and provide the aim, questions, and outline 
of this thesis.
BACKGROUND
Epidemiologic surveillance
The word surveillance is derived from the French sur (over) and veiller (to watch).1 It was 
introduced into English at the time of the Napoleonic wars and meant: keeping a close 
watch over an individual or group of individuals in order to detect any subversive 
tendencies.2 Within epidemiology, surveillance is the continuous and systematic pro-
cess of collection, analysis, interpretation and dissemination of descriptive information 
for monitoring health problems.3 The term ‘epidemiologic surveillance’ is used inter-
changeably with the term ‘public health surveillance’. The fi rst term emphasizes that 
surveillance is based on epidemiology, widely defi ned as the study of the distribution 
and determinants of disease frequency in man,4 while the latter focuses on the use of 
the data for public health practice – i.e. information for action.5
 Surveillance can be aimed both at the individual and at the population level. At the 
individual level, surveillance focuses on the identifi cation of individuals with certain 
9General introduction
diseases in order to take action. In case of tuberculosis, for instance, surveillance aims 
to identify infectious individuals before they infect others, in an attempt to prevent 
an epidemic. At the population level, surveillance focuses on disease in populations, 
and serves to guide public health practice. In particular, surveillance is used for setting 
priorities, planning, and evaluation of public health programs. Furthermore, surveil-
lance can serve as the starting point for more detailed epidemiologic investigations.3;6 
This thesis focuses on population-based epidemiologic surveillance.
 The objective of population-based surveillance is to provide descriptive information 
regarding when and where health problems occur and who is affected, i.e. descriptive 
epidemiology of the time, place, and person. Basic epidemiologic measures that are 
used to compare disease occurrence at different times, in different locations or among 
different sub-groups, are the prevalence and incidence of disease. The prevalence is the 
proportion of a population that has a disease at a specifi c point in time, while the inci-
dence refers to the occurrence of new cases of disease over a specifi ed period of time. 
The incidence is either calculated as a proportion (the number of new cases divided by 
the population at risk) or as a rate (the number of new cases divided by the corresponding 
population time (a combination of population size and follow-up time)). The relation 
between incidence and prevalence can be understood by using a bathtub analogy in 
which the water level represents the stock (prevalence) which depends both on the infl ow 
(incidence) and outfl ow (cure and mortality). When studying the etiology of disease, the 
incidence rather than the prevalence is useful, whereas the prevalence is more relevant 
than the incidence in applications such as planning for health resources.7
History of surveillance
The modern concept of surveillance has evolved along with changes in the way health 
information has been collected and used to guide public health practice. Table 1.1 pro-
vides a timeline of a number of key events in the history of surveillance.2;3;5;8;9 The fi rst 
public health use of surveillance occurred in 1348 during the bubonic plague, when 
public health authorities boarded ships in the port near the Republic of Venice to prevent 
persons suffering from plague illness from disembarking.9 Beginning in the late 1600s, 
death reports were fi rst used as a measure of the health of populations.3 
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Table 1.1 Key events in the history of surveillance
1300-1800 
1348 Public health authoriti es board ships near the Republic of Venice to prevent persons 
suﬀ ering from plague-like illness from disembarking.
1662 In London, John Graunt publishes Natural and Politi cal Observati ons Made upon the Bills 
of Mortality, which defi nes disease-specifi c death counts and rates.
1680s Gottf  ried Wilhelm von Leibnitz (Germany) calls for analysis of mortality in health planning.
1700s The use of stati sti cal methods to matt ers related to health spreads in Europe.
1741 Rhode Island requires tavern keepers to report contagious disease among their patrons.
1840-1850 Sir Edward Chadwick (UK) demonstrates that poverty and disease are closely related. 
Lemuel Shatt uck (US) relates deaths, infant and maternal mortality, and communicable 
diseases to living conditi ons.
1839-1879 William Farr collects, analyses, and disseminates vital stati sti cs for England and Wales to 
the authoriti es and to the general public.
1874 In Massachusett s, physicians reported prevalent diseases using a standard postcard 
reporti ng format.
Late 1800s Compulsory reporti ng of communicable diseases, such as plague, cholera, and smallpox, 
in Europe, and in the US.
1900-1979 
1925 All states in the US begin parti cipati ng in nati onal morbidity reporti ng.
1935 First nati onal health survey in the US.
1943 Danish Cancer Registry is established.
1946 Malaria Eradicati on Program starts in the US.
1955 Poliomyeliti s vaccinati on program in the US.
1963 Alexander Langmuir (US) formulates the modern concept of surveillance in public health, 
focusing on populati ons rather than individuals.
1967 Networks of ‘senti nel’ general practi ti oners are established in England and Wales and in the 
Netherlands.
1968 Surveillance is used to target worldwide smallpox vaccinati on programs, leading to global 
eradicati on. The WHO broadens the concept of surveillance beyond communicable diseases.
1976 Surveillance in the US reveals a relati on between Guillain-Barré syndrome and the swine 
infl uenza vaccine.
1979 Epidemic of toxic shock syndrome in the US; surveillance revealed that disease onset was typ-
ically during menstruati on, providing a causal clue to tampon use.
1980-present 
1980 The introducti on of microcomputers enables decentralized data analyses and electronic 
linkage of parti cipants in surveillance networks.
Early 1980s Surveillance of the acquired immunodefi ciency syndrome (AIDS) in the US guides preventi on ac-
ti viti es before the eti ology of disease is defi ned.
1990s, 2000s Worldwide surveillance focuses on emerging and re-emerging diseases, such as AIDS, SARS, 
cholera, plague, and Ebola hemorrhagic fever. The internet is used increasingly to transmit 
and report data. Public concerns about privacy and confi denti ality increase in parallel with 
the growth in informati on technology.
2001 Cases of anthrax associated with exposure of intenti onally contaminated mail in the US lead 
to growth in ‘syndromic surveillance’ aimed at early detecti on of epidemics.
2002 Release of the Nati onal Electronic Disease Surveillance System (NEDSS) in the US, aimed at 
the ongoing, automati c capture and analysis of data that is already available electronically.
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Two prominent names in the history of surveillance are Lemuel Shattuck and William Farr. 
In 1850, Shattuck published a landmark report that related death, infant and maternal 
mortality, and communicable diseases, to living conditions. William Farr is considered 
to be the founder of the basic principles of surveillance.9 Box 1.1 provides a brief descrip-
tion of the work of William Farr.
Box 1.1 Where do we come from?
William Farr (1807-1883), a struggling general practi ti oner and medical journalist, was 
appointed compiler of stati sti cal abstracts in 1838 when the General Register Oﬃ  ce was 
established to collect informati on on births and deaths in England and Wales. Soon he 
became superintendent of the stati sti cal department, a role in which he had access to 
unprecedented quanti ti es of vital data, the aid of a staﬀ , and even a mechanical computer, 
a model of a Babbage calculator. In this positi on, he developed the fi rst nati onal vital 
stati sti cs system and assured its use as a surveillance instrument. To support his work, 
he developed a new system of nosology that provided the structure of the modern Inter-
nati onal Classifi cati on of Disease. Farr subscribed to the prevailing miasma theory that 
diseases were spread through atmospheric vapours and gathered stati sti cal evidence 
that cholera was caused by miasma. Later on, however, he adopted John Snow’s theory 
that cholera was caused by contaminated water. Farr fashioned stati sti cal methods to 
describe the health of populati ons, such as age specifi c death rates, that are sti ll in use 
today.10-12
In the 1900s, national systems for tracking certain diseases were established, and 
the term ‘surveillance’ evolved to describe a population-wide approach to monitor 
disease.3 The Malaria Eradication Program, undertaken in 1946, demonstrated the 
importance of case defi nitions in surveillance. Concern that cases of malaria were 
being over-reported in the southern United States led to a requirement that case reports 
be documented. This change revealed that malaria had disappeared as an endemic
disease.9 The usefulness of an active outreach to identify cases (active surveillance) was 
clearly demonstrated during the poliomyelitis and smallpox vaccination programs. 
Cases of vaccine-associated poliomyelitis were shown to be limited to recipients of 
12
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vaccine from one manufacturer, allowing continuation of the national immunization 
program. During the smallpox elimination program, surveillance was used to redirect 
vaccination efforts away from mass vaccinations to highly targeted vaccination pro-
grams, leading to global eradication.3 In 1967, surveillance of disease based on gen-
eral practice networks started in theNetherland (Continuous Morbidity Registration 
Nijmegen)13 and in England and Wales (Weekly Returns Service),14 both of which still 
operate today. The use of surveillance to provide clues for further investigation was evi-
dent when surveillance of illnesses after infl uenza vaccination revealed Guillan-Barré 
syndrome in vaccine recipients, which resulted in the cessation of the vaccine program 
for that year.9 In addition, surveillance initiated after the detection of the epidemic of 
toxic shock syndrome provided a causal clue to tampon use.3 
 In the 1980s, microcomputers transformed surveillance practice enabling more effi -
cient methods for data collection, management and analysis.3 The role of surveillance 
in the development of prevention measures before the etiology of a disease is defi ned 
was demonstrated in the early 1980s, when surveillance of AIDS guided prevention 
activities before the human immunodefi ciency virus (HIV) was discovered.3 In the 
1990s, surveillance activities started to focus on emerging and re-emerging diseases. 
The threat of re-emerging diseases became obvious when cholera reappeared in South 
America in 1991, followed by an outbreak of plague in India in 1994.15 The 1990s also 
saw advances in the science of informatics and growth in the use of internet, which accel-
erated the automation of existing activities and enabled new approaches to surveillance, 
such as the use of sophisticated statistical methods.9;16 In 2000, the new discipline of pub-
lic health informatics evolved, defi ned as ‘the systematic application of information and 
computer science and technology to public health practice, research, and learning’.16 In 
2001, the intentional dissemination of anthrax spores in the US led to the growth of ‘syn-
dromic surveillance systems’ that emphasized the earliest possible detection of epidemics. 
These systems involve automation of nearly the entire process of surveillance.3 In 2002, 
the Centers for Disease Control and Prevention released a surveillance system for captur-
ing data that is already available electronically using internet-based transmission of data.8 
 The advances in informatics, as well as the concerns regarding potential terrorist 
events, had a substantial effect on the current concept of surveillance. Various surveil-
lance paradigms began shifting in the 1990s and continue to evolve today (Table 1.2). 
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Table 1.2 Evolving paradigms of surveillance 17
  Traditi onal Modern
Focus  Diseases Syndromes, indicators
Data sources Clinicians/laboratories Multi ple
Data collecti on method Manual Electronic/existi ng
Approach  Categorical (disease-specifi c) Cross-cutti  ng
Cause of problem Natural occurrence Deliberately caused
The focus of surveillance broadened to encompass syndromes, new and multiple sources of 
data, and deliberately-caused diseases. Furthermore, the methodology moved from a frag-
mented and largely disease-specifi c approach to a cross-cutting and integrated one, which 
focuses on electronic capture of existing data instead of labor-intensive manual methods.17
Surveillance based on EMRs in Dutch general practi ce
Surveillance based on EMRs
Continuous monitoring of changes in morbidity based on data derived from EMRs is an 
important aspect of the modern concept of surveillance. Such analysis is computationally 
intensive and has not been possible until recently because the data were not available 
in electronic form, and the number of possible symptom/sign patterns was too large to 
manage.16 Data from EMRs in general practice is particularly interesting for public health 
agencies, because morbidity in general practice refl ects, to a considerable extent, the 
state of public health. In this thesis, we focus on surveillance of health problems based 
on EMRs of general practices in the Netherlands. 
Dutch general practi ce
In the Netherlands nearly all citizens are registered by name in a general practice over 
a long period of time. The few exceptions are the homeless, illegal and uninsured people, 
and people staying in nursing homes; altogether these groups represent a tiny minority.18 
Anyone with health problems fi rst contacts the GP, who functions as a gatekeeper of the 
Dutch healthcare system. The GP may refer patients to medical specialists, who report 
their fi ndings to the GP. Almost all contacts (96%) are handled in general practice, 
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while the remaining part (4%) results in referrals.19 During out-of-hours, patients are 
referred to GP out-of-hours cooperatives, who report back to the patients’ own GP. 
Until 2005, patients were either privately or publicly insured, and access to general 
practice was free for the latter. In 2006, these insurances merged into a new, privately 
administered, basic health insurance system.18 
 The Netherlands has a leading position in the use of EMRs in general practice. 
Practically all general practices were computerized in 2001.20;21 Computerization of 
general practices in the Netherlands is regulated by the automation group within the 
Dutch College of General Practitioners (successor of the previous Working Group on 
Coordination of Information Automation (WCIA)), which develops software requirements 
for manufacturers of general practice information systems, evaluates those systems, and 
urges GPs to purchase only those systems that meet these requirements. The early and 
active role of this group in coordinating automation in general practice has contributed 
notably to the current leading position of Dutch GPs in using EMRs.13;22
Nati onal surveillance in Dutch general practi ce
The national public health agency (i.e. the National Institute for Public Health and the 
Environment (RIVM)) utilizes (among other sources) data derived from EMRs of fi ve dif-
ferent continuous GP registries to describe the state of public health in the Netherlands. 
One registry is countrywide: the National Information Network of General Practice 
(LINH), the remaining four are regional.18 In this thesis, we used the countrywide 
registry to establish a national, continuous surveillance system of health problems in 
general practice.
 LINH has its roots in the fi rst Dutch National Survey of General Practice (DNSGP-1), an 
extensive study among a random sample of 161 GPs who collected data using paper and 
pencil during a 3-month period in 1987/1988. Additional data was gathered using health 
interview surveys, GP questionnaires, and video-recordings. Diagnoses recorded by the 
GPs were coded using the International Classifi cation of Primary Care (ICPC)23 and 
grouped into episodes to calculate morbidity rates (i.e. prevalence and incidence rates). 
Box 1.2 provides defi nitions of the terms ‘diagnosis’ and ‘episode’ and explains why diag-
noses need to be grouped into episodes in order to calculate morbidity rates. For a number 
of years, the DNSGP-1 provided enough information for policy and research.24;25
15
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Box 1.2 Diagnoses, episodes, and morbidity rates
A diagnosis in general practi ce can refer to a symptom or complaint (symptom diagno-
sis), a syndrome (nosological diagnosis) or a disease (pathological/pathophysiological 
diagnosis).26 In this thesis, we use the umbrella term diagnosis to refer to any of these 
categories. An episode of care refers to all encounters for the management of a specifi c 
health problem.26 Diagnoses recorded in general practi ce need to be grouped into episodes 
in order to calculate morbidity rates. Consider, for example, a pati ent who consults the 
GP for a cough (diagnosis a), which develops into a pneumonia (diagnosis b) several days 
later. This health problem should be counted only once when esti mati ng morbidity rates, 
namely as a case of pneumonia. To avoid double counti ng, the two diagnoses need to be 
grouped into one episode of care.
In the early 1990s, however, the Dutch Ministry of Health needed to monitor referrals 
from general practice to specialist medical care. By that time, personal computers had 
entered general practice, and LINH, a national network of computerized general practices, 
was established under the auspices of the Ministry of Health in 1991. This network is a 
joint project of two research organizations and two professional associations of GPs, 
i.e. the Netherlands Institute for Health Services Research (Nivel), the Scientifi c Institute 
for Quality of Healthcare (IQ healthcare), the Dutch College of General Practitioners 
(NHG), and the Dutch National Association of General Practitioners (LHV). Initially 
only referrals were collected (1992-1995); later on, prescriptions and contact counts 
were added (1996-1999).24
 About ten years later, the Ministry of Health required not only valid information on 
the health of the population but also on the performance of general practice in the 
Netherlands, and decided to repeat the DNSGP-1. This time, data were collected 
electronically over a one-year period (2001/2002). LINH served as the basis of the 
DNSGP-2 and was extended to collect a dataset similar to the DNSGP-1.24 Additional 
software was installed to record diagnoses of consultations within the EMRs. Afterwards, 
these diagnoses were manually grouped into episodes by medical coders.27 An exception 
were six practices that used episode-oriented EMRs, a new generation of EMRs in which 
the GP records diagnoses directly into episodes.
16
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After the DNSGP-2, the LINH practices continued to record data on consultations, pre-
scriptions, and referrals, each with the associated diagnosis code. The manual grouping of 
episodes, however, was too costly and time consuming to continue on a routine basis. 
Therefore, continuous surveillance of all health problems recorded in EMRs in general 
practice was not possible. In this thesis, we explored the possibility to develop an auto-
mated method for constructing episodes, which would enable us to estimate national 
morbidity rates of all health problems in general practice. Furthermore, we focused on 
the development of methods to analyze and interpret these morbidity rates and to further 
investigate causal clues to detected trends. All in all, we aimed to develop an overall 
strategy for continuous surveillance of health problems on the basis of data collected 
within LINH.
AIM, QUESTIONS AND OUTLINE OF THE THESIS
Aim
The main aim of this thesis was to develop a useful strategy for continuous surveillance 
of health problems based on data from EMRs collected in a national general practice 
database. This overall strategy entails four subsequent steps:
a) constructing episodes
b) analyzing the data
c) interpreting the results
d) follow-up of detected trends.
In this thesis, we describe the development and the application of this strategy to 
monitor health problems in Dutch general practice over subsequent years.
Research questions
We formulated the following research questions, all of which refer to the use of data 
derived from EMRs in general practice. The term ‘useful’ in these questions denotes 
effective, effi cient, and applicable.
17
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1. What is a useful design of an automated method for constructing episodes?
2. What is the validity of this method for the purpose of estimating morbidity rates?
3. What is a useful general strategy for constructing episodes, analyzing, and interpreting 
the dataset at large?
4. What is a useful follow-up strategy for investigating causal clues to a detected trend 
in detail?
5. Which striking trends in the incidence of health problems are detected by application 
of the developed overall strategy over subsequent years?
Outline
The fi rst two research questions of this thesis focus on the development (chapter 2) 
and validation (chapters 3 and 4) of an automated method for constructing episodes 
from diagnoses recorded in EMRs in general practice (EPICON). The implementation of 
this method in the national general practice database enabled us to actually monitor 
health problems based on EMRs in general practice. To this end, we needed a general 
surveillance strategy for the dataset at large. The third research question focuses on this 
general strategy (chapter 5), while the fourth question addresses a follow-up strategy to 
further investigate a detected trend (chapter 6). The last research question focuses on the 
practical value of the developed overall strategy (chapters 5 and 6). Because chapters 2 
to 6 were written as separate articles for publication in scientifi c journals there is some 
overlap between the chapters, especially in the description of EPICON. This thesis con-
cludes with chapter 7, which discusses the main fi ndings, the methodological issues, 
and the implications of this thesis.
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 ABSTRACT
Introduction: This article describes the development of EPICON; 
an application to group ICPC-coded diagnoses from electronic 
medical records in general practice into episodes of care. These 
episodes can be used to estimate prevalence and incidence rates.
Methods: We used data from 89 practices that participated in 
the Dutch National Survey of General Practice. Additionally, we 
held interviews with seven experts, and studied documentation 
to establish the requirements of the application and to develop 
the design. We then performed a formative evaluation by assess-
ing incorrectly grouped diagnoses.
Results: EPICON is based on a combination of logical expres-
sions, a decision table, and information extracted from individual 
cases by case-based reasoning. EPICON is able to group all 
diagnoses in the selected 89 practices, and groups 95% correctly.
Conclusion: The results cautiously indicate that EPICON’s per-
formance will probably be adequate for the purpose of estimating 
morbidity rates in general practice.
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INTRODUCTION
Application domain
General practitioners increasingly register patient data in electronic medical records 
(EMRs). These data could be a valuable source for epidemiologic research. Accurate 
recording and coding of diagnoses during consultations can be an especially useful 
source for estimating prevalence- and incidence rates of diseases encountered in general 
practice. These rates are important for making probability diagnoses, monitoring diseases 
in the population, conducting scientifi c research, and evaluating health care policy.
 A diagnosis in general practice can refer to a symptom or a complaint (symptom 
diagnosis), a syndrome (nosological diagnosis) or a disease (pathological/pathophysio-
logical diagnosis).1 In this article, we use the umbrella term diagnosis to refer to any of 
these categories.
 Diagnoses in general practice are not directly suitable for estimating prevalence- and 
incidence rates. This would require that all diagnoses of a patient which refer to the 
same health problem are grouped. For instance, a patient visits the general practitioner 
for a cough (diagnosis a) which develops into a pneumonia (diagnosis b) several days 
later. This health problem should be counted only once when estimating occurrences of 
diseases, namely as a case of pneumonia. To avoid double counting, diagnosis a and b 
have to be grouped. Diagnoses referring to the same health problem can be grouped 
into an episode of care, i.e.; “all encounters for the management of a specifi c health 
problem”.1 An episode of care is usually named after the last diagnosis, which can be 
used to estimate the numerator of the epidemiological fraction.
 Generally, two approaches for constructing episodes can be used. In the fi rst approach, 
the general practitioner groups diagnoses directly into a problem-oriented or episode-
oriented medical record. Lawrence Weed introduced the problem-oriented medical 
record (POMR) in 1968. The POMR is centered around problems in a problem list.2 
Diagnoses that refer to the same health problem receive the same problem number, 
which can be used to estimate morbidity rates.3 A disadvantage of using this method for 
epidemiologic research is that problem lists are frequently not kept up to date.4 The new 
generation of Dutch primary care information systems is episode-oriented: all patient 
information is actually recorded into episodes of care.5 Data from these episode-oriented 
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systems are probably very well suited for epidemiologic research. However, these 
systems are still in an implementation phase. In the second approach, diagnoses are 
grouped afterwards, through manual review or a computerised method. This approach 
is useful if episodes are not or inadequately constructed by the general practitioner. In 
this article, we will describe the development of EPIsode CONstructor (EPICON), an 
application for grouping diagnoses afterwards into episodes. EPICON makes it possible 
to use data from EMRs in general practice for estimating prevalence- and incidence rates.
Previous research
Our project builds upon the second Dutch National Survey of General Practice 
(DNSGP-2), which has been described elsewhere.6;7 In the DNSGP-2, diagnoses were 
grouped afterwards into episodes for 89 general practices. A semi-computerised method 
was used in which ‘easy to group’ diagnoses were grouped automatically (80% of all 
diagnoses), and ‘diffi cult to group’ diagnoses were grouped manually (20% of all diag-
noses). An example of a diffi cult case is a patient who is diagnosed with tiredness, and 
who has also been diagnosed with hypothyroidism and general deterioration. This case 
is complicated, because tiredness is a very non-specifi c symptom that is observed in 
many medical conditions. In other words, there are no explicit rules to decide whether 
tiredness should be grouped with hypothyroidism, with general deterioration, or as a 
separate episode. In general, complicated cases involve a multi-class classifi cation task 
and an absence of clear-cut classifi cation rules. The DNSGP-2 dataset, in particular the 
manually grouped diagnoses, contains implicit knowledge of the signs, symptoms, and 
the course of diseases, which could be used to solve the problem of grouping diagnoses.
Case-based reasoning
Basic problem-solving approaches in the fi eld of artifi cial intelligence are rule-based 
reasoning (based on if… then… rules), model-based reasoning (based on a causal or 
functional model), and case-based reasoning (based on examples).8 We selected case-
based reasoning (CBR), because the domain knowledge needed to group diagnoses into 
episodes, is implicit knowledge, which lends itself more for reasoning based on analogy 
than for formulating domain rules or for constructing a model. Also, ample cases were 
available, for the DNSGP-2 dataset provided an extensive case library.
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CBR is a problem-solving paradigm based on psychological theories of human cognition 
which provides a method for constructing intelligent systems. It focuses on analogy as 
a strategy for solving real-world problems. Human experts differ from novices in their 
ability to relate problems to previous ones, to reason based on analogies between current 
and old problems, and to use solutions from earlier experiences. A case-based reasoner 
solves a new problem by remembering a previous similar situation and reuses information 
and knowledge from that situation. The following four processes describe a general CBR 
cycle:
1.  Retrieve: Given a new problem, former similar cases are retrieved.
2.  Reuse: Information and knowledge in the retrieved cases are used to solve the 
problem.
3.  Revise: The solution is tested for success, and repaired if it fails.
4.  Retain: A successful solution is incorporated into the case base for future use. Many 
case based systems are so-called retrieval-only systems or act primarily as retrieval and 
reuse systems. They merely perform the retrieval or the retrieval-and-reuse task.9-14
Research questions
The objective of our research was to develop a fully-computerised method for the 
construction of care episodes. This project is divided into a development and evaluation 
phase. In the development phase, we assessed the requirements, designed, and built the 
system. In the evaluation phase, we performed a formative evaluation. We formulated 
the following questions:
Development phase
1.  How were diagnoses grouped in the semi-computerised method?
2.  a) What are the requirements, and b) what is the case-based design of the fully-
computerised method?
Evaluati on phase
3.  How many, and which diagnoses are misclassifi ed by EPICON?
The aim of this project is to determine whether the development of a computerised 
grouping method can disclose data from EMRs in general practice for epidemiologic 
research.
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METHODS
Dataset
The dataset used in this research is a longitudinal set of patient records provided by a 
Dutch network of computerised general practices (LINH).15;16 The general practitioners 
within this network record longitudinal data on consultations, including diagnoses, pre-
scriptions, and referrals. 
 Within the framework of the DNSGP-2, episodes were constructed for LINH-data 
of one year (2001), which were used to estimate prevalence- and incidence rates of 
diseases in general practice.17
 We selected all 89 general practices (comprising 166 individual general practitioners) 
for which diagnoses were grouped afterwards into episodes from the total number of 96 
practices that were included in the DNSGP-2. The patient population, which can be 
used to estimate the denominator of the epidemiologic fraction, includes all listed 
patients (n = 343 853). Compared to population fi gures from Statistics Netherlands, the 
patient population comprises a representative sample of 2% of the Dutch population 
regarding age, gender, and type of insurance. 
 Diagnoses were coded according to the International Classifi cation of Primary Care 
(ICPC).18 This classifi cation system has a biaxial structure. The primary axis represents 
17 chapters referring primarily to a body system. The other axis represents seven 
components (C1: symptoms and complaints, C2-C6: process, and C7: syndromes and 
diseases). For coding diagnoses, both C1 (codes 1-29) and C7 (codes 70-99) can be 
used. Diagnosis codes were assigned to consultations, prescriptions, and referrals.
 For consultations only, the general practitioners, in accordance with strict guidelines, 
characterised each diagnosis as either belonging to a new or an ongoing ’type of episode’. 
A new episode refers either to a newly presented health problem or to a recurrent 
health problem, and contributes to both the incidence and the prevalence. An ongoing 
episode refers to a continuing health problem, and contributes to the prevalence only.
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Development phase
The semi-computerised method that was used in the DNSGP-2 has not been described 
previously in any detail. Therefore, the development of EPICON started with an inventory 
of this method (question 1). Information was gathered through semi-structured interviews 
with four experts who were responsible for different aspects of this method. In addition, 
we studied documentation on decisions and procedures. Requirements (question 2a) for 
the fully-computerised method were assessed through semi-structured interviews with 
three other experts who are currently responsible for scientifi c research based on LINH. 
The design of the fully-computerised method (question 2b) is partly based on the comput-
erised part of the semi-computerised method. We started by designing EPI-0, a simple 
non-case-based variant. EPI-0 groups diagnoses only on the basis of the computerised 
part of the semi-computerised method; all remaining diagnoses are grouped as separate 
episodes. Next, in order to group these remaining diagnoses, we developed the case-
based design for EPICON by considering various case-based or exemplar-based classifi -
cation techniques.19;20 We decided to design EPICON as a retrieval-and-reuse system.
 Detailed information on the semi-computerised method, the requirements and the 
design of the fully computerised method was documented, verifi ed, discussed, and 
adjusted accordingly. EPICON is constructed according to the developed case-based 
design, and it is written in Transact-SQL.
Evaluation phase
We compared EPICON to the original, semi-computerised method, which is considered 
the ‘gold standard’. We also compared EPI-0 to the gold standard in order to examine 
what the case-based part in EPICON adds to EPI-0 (the computerised part of the semi-
computerised method).
 All diagnoses in the original dataset were regrouped by EPI-0, and by EPICON. 
To gain insight into the process in which diagnoses are grouped by each variant, we 
calculated the number of diagnoses grouped in each step in both EPI-0 and EPICON.
 For each diagnosis, we assessed whether or not, compared to the ‘gold standard’ 
it was grouped correctly by EPI-0 and EPICON. This comparison yielded three types of 
misclassifi cations. Table 2.1 shows examples of these three types.
Chapter 2
Table 2.1 Examples of misclassifi ed diagnoses
Pati ent Diagnosis*
 (ICPC)   Episode numbers  Misclassifi cati ons 
    Semi-comp. EPI-0 EPICON EPI-0 EPICON
    method
Jones L03   1 1 1 no no
Jones L02   1 2 1 link failure no
Parker R78   1 1 1 no no
Parker R75   2 2 1 no false link
Adams L74   1 1 1 no no
Adams K74   2 2 2 no no
Adams K07   1 3 2 link failure wrong comb.
* L03: Low back symptoms/complaints without radiati on
  L02: Back symptoms/problems
   R78: Acute bronchiti s/bronchioliti s
   R75: Sinusiti s acute/chronic
   L74: Fracture hand/foot bones
   K74: Angina pectoris 
   K07: Swollen ankles/edema
Type 1: link failure. A diagnosis, which is linked to another diagnosis by the semi-
computerised method, is not linked by EPI-0 or EPICON. Table 2.1 shows the example 
of patient Jones with two diagnoses relating to back symptoms (L03 and L02). The 
semi-computerised method linked the two diagnoses by assigning the same episode 
number to both diagnoses, whereas EPI-0 failed to link the two diagnoses (they received 
different episode numbers by EPI-0).
 Type 2: false link. A diagnosis not linked to another diagnosis by the semi-computerised 
method, is linked by EPI-0 or EPICON. In the case of patient Parker in table 2.1, EPICON 
makes a false link between the diagnoses ‘acute bronchitis/bronchiolitis’ (R78) and 
‘sinusitis acute/chronic’ (R75).
 Type 3: wrong combination. A diagnosis linked to another diagnosis by the semi-
computerised method, is also linked by EPI-0 or EPICON, but to the wrong diagnosis. 
Table 2.1 shows that the semi-computerised method linked the diagnosis ‘swollen ankles/
edema’ (K07) for patient Adams to the diagnosis ‘fracture hand/foot bones’ (L74). 
EPICON, however, linked the diagnosis ‘swollen ankles/edema’ (K07) to the diagnosis 
‘angina pectoris’ (K74).
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RESULTS
Development phase
Semi-computerised method
Results of our inventory of the semi-computerised method that was used in the DNSGP-2 
are presented in the form of a fl owchart. Figure 2.1 shows this method, which consisted 
of 5 steps (shown in between parentheses).
Next diagnosis
First diagnosis 
this year?
Create separate 
episode
Type of episode?
No
Link by decision table?
Create link
Ongoing
More ungrouped 
diagnoses?
File consultation 
episodes into 
database
Yes (1)
New (2)
No (3)
Unknown
Yes
Add episodes from 
prescriptions and 
referrals (5)
No
All consultation diagnoses 
of a patient
Link manually? No (4)Yes (4)
Unknown
Yes (3)
Fig. 2.1 Semi-computerised grouping method
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Step 1. The fi rst consultation diagnosis of a patient in a one-year registration period was 
grouped into a separate episode. ‘Create separate episode’ means that a separate episode 
number was assigned to a diagnosis. Operationally, an episode is a row of diagnoses 
with the same episode number. The fi rst diagnosis of this row could be either new or on-
going (as explained in the last paragraph of the section ‘Dataset’), whereas subsequent 
diagnoses were always ongoing. The fi rst diagnosis in the row determined whether the 
episode was new or ongoing, the last syndrome/disease diagnosis in the row determined 
the name of the episode. If no syndrome/disease diagnosis existed, the episode was 
named after the last symptom diagnosis in the row.
 Step 2. The remaining diagnoses were grouped by ‘type of episode’ (new or ongoing). 
A new diagnosis was grouped as a separate episode. Diagnoses for which the ‘type of 
episode’ was missing (9% of the total number of diagnoses) were grouped manually. 
Note the difference between a separate and a new episode. A separate episode can be 
either new or ongoing.
 Step 3. If possible, ongoing diagnoses were grouped based on a decision table, which 
consists of a combination of an ongoing diagnosis and a previous diagnosis, and a 
decision whether or not they should be grouped together (see table 2.2). These deci-
sions were made by two physicians (a medical doctor experienced in rheumatology 
research and a general practitioner experienced in Dutch primary care) who relied on their 
clinical experience. The table includes only the most frequently occurring combinations 
(27 092 in total, which is 11% of the total number of 237 016 possible combinations of 
two diagnoses).
Table 2.2 Decision table for linking an ongoing diagnosis to a previous* diagnosis
Ongoing diagnosis  Previous (new or ongoing) diagnosis Decision 
(ICPC-code)    (ICPC-code) 
URI (head cold) (R74) Knee symptoms/complaints (L15) Make no link
URI (head cold) (R74) Muscle pain/fi brositi s (L18)  Unknown
URI (head cold) (R74) Infl uenza (R80)   Make link
. . .    . . .    . . .                  (n = 27 092)
* The program fi rst checked if the diagnosis could be linked to the previous diagnosis. If the result 
was ‘make no link’ or ‘unknown’, the diagnosis before the previous diagnosis was checked, and so on 
backwards in ti me. The program takes thus the sequence of diagnoses (but not the interval between 
diagnoses) into account.
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Step 4. The manual grouping was carried out by 29 medical coders (mostly medical 
students). The coders had access to all the available data of a patient, including age, 
gender, and type, date, and the ICPC-code of all former diagnoses. Free text added to 
an ICPC-code by a general practitioner was also available to the coders. To increase 
agreement among grouping diagnoses, the coders were personally supervised, worked 
on the basis of an extensive manual with grouping rules, and discussed diffi cult cases 
during meetings.17
 Step 5. Diagnoses from prescriptions and referrals (i.e., the indications for the pre-
scription or referral) did not pass through the foregoing steps, because they had no ‘type 
of episode’. Diagnoses from prescriptions and referrals that were different from any of 
the consultation diagnoses of a patient, were added to the database as ongoing episodes 
afterwards.
Requirements
The main outcome of the interviews was that the fully-computerised method should be 
in line with the basic principles and methods used in the semi-computerised method. 
The three experts emphasised that the primary aim of constructing episodes was to 
estimate the prevalence and incidence rates; a secondary aim was to describe health 
care use in general practice. A constraint in our study was posed by privacy legislation,21 
which rendered the free text added to diagnosis codes by general practitioners unavail-
able for the fully-computerised method. Therefore, we could not investigate whether or 
not the free text contained additional, medical information that would be useful for 
grouping diagnoses into episodes.
Design
In line with the requirements, we designed the fully computerised-procedure as an ex-
tension of the semi-computerised method. Figure 2.2 shows the design for EPICON. The 
grey parts are derived from the computerised part of the semi-computerised method. 
EPI-0 consists of these grey parts, and step 4d. Step 2 differs somewhat from the semi-
computerised method: all diagnoses for which ‘type of episode’ is missing, are consid-
ered as ongoing by EPI-0 and EPICON.
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The black parts in fi gure 2.2 are new. They consist of three case-based steps (4a - 4c), 
and one ‘rest’ step (4d). 
 First, we will explain the case-based design in general and then we will describe the 
various steps in more detail. Important design decisions in developing a case-based 
system concern the similarity and granularity of cases. If we would use a very fi ne grain 
size (like defi ning similar cases as patients with the same sex, the same birth date, and 
Next diagnosis
First diagnosis this year?
Type of episode?
Link by decision table?
More ungrouped diagnoses?
File episodes into 
database
Add episodes out of 
prescriptions and 
referrals (5)
Link at diagnosis level?
Link at episode level?
Link at chapter level?
Remaining diagnoses (4d)
Create 
separate 
episode
Create link
No
Ongoing/Missing
Unknown
Unknown
Unknown
No
Yes (1)
New (2) 
No (3)
No (4a)
No (4b)
Yes (3)
Yes (4a)
Yes (4b)
Unknown
Yes
No (4c)Yes (4c)
All consultation diagnoses of a patient
Fig. 2.2 Fully-computerised grouping method
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the same diagnoses in the same week of the year) we would not fi nd any similar cases. 
Using a very coarse grain size (such as defi ning similar cases as patients who also have 
a symptom diagnosis) would lead to many misclassifi cations. During the design process, 
we experimented with various defi nitions of cases, with the sequence of steps, with the 
cut-off points used, and evaluated the outcome in order to improve the design. In the fi nal 
design, we used a defi nition of cases at the level of diagnoses (step 4a), because this 
defi nition provides cases that are both suffi ciently similar and numerous (n = 5 772 908 
cases). However, not all diagnoses could be grouped in this way. For these remaining 
diagnoses, we increased the grain size of cases to the level of episodes (step 4b), which 
resulted in a suffi ciently similar, but smaller number of cases (n = 2 095 536 cases). For 
any remaining diagnoses, we increased the grain size of cases once more to the level of 
chapters (step 4c) resulting in a large number of broadly similar cases (n = 5 855 741 
cases). The various steps are explained in more detail in the section below.
 Step 4a. In this step, we used case-based reasoning at the level of diagnoses. In the 
retrieval process, we defi ned a problem or an unsolved case as follows: Should diagnosis 
X be linked to one of the other diagnoses of the same patient? For instance, patient 
Smith visited the general practitioner because he fainted that day. The general practitioner 
assigned the diagnosis fainting (A06), and characterised it as ongoing (i.e., it refers to a 
continuing health problem). Earlier that year, patient Smith visited the general practitioner 
for other health problems, namely dermatophytosis (S74), general tiredness (A04), and 
hypoglycemia (T87). In this example, the unsolved case is; should the diagnosis fainting 
for patient Smith be linked to one of the other diagnoses of patient Smith, i.e. dermato-
phytosis, tiredness or hypoglycemia?
 We defi ned a former similar or solved case as a manually grouped diagnosis X that 
belongs to a patient who also has one of the other diagnoses. In the example above, we 
selected all the patients for whom the diagnosis fainting was manually grouped by one 
of the medical coders. From this group, we then retrieved those patients who were also 
diagnosed with dermatophytosis, or tiredness or hypoglycemia.
 We were unable to retrieve these solved cases directly from the DNSGP-2 dataset. 
Therefore, the structure of the original dataset had to be changed into a case base that 
represents cases. Table 2.3 shows this case base. Each row shows a number of similar 
cases that belong to the same category because they have the same combination of 
diagnoses in common.
34
Chapter 2
Table 2.3 Case base 1: cases at diagnosis-level* 
Manually grouped  Other diagnosis of Total no Grouped Grouped
diagnosis   the same pati ent of similar into same into same
(ICPC-code)  (ICPC) cases episode (n) episode (%)
URI (head cold) (R74) Pain: generalised/  38 5 13.2%
  unspecifi ed (A01) 
URI (head cold) (R74) Chills (A02) 13 12 92.3%
URI (head cold) (R74) Fever (A03) 362 202 55.8%
. . .  . . . . . .              . . . (n =106 908) 
* Combinati ons were only included in this table if (the total number of combinati ons was at least 5) or (if 
the total number of combinati ons was 3 or 4 and either 0% or 100% was grouped into the same episode).
In the reuse process, we carried out the following activities. First, we counted the number 
of cases that was solved by either grouping or separating for each category, and calcu-
lated the percentage of cases that were ‘grouped together’. This percentage was then 
used to solve the case. For each unsolved case, the percentages of all eligible categories 
were compared to a previously defi ned cut-off point. If one of the percentages exceeded 
the cut-off point, diagnosis X was linked to this other diagnosis. If all percentages were 
below the cut-off point, diagnosis X was grouped separately. 
 In the patient Smith case, the following cases are retrieved from the case base:
A06-S74, a total of 93 cases, 0 times grouped into the same episode (0.0%);
A06-A04, a total of 167 cases, 68 times grouped into the same episode (40.7%);
A06-T87, a total of 15 cases, 8 times grouped into the same episode (53.0%).
The percentage of the category A06-T87 exceeded the cut-off point for EPICON (set at 
48% as explained below). Therefore, EPICON linked the diagnosis fainting for patient 
Smith to the diagnosis hypoglycemia.
 Step 4b. In this step, we defi ned cases at the level of episodes. Here, an unsolved case is 
defi ned as: Should diagnosis X be linked to one of the other episodes of the same 
patient? We constructed a second case base (n = 84 059 different cases) and used the same 
procedure as the one in step 4a.
 Step 4c. We used case-based reasoning at the level of chapters to handle rare cases 
that cannot be grouped by any of the preceding steps. In this step, an unsolved case is 
described as whether diagnosis X should be linked to one of the chapters to which other 
diagnoses of the same patient belong. We constructed a third case base (n = 10 068 
different cases), based on the chapter to which another diagnosis of the same patient 
belongs, and used the same procedure as in step 4a. 
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Step 4d. Diagnoses that cannot be grouped by any of the aforementioned steps were set 
aside. The computerised method continuously tried to group these remaining diagnoses 
because it would still be possible to group some of these diagnoses when more infor-
mation from following diagnoses of the same patient became available. In the end, all 
remaining diagnoses were grouped as separate episodes.
Assessing the cut-oﬀ  points
The optimal cut-off point for each case-base was assessed by calculating, for various 
cut-off points, the total number of correctly and incorrectly grouped combinations. 
For example, using a cut-off point of ≥ 70% in case base 1 (see table 2.3) means that 
all 38 head cold-pain (R74-A01) combinations are not grouped together, because 
13.2% < 70%. This results in 5 incorrectly grouped (link failures) and 33 correctly 
grouped combinations.
 We used two criteria to assess the optimal cut-off points. First, the total number of 
incorrectly grouped combinations should be as low as possible. Second, to avoid 
systematic bias, the number of link failures should equal the number of false links. 
Subsequently, the optimal cut-off points are ≥ 48% for case base 1, ≥42% for case base 
2, and ≥ 71% for case base 3.
Evaluation phase
Table 2.4 shows the percentage of diagnoses assigned to each step, in EPI-0 and 
EPICON. The results show that the large majority of the diagnoses can be grouped by 
EPI-0; only 13.1% of all diagnoses are remaining diagnoses. Practically all of these 
remaining diagnoses were grouped by the additional case-based steps in EPICON.
Table 2.4 Percentage of diagnoses grouped in each step
Steps   EPI-0 EPICON
1.  First diagnosis  20.4% 20.4%
2.  New episode  27.4% 27.4%
3.  Decision table  29.4% 29.4%
4a. Diagnosis level  - 11.3%
4b. Episode level  - 0.2%
4c. Chapter level  - 1.4%
4d. Remaining  13.1% 0.1%
5.  Diagnoses from prescripti ons/referrals  9.8% 9.8%
Total no of diagnoses  1 201 234 1 201 234
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Figure 2.3 shows the number and type of incorrectly grouped diagnoses. EPI-0 misclas-
sifi es 7.1% of all diagnoses. This percentage drops to 4.7% in EPICON, which is a small, 
but appreciable improvement. Practically all errors in EPI-0 are link failures, whereas 
EPICON shows a good balance between link failures and false links. For both variants, 
wrong combinations (81 by EPI-0 and 344 by EPICON) are rare.
 Both numerous link failures and numerous false links will produce biased morbidity 
rates, but in opposite directions. In particular, prevalence rates will be overestimated by 
link failures and underestimated by false links. Numerous wrong combinations will 
produce bias in both directions.
We also examined the number of misclassifi ed diagnoses per ICPC-chapter. Figure 2.4 
displays the distribution of misclassifi cations (link failures and false links) across chapters 
in EPICON. In general, this fi gure shows a balanced distribution of misclassifi cations 
across chapters, i.e., the number of misclassifi cations is proportional to the total number 
of diagnoses in a chapter. With the exception of chapter A, the percentage of misclassi-
fi cations per chapter ranges from 1.4% in chapter W (pregnancy and family planning) 
to 6.1% in chapter Z (social problems). Additionally, the number of link failures equals 
the number of false links. An exception is chapter A (general and unspecifi ed), which 
shows a relatively large number of link failures.
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CONCLUSIONS AND DISCUSSION
To our knowledge, this is the fi rst study into the development of a case-based system for 
grouping diagnoses in general practice. Previous research in constructing episodes of 
care focused primarily on grouping insurance claims records and did not use a case-
based approach.22-24
 EPICON groups diagnoses into episodes, based on a combination of logical expressions, 
a decision table, and information extracted from individual cases by CBR. This application 
is able to group all diagnoses in our dataset, and groups 95% correctly. These results 
cautiously indicate that EPICON’s performance will probably be adequate for the purpose 
of estimating morbidity rates in general practice.
 It is important to note that not all misclassifi cations will have an effect on the prevalence 
and incidence rates. Only misclassifi cations that alter episode names can affect morbidity 
rates. Furthermore, the number of altered episode names has to be suffi ciently large in 
proportion to the population ‘at risk’ in the denominator, to have an effect at all. There-
fore, the analyses of misclassifi cations should be considered a formative evaluation, 
with the purpose of studying the process of grouping diagnoses. In the next phase of this 
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project, we will perform a summative evaluation in which we will examine if EPICON 
serves its purpose by comparing morbidity rates. Dependent on the results of the sum-
mative evaluation, EPICON will be applied to the LINH database to estimate yearly 
prevalence and incidence rates of diseases in general practice.
 We developed two variants of the fully-computerised method. The most simple variant, 
EPI-0, is based on the computerised part of the semi-computerised method that was 
used in the DNSGP-2. EPI-0 consists of logical expressions and a decision table. This 
variant performs fairly well; it only misclassifi es 7.1% of all diagnoses. In the other variant, 
EPICON, we added three case-based steps, based on the manual grouping that was 
used in the DNSGP-2. Comparing EPI-0 to EPICON reveals what CBR adds to EPI-0. 
This procedure lowers the number of misclassifi ed diagnoses only by 2.4%. These results 
indicate that the large majority of diagnoses made in general practice can be grouped 
using simple methods, whereas additional information and more complicated methods 
are required to group the remaining diagnoses correctly.
 EPICON shows a balanced distribution of misclassifi cations across chapters with the 
exception of chapter A. This chapter includes general and unspecifi ed diagnoses such 
as pain and tiredness, which are symptoms of many different diseases. Such diagnoses 
exemplify the problem of grouping diagnoses in general practice. Compared to other 
medical doctors, general practitioners encounter many patients with a broad range of 
symptoms, syndromes, and diseases, and will often have to make an educated guess 
about the relations between them. EPICON is specifi cally developed for this setting, 
and is not applicable to other disciplines. The followed procedure, however, could be 
adopted to develop a system for grouping codes from other classifi cations systems.
 We used the original grouping of the dataset as a ‘gold standard’, which is both the 
strength and the weakness of this study. The strength lies in the fact that we had access 
to a large database of carefully constructed episodes to develop, and evaluate the new 
episode constructions. The weakness is that our comparison may overestimate the per-
formance of EPICON, because the new grouping method is partly based on the same 
rules as the original grouping method. Furthermore, our study is based on the assump-
tion that the original grouping is the gold standard. We did not test this assumption, 
because an evaluation of the gold standard was not a focus of our project. Consequently, 
this study cannot reveal possible fl aws in the gold standard, for instance in the decision 
table, that passed on to EPICON.
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This project was carried out in the Netherlands. Dutch general practitioners are in the 
lead in when it comes to using EMRs; practically all practices were computerized in 
2001.25 Therefore, this project can be seen as representative for all countries with a 
high degree of Information Technology in general practice. The followed method is 
essentially applicable to all large databases of routinely recorded diagnoses in general 
practice.
 In this study, we developed a fi rst, workable application that lends itself for further im-
provement. A further reduction of misclassifi cations might be achieved by adding time 
intervals between diagnoses to the case bases. In addition, EPICON could be extended 
to a learning, and interactive decision support system by presenting grouped diagnoses 
to a general practitioner in order to test its solutions. The decision support system would 
assist the general practitioner in grouping diagnoses directly into episodes.
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ABSTRACT
Objectives: In this study, we evaluated the internal validity of 
EPICON; an application for grouping ICPC-coded diagnoses 
from electronic medical records into episodes of care. These 
episodes are used to estimate morbidity rates in general practice.
Methods: Morbidity rates based on EPICON were compared to 
a gold standard; i.e. the rates from the second Dutch National 
Survey of General Practice. We calculated the deviation from 
the gold standard for 677 prevalence and 681 incidence rates, 
based on the full dataset. Additionally, we examined the effect 
of case-based reasoning within EPICON using a comparison to 
a simple, not case-based method (EPI-0). Finally, we used a split 
sample procedure to evaluate the performance of EPICON.
Results: Morbidity rates that are based on EPICON deviate only 
slightly from the gold standard and show no systematic bias. The 
effect of case-based reasoning within EPICON is evident. The ad-
dition of case-based reasoning to the grouping system reduced 
both systematic and random error. Although the morbidity rates 
that are based on the split sample procedure show no systematic 
bias, they do deviate more from the gold standard than morbidity 
rates for the full dataset.
Conclusions: Results from this study indicate that the internal 
validity of EPICON is adequate. Assuming that the standard is 
gold, EPICON provides valid outcomes for this study population. 
EPICON seems useful for registries in general practice for the 
purpose of estimating morbidity rates.
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INTRODUCTION
Prevalence and incidence rates in general practice are used by scientists to monitor 
symptoms and diseases in the population, by policymakers to formulate and to evaluate 
health care policy, and by general practitioners to make probability diagnoses. Under 
certain conditions, listed below, the data from electronic medical records (EMRs) in 
general practice are a valuable source for estimating these rates.
 A necessary condition for estimating morbidity rates from EMRs is that patient lists are 
available. These lists are needed to determine the size of the underlying practice popu-
lation, i.e., the denominator of the morbidity rates. Countries with a list system, such as 
the Netherlands, Denmark, the United Kingdom, Italy, Spain, Portugal, and Slovenia, 
are also countries with a gatekeeping system.1 The presence of such a system is a very 
favorable condition, because within this system, the main pathway to medical care is 
through general practice. Hence, morbidity rates in general practice within these systems 
provide a good indication of the health status of the general population.2;3
 Another requirement is that general practitioners record coded diagnoses in their 
EMRs. To estimate incidence rates, knowing whether diagnoses refer to a new or a con-
tinuing health problem is an additional prerequisite. Furthermore, all diagnoses need to 
be grouped into episodes to estimate the numerator of the morbidity rates. An episode 
of care includes “all encounters for the management of a specifi c health problem”.4 
Consider, for example, a patient who consults the general practitioner for a tension 
headache (diagnosis a), which, the next day, develops into migraine (diagnosis b). Most 
likely, both diagnoses refer to the same health problem which, when estimating morbidity 
rates, should be counted only once, namely as a case of migraine. To avoid double count-
ing, the two diagnoses need to be grouped in one episode of care named ‘migraine’.
 Diagnoses can be grouped into episodes, either directly by the general practitioner, or 
afterwards, through manual review or use of a computerized method. In an earlier 
study,5 we described the development of an application called EPICON, which can be 
used for the grouping of coded diagnoses from EMRs in general practice into episodes 
of care. EPICON renders it possible to estimate morbidity rates from EMRs in general 
practice without having to resort to expensive and time-consuming manual review.
 EPICON is based on a combination of logical expressions, a decision table, and infor-
mation extracted from manually grouped diagnoses by case-based reasoning. Previous 
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research on the process of grouping diagnoses shows that EPICON groups 95% of all 
diagnoses correctly.5 The present study focuses on how the grouped diagnoses translate 
into morbidity rates. In this study, we will examine if EPICON serves it purpose by com-
paring morbidity rates based on EPICON to a gold standard.
 The prevalence and incidence rates from the second Dutch National Survey of 
General Practice (DNSGP-2) are considered as the gold standard.6-8 In the DNSGP-2, 
diagnoses from 89 general practices were grouped afterwards into episodes by a semi-
computerized method. This method consists of a computerized component, in which 
diagnoses are grouped automatically, and a manual component, in which diagnoses are 
grouped by medical coders.
 The development of EPICON started with a simple, fully computerized method, called 
EPI-0. This variant is identical to the computerized component of the semi-computerized 
method, but instead of referring ‘diffi cult diagnoses’ to the manual component, it groups 
all remaining diagnoses automatically as separate episodes. EPICON groups these 
remaining diagnoses by case-based reasoning. In this process, EPICON imitates the 
manual grouping by retrieving and reusing information and knowledge from the 
DNSGP-2 dataset. For instance, EPICON solves the grouping problem in the example 
above by counting how often, in the DNSGP-2 dataset, manually grouped combinations 
of migraine and tension headache were placed together into one episode. The appendix 
provides a brief description of EPICON and EPI-0.
 The main aim of this study is to assess the internal validity of EPICON. Internal validation 
refers to the performance of a system in a sample used to develop the system. Internal 
validation is a requirement for external validation, which refers to the performance of a 
system in a new sample of patients.9
 In this study, we will address the following research questions:
1. What is the deviation from the gold standard for morbidity rates based on EPICON? 
In particular, what is the effect of case-based reasoning on the deviation from the 
gold standard?
2. What is the performance of EPICON among patients not included in the development 
of EPICON but from the same population?
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METHODS
Dataset
We used data from EMRs of practices associated with the Netherlands Information 
Network of General Practice (LINH).10-11 The general practitioners within this network 
assign diagnosis codes to consultations, prescriptions, and referrals. The diagnoses are 
coded according to the International Classifi cation of Primary Care (ICPC, fi rst edition).12 
This classifi cation system includes 685 different diagnosis codes, classifi ed into 17 chap-
ters each of which refers to a specifi c body system or problem area. Within each chapter, 
codes 1-29 refer to symptoms and complaints, and codes 70-99 refer to diseases.
 Each consultation diagnosis is characterized as either belonging to a new or an ongoing 
‘type of episode’. A new episode refers either to a newly presented health problem or 
to a recurrent health problem, while an ongoing episode describes a continuing health 
problem.
Representativeness
The 89 practices are representative of all Dutch general practices with respect to region 
of residence (i.e. the province in which the practice is located), dispensing status 
(i.e. whether the practice is permitted to dispense its own prescriptions), and degree of 
urbanization.13 Solo practices, however, are slightly underrepresented in this sample 
(53% versus 64%). The patient population comprises a representative sample of 2% of 
the Dutch population regarding age, gender, and type of medical insurance.14
Episode construction
Within the framework of the DNSGP-2, episodes were constructed afterwards for 89 
LINH practices for a period of one year (2001). Episodes were named after the last 
disease code within an episode. If no disease code existed, the episode was named 
after the last symptom code within an episode. In this study, we regrouped all diagnoses 
in these 89 practices into episodes using both EPI-0 and EPICON. Consequently, we 
had one dataset with three different episode constructions: 1) the existing DNSGP-2 
episodes (the gold standard), 2) the EPI-0 episodes, and 3) the EPICON episodes.5
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Split-sample
We used a split-sample approach to examine the performance of EPICON. This 
approach allows for overestimation, a well known statistical problem where a model is 
fi tted and evaluated using the same dataset.15 We randomly split the group of patients 
with diagnoses (n = 256 227) in half. We used half of the dataset (the training set, 
n = 128 113 patients) to construct the case bases used by EPICON to group diagnoses 
into episodes. We then used the other half of the dataset (the test set, n = 128 114 patients) 
to test EPICON, i.e., the diagnoses of these patients were grouped into episodes based 
on the split sample case bases. This split sample procedure adds a fourth episode 
construction.
 The obvious disadvantage of the split sample technique is its ineffi ciency, i.e., the 
training set only makes up half of the total dataset. To quantify this ineffi ciency, we 
made a fi fth episode construction, in which we applied the split sample case bases 
(based on the training set) to the training set. In this way, we could ‘separate’ the inter-
twining effects of overestimation and ineffi ciency in the testset. We would know that 
overestimation (and not ineffi ciency of the split sample approach) was a problem if the 
trainingset would show less deviation than the testset.
Prevalence and incidence rates
The prevalence rate is defi ned as the proportion of the population with a disease during 
the one-year study period. The incidence rate refers to the occurrence of new episodes 
of disease during the observed person-years at risk.
 We used the episode names that resulted from the fi ve episode constructions for the 
numerator of the morbidity rates. Eight practices did not record exactly 365 days, 
because of vacation, sick leave, etc. For that reason, the episodes were weighted for the 
number of days recorded (i.e. 365/number of days recorded). For the numerator of the 
prevalence rates, we counted, per episode name, the number of patients with at least 
one new or ongoing episode. For the numerator of the incidence rates, we counted, per 
episode name, the number of new episodes.
 The mid-year population (i.e., the average of the population at the beginning and the 
end of the one-year study period, n = 343 853) of the 89 general practices was used as 
the denominator. Half of the mid-year population was used to calculate the split-sample 
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morbidity rates. Morbidity rates of symptoms and diseases that occur only in the female 
(W, X) or the male chapters (Y) are based only on the female or the male mid-year 
population.
 A total of 677 different prevalence rates and 681 different incidence rates were cal-
culated for each of the fi ve episode constructions. Some of the 685 possible rates were 
excluded, because they do not refer to a symptom or disease (‘no disease’ (A97)), they 
refer to incident events only (‘perinatal mortality’ (A95), ‘death’ (A96), ‘(un)complicated 
labour/delivery of live/stillbirth (W90 -W93)), or no cases (‘trachoma’ (F86)) or no new 
cases occurred (‘neoplasm cardiovascular’ (K72), ‘syphilis female’ (X70)).
Comparison of morbidity rates
Figure 3.1 shows the design of the study. We calculated the differences between the 
rates based on EPI-0, EPICON, the test set or the training set on the one hand, and the 
gold standard on the other hand. We compared the deviation of rates based on EPI-0 to 
the deviation of rates based on EPICON to examine the effect of case-based reasoning. 
The comparison between the deviation in the testset to the deviation in the trainingset 
provides insight into the separate effects of overestimation and ineffi ciency.
EPI-0 method
2. EPI-0 
episodes
EPICON method
3. EPICON 
episodes
DNSGP-2 method
1. DNSGP-2 
episodes
DNSGP-2 
morbidity rates
EPICON 
morbidity rates
EPI-0 morbidity 
rates
DNSGP-2 
diagnoses (total 
dataset)
Testset 
(half of total 
dataset)
Trainingset 
(half of total 
dataset)
EPICON method 
based on 
trainingset
Trainingset 
morbidity rates
5. Trainingset 
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4. Testset 
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apply to
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Comparison shows 
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(+ inefficiency)
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Comparison reveals 
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the effect of case-based 
reasoning Fig. 3.1 Design of the study
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We distinguished between infrequently (rate < 1 per 1000 per year) and frequently (rate 
≥ 1 per 1000 per year) occurring symptoms and diseases (rates are based on the gold 
standard). This divided the large number of rates into two approximately equal parts. For 
infrequently occurring symptoms and diseases, we calculated the absolute differences 
between the morbidity rates (absolute deviation). For symptoms and diseases that 
occurred frequently, we calculated the percentage to which the rates differed from the 
gold standard (relative deviation).
RESULTS
 
Morbidity rates based on EPICON
Figures 3.2-3.5 show the morbidity rates based on EPICON in comparison to the gold 
standard. In general, these morbidity rates deviate slightly from the gold standard and 
show no systematic bias.
 Infrequent prevalence rates (fi gure 3.2) deviate from –0.04 (‘hypoglycemia’ (T87)) to 
0.06 (‘fear of other respiratory disease’ (R27)). An outlier is the diagnosis ‘investigation 
with abnormal results’ (A91)). The prevalence of this diagnosis is 0.94 per 1000 patients 
based on EPICON (read from the x-axis of fi gure 3.2) and 0.85 per 1000 patients 
according to the gold standard, which is a difference of 0.09 (read from the y-axis of fi gure 
3.2). EPICON probably failed to group this diagnosis correctly in a number of cases, be-
cause it is a very non-specifi c diagnosis that can be linked to many different diagnoses. 
Frequent prevalence rates (fi gure 3.3) deviate from -6% (‘vomiting/nausea of pregnancy’ 
(W05)) to 12% (‘abnormal unexplained blood test’ (B85)).
 The deviation for infrequent incidence rates (figure 3.4) ranges between –0.05 
(‘cervicitis/other cervical disease’ (X85)) and 0.07 (‘hypertension with involvement 
target organs‘ (K87)). Outliers are ‘generalized/unspecifi ed pain’ (A01), which is diffi -
cult to group because of its non-specifi city, and ‘osteoporosis’ (L95). EPICON grouped 
the latter incorrectly in a number of cases because ‘osteoporosis’ (L95) can be linked to 
many other diagnoses in the musculoskeletal chapter (L), and occurs mainly in elderly 
patients who have a great deal of comorbidity. The deviation for frequent incidence 
rates (fi gure 3.5) varies from –5% (‘acute myocard infarction’ (K75)) to 9% (‘asthma’ 
(R96)). 
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An exception is ‘emphysema/copd‘ (R95)). The incidence rate of this diagnosis based on 
EPICON is 17% higher than the gold standard (1.78 versus 1.52 per 1000 person-years). 
The reason for this difference could be that ‘emphysema/copd’ (R95) occurs frequently 
in elderly patients with concurrent diseases such as ‘decompensatio cordis’ (K77), 
‘pneumonia’ (R81), ‘chronic bronchitis/bronchietasis’ (R91), and ‘asthma’ (R96). The in-
tricate distinction between exacerbations (usually grouped within an ongoing episode) 
and complications (usually grouped as a separate episode) within this group of diseases 
may have caused variation in the manual (the gold standard) and subsequently also in 
the automatic grouping procedure (EPICON).
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The effect of case-based reasoning
The comparison between morbidity rates based on EPI-0 (fi gures 3.6-3.9) and morbidity 
rates based on EPICON (fi gures 3.2-3.5) reveals the effect of case-based reasoning. Mor-
bidity rates based on EPI-0 display a systematic bias, which manifests itself differently for 
prevalence and incidence rates.
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Prevalence rates based on EPI-0 (fi gures 3.6-3.7) show a systematic bias toward higher 
prevalence rates. EPI-0 produces obviously more episodes than the gold standard, 
which was to be expected since it processes all remaining diagnoses as separate 
episodes. For instance, EPI-0 always groups the remaining diagnosis ‘other complaints 
of urine’ (U07) as a separate episode, whereas medical coders, i.e., the gold standard, 
frequently grouped this diagnosis into an episode called ‘cystitis/other urinary infection’ 
(U71). The resulting prevalence rates for ‘other complaints of urine’ (U07) are 1.43 
per 1000 patients based on EPI-0 (492 patients/343853), and 1.02 per 1000 patients 
(350 patients/343853) according to the gold standard, which is a difference of 40% 
(fi gure 3.7). 
 Incidence rates based on EPI-0 (fi gures 3.8-3.9) show a systematic bias toward higher 
incidence rates for symptoms and complaints (codes 1-29), and lower incidence rates 
for diseases (codes 70-99). The total number of new episodes in EPI-0 is identical to the 
total number of new episodes in the gold standard; in both episode constructions, a 
new diagnosis is grouped as a separate episode. The episode name, however, can be 
different. For example, all new diagnoses ‘other complaints of urine’ (U07) were grouped 
as new episodes in EPI-0, whereas the gold standard grouped part of these diagnoses 
into new episodes of ‘cystitis/other urinary infection’ (U71).
 When case-based reasoning is added to the grouping system (EPICON), this systematic 
bias is removed and the precision of the estimates is improved.
Performance of EPICON in split sample procedure
Figures 3.10-3.13 show the results of the split sample method. Morbidity rates of the test 
set, that are based on the training set, show no systematic bias, but deviate more from 
the gold standard than the morbidity rates that are based on the full dataset. Figures of 
morbidity rates of the training set that are based on that same training set show a simi-
lar pattern (not shown). We therefore believe that a major part of the imprecision of our 
testset is due to ineffi ciency (for the training set is only half of the total dataset) and a 
minor part is due to overestimation.
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DISCUSSION AND CONCLUSIONS
Results from this evaluation study indicate that EPICON is a useful tool to disclose data 
from EMRs in general practice for estimating morbidity rates. In general, morbidity rates 
based on EPICON deviate only slightly from the gold standard and show no systematic 
bias. EPICON performs less well, however, when it comes to diagnoses that can be 
linked to many other diagnoses, such as ‘generalized/unspecifi ed pain’ (A01).
This judgement is related to the purpose of EPICON, which is to estimate morbidity 
Fig. 3.11 Deviati on from the gold standard for frequent 
test set prevalence rates
Fig. 3.13 Deviati on from the gold standard for frequent 
test set incidence rates
Fig. 3.12 Deviati on from the gold standard for infrequent 
test set incidence rates
Fig. 3.10 Deviati on from the gold standard for infrequent  
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rates in general practice. These rates are used at population level. For instance, to 
describe the extent of health problems, to forecast public health or to study health 
differences in time or between regions. Considering what morbidity rates are used for, 
some deviation from the gold standard, such as an increase from 13 to 14 per 1000 
patients per year, is regarded as acceptable. Our judgement might be completely different 
with another purpose in mind. For example, we would not recommend to use EPICON 
for a decision about the individual treatment of a patient.
 This study revealed that the role of case-based reasoning in EPICON is very important 
for acquiring precise and unbiased morbidity rates. We started with a simple, not case-
based method (EPI-0) to automatically group diagnoses into episodes. In the next step, 
we added case-based reasoning, which led to the creation of EPICON. The evaluation 
showed that the performance of the grouping system improved considerably by adding 
case-based reasoning. Furthermore, the results indicate that the current set of cases is 
large enough for the purpose of estimating morbidity rates. Nevertheless, the perfor-
mance of EPICON could be improved by increasing the number of cases, in particular 
by adding cases of patients with rare symptoms and diseases.
 A limitation of our study is that both EPICON and the evaluation are based on the 
assumption that the standard is gold. This assumption seems plausible since data from 
the DNSGP-2 are widely used in the Netherlands, but there is no evidence to support 
this assumption. However, an evaluation of the gold standard was not a focus of our 
project. Therefore, this study cannot reveal possible fl aws in the gold standard that were 
subsequently passed on to EPICON.
 An evaluation of the gold standard would include a comparison between morbidity 
rates from the DNSGP-2 and rates from other registries in general practice. Such a 
comparison is challenging, because the existing registries differ in factors as region of 
residence, patient population, classifi cation system used to code diagnoses, measures 
taken to ensure the quality of the registration, practice software, and in the methods 
used to calculate morbidity rates.3 More research is needed to quantify the impact of 
these factors on morbidity rates.
 Findings from the split sample procedure indicate that EPICON performs reasonably 
well on a simulated, independent dataset. Therefore, EPICON seems transportable to 
other similar datasets of diagnoses in general practice. The split sample procedure is a 
tough test, because only half of the total dataset is used to construct the case bases. Less 
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demanding tests16 would probably show that overestimation is only a limited issue in 
this case. 
 We conclude that the internal validity of EPICON is satisfactory. EPICON seems 
useful for LINH and similar registries in general practice for the purpose of estimating 
morbidity rates. Further research should aim at the external validation of EPICON.
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APPENDIX 
Figure 3.14 shows EPICON in the form of a fl owchart. EPICON consists of 5 steps 
(shown in between parentheses).
Next diagnosis
First diagnosis this year?
Type of episode?
Link by decision table?
More ungrouped diagnoses?
File episodes into 
database
Add episodes out of 
prescriptions and 
referrals (5)
Link at diagnosis level?
Link at episode level?
Link at chapter level?
Remaining diagnoses (4d)
Create 
separate 
episode
Create link
No
Ongoing
Unknown
Unknown
Unknown
No
Yes (1)
New (2) 
No (3)
No (4a)
No (4b)
Yes (3)
Yes (4a)
Yes (4b)
Unknown
Yes
All consultation diagnoses of a patient
No (4c)Yes (4c)
Fig. 3.14 EPICON
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Step 1. The fi rst consultation diagnosis of a patient in a one-year registration period is 
grouped as a separate episode (i.e. the diagnosis receives a separate episode number). 
Operationally, an episode is a row of diagnoses with the same episode number. The fi rst 
diagnosis of this row can be either new or ongoing, whereas subsequent diagnoses are 
always ongoing. The fi rst diagnosis in the row determines whether the episode is new or 
ongoing, the last disease diagnosis in the row determines the name of the episode. If no 
disease diagnosis exists, the episode is named after the last symptom diagnosis in the 
row.
 Step 2. The remaining diagnoses are grouped by ‘type of episode’ (new or ongoing). 
A new diagnosis is always grouped as a separate episode.
 Step 3. If possible, ongoing diagnoses are grouped by a decision table, which consists 
of a combination of an ongoing diagnosis and a previous diagnosis, and a decision 
whether or not they should be grouped together.
 Step 4. The remaining diagnoses are grouped by case-based reasoning, which is a 
problem-solving approach in the fi eld of artifi cial intelligence. A case-based reasoner 
solves a problem by remembering a previous similar situation and reuses information 
and knowledge from that situation. We used the manual grouping in the DNSGP-2 as a 
case library from which previous cases could be retrieved to solve the problem of group-
ing diagnoses. EPICON uses three kinds of cases, one at the level of diagnoses (4a), one 
at the level of episodes (4b), and one at the level of chapters (4c).
 In step 4a, an unsolved case is defi ned as: Should diagnosis X be linked to one of the 
other diagnoses of the same patient? A solved case is defi ned as a manually grouped 
diagnosis X that belongs to a patient who also has one of the other diagnoses. EPICON 
reuses these solved cases to group diagnosis X.
 In step 4b, EPICON uses the same procedure as in step 4a, but it uses a more coarse 
defi nition of cases in order to group any remaining diagnoses. Here, an unsolved case is 
defi ned as: Should diagnosis X be linked to one of the other episodes of the same patient?
 In step 4c, the grain size of cases is increased once more, to the level of chapters, to 
handle rare cases that cannot be grouped by any of the preceding steps. In this step, an 
unsolved case is described as whether diagnosis X should be linked to one of the chapters 
to which other diagnoses of the same patient belong.
 Diagnoses that cannot be grouped by any of the aforementioned steps are set aside in 
step 4d. EPICON continuously tries to group these remaining diagnoses, because it 
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might still be possible to group some of these diagnoses when more information from 
following diagnoses of the same patient becomes available. In the end, EPICON groups 
all remaining diagnoses as separate episodes.
 Step 5. Diagnoses from prescriptions and referrals (i.e., the indications for the pre-
scription or referral) do not pass through the foregoing steps, because they have no ‘type 
of episode’. Diagnoses from prescriptions and referrals that are different from any of the 
consultation diagnoses of a patient are added to the database as ongoing episodes.
 EPI-0 consists of the same steps, except for the case-based part (4a - 4c), which does 
not exist in EPI-0.
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ABSTRACT
Objective: To externally validate EPICON, a computerized sys-
tem for grouping diagnoses from EMRs in general practice into 
episodes of care. These episodes can be used for estimating 
morbidity rates.
Design: Comparative observational study.
Measurements: Morbidity rates from an independent dataset, 
based on episode-oriented EMRs, were used as the gold standard. 
The EMRs in this dataset contained diagnoses which were man-
ually grouped by GPs. The authors ungrouped these diagnoses 
and regrouped them automatically into episodes using EPICON. 
The authors then used these episodes to estimate morbidity rates 
that were compared to the gold standard. The differences 
between the two sets of morbidity rates were calculated and the 
authors analyzed large as well as structural differences to establish 
possible causes.
Results: In general, the morbidity rates based on EPICON deviate 
only slightly from the gold standard. Out of 675 diagnoses, 36 
(5%) were considered to be deviating diagnoses. The deviating 
diagnoses showed differences for two main reasons: “differences 
in rules between the two methods of episode construction” and 
“inadequate performance of EPICON.”
Conclusion: EPICON performs well for the large majority of the 
morbidity rates. We can therefore conclude that EPICON is useful 
for grouping episodes to estimate morbidity rates using EMRs 
from general practices. Morbidity rates of diseases with a broad 
range of symptoms should, however, be interpreted cautiously.
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INTRODUCTION
General Practitioners (GPs) increasingly use Electronic Med ical Records (EMRs) to 
record information regarding the treatment of patients. North Western Europe, especially 
Sweden, Denmark, and the Netherlands, has a leading position in the use of EMRs in 
general practice.1;2 Primarily used for patient care, EMRs can also be utilized for scientifi c 
research, particularly the estimation of prevalence and inci dence rates (i.e., morbidity 
rates) in general practice. Mor bidity rates in general practice may provide a good 
indication of the health status of the general population. This is especially true for coun-
tries where the main pathway to medical care runs through general practice. These rates 
are useful for monitoring health in the population as well as for developing and evalu-
ating health care policy. 
 In order to estimate morbidity rates, diagnoses recorded in EMRs in general practice 
need to be grouped into episodes of care. We developed EPIsode CONstructor (EPICON), 
a tool for the computerized grouping of diagnoses in general practice.3 The EPICON 
tool renders it possible to estimate morbidity rates automatically from EMRs in general 
prac tice. Results from a previous evaluation study indicate that the internal validity of 
EPICON is adequate.4 The present study is aimed at examining the external validity of 
EPICON through the use of an independent dataset.
Background
A diagnosis in general practice can refer to a symptom or a complaint (symptom diag-
nosis), a syndrome (nosological diagnosis), or a disease (pathological/pathophysiological 
diagnosis).5 In this article, we will use the umbrella term “diagnosis” to refer to any of 
these categories. In order to estimate the numerator of morbidity rates, the diagnoses 
recorded in EMRs need to be coded and grouped into episodes of care (all encounters 
for the management of a specifi c health problem),5 since double counting may occur if 
episodes are not grouped. For instance, if a patient visits the GP initially with abdominal 
pain, and during a second visit a few days later the pain appears to be based on appen-
dicitis, only the appendicitis should be counted in the morbidity rates. The abdominal 
pain has to be linked to the episode appendicitis.
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Generally, two approaches for constructing episodes can be distinguished. In one 
approach, diagnoses are recorded in contact-oriented EMRs. To be able to distinguish 
between incidence and prevalence, an indication is usually given whether a diagnosis 
represents the start of a new episode (new) or is part of an episode that started in the 
past (ongoing). In this approach, diagnoses are grouped into episodes afterwards, either 
through manual review or by using EPICON. In the second approach, diagnoses are 
directly recorded into episodes by the GP in episode-oriented EMRs.6 As far as we 
know, these episode-oriented EMRs are used routinely only in the Netherlands and in 
Malta.7 In this respect, the Netherlands is a leading country in the Western world. In the 
Netherlands, all GPs rely on EMRs. Most practices use contact-oriented EMRs, while 
some of them use the new generation of episode-oriented EMRs.
 We developed EPICON, a case-based application for group ing into episodes the 
diagnoses from contact-oriented EMRs. The EPICON application is based on a combi-
nation of logical expressions, a decision table, and former cases in which diagnoses 
from patients in general practice were grouped manually. These former cases were 
derived from 89 practices that participated in the second Dutch national survey of 
general practice (DNSGP-2).8;9 The development of this application has been described 
in detail elsewhere.3
 The evaluation of EPICON, which can be qualifi ed as a classifi cation system, falls 
within the fi eld of validating prognostic models. Different hierarchical levels of validation 
can be distinguished in evaluating prognostic models, start ing with the internal validation 
(i.e., the performance of a system in the sample used to develop the system) as level 0.10 
In a previous study, we used a split sample approach to examine the internal validity of 
EPICON.4 The dataset was split into two sets; one was used to develop EPICON and the 
other was used to test the developed system. Findings from the split-sample procedure 
showed that the internal validity of EPICON is adequate. Based on these results, EPICON 
has been brought into use to generate the yearly morbidity rates of practices with contact-
oriented EMRs of the Netherlands Information Network of General Practice (LINH).11;12
 The next levels of validation refer to the transportability of the system, i.e., whether 
the system has the ability to generate accurate results in a sample taken from a popula-
tion other than the one that was used to developed the system. In an independent vali-
dation, several components of transportability, including historical, geographic, and 
methodologic transportability, can be distinguished.10
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The goal of this study is to provide an independent valida tion of EPICON. We will use 
data from episode-oriented EMRs, in which GPs actually record diagnoses into episodes 
of care, as an independent dataset. Morbidity rates based on these GP-grouped 
episodes are considered the gold stan dard and will be compared to morbidity rates 
based on EPICON-grouped episodes. In this study, we will ad dress the following 
research questions: 1)What is the devi ation from the gold standard for morbidity rates 
that are based on EPICON-grouped episodes? 2)What are the causes of these deviations? 
METHODS
Dataset
We used data from six general practices that participate in a network of general practices 
in the northern part of the Netherlands (RNG) and that record all patient data using 
episode-oriented EMRs.13 We consider this dataset to be independent because the data 
from these practices were not used in the development of EPICON. We used data from 
2002 through 2005, although in the case of one practice, the data from 2005 were not 
available at the time of analysis. The dataset consists of a total number of 473,350 
diagnoses which were coded according to the International Classifi ca tion of Primary 
Care (ICPC, fi rst edition).14 The six practices participate in LINH, and this network 
requires that all practices record whether a consultation diagnosis is new or ongoing, a 
necessity to distinguish between incidence and prevalence. For the six included practices, 
this fi eld was derived from the GP-grouped episodes.*
Episode Constructions
The GPs manually recorded and grouped the diagnoses for all their patients into 
episodes at the moment of the consul tation. A second episode construction that 
regrouped the same diagnoses automatically was created by EPICON. It is possible for 
EPICON to group episodes differently from the GPs, which is called a misclassifi cation. 
There are three types of possible misclassifi cations: Link failure (type 1) occurs when a 
diagnosis, which is linked to another diagnosis by the GP, is not linked by EPICON. A 
* Operationally, an episode is a row of diagnoses that carry the same episode number. The first diagnosis of a new 
episode number was characterized as new; all other diagnoses were marked as ongoing.
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false link (type 2) originates when two diagnoses that were not linked by the GP are 
linked by EPICON. A wrong combination (type 3) occurs when both the GP and EPICON 
linked a diagnosis to another diagnosis, but the second diagnoses were different.3 
Misclassifi cations do not always cause differences in mor bidity rates; they can only 
cause differences when they change a suffi cient number of episode names (some 
misclas sifi cations do change the sequence of links within an epi sode, but ultimately do 
not change the episode name). 
Morbidity Rates
The next step in the study was to calculate two sets of prevalence and incidence 
rates: one set based on the GP-grouped episodes and the other set based on the 
EPICON -grouped episodes. The prevalence rate is defi ned as the proportion of the 
population with a particular disease during the period of one year, and the incidence 
rate refers to the occurrence of new episodes of a certain disease during the observed 
person-years at risk. 
 To establish the numerator of the prevalence rates, we counted, per episode name, 
the number of patients with at least one (new or ongoing) episode. When calculating 
the numerator of the incidence rates, we counted, per episode name, the number of 
new episodes. We used the mid-year population (i.e., the average of the population at 
the begin ning and the end of each year) as the denominator, which varied from 24,067 
in 2005 to 32,053 in 2003. Morbidity rates of diagnoses that occur only in the female 
(W, X) or male chapters (Y) are based only on the female or the male mid-year 
population. In total, we calculated morbidity rates for 675 different diagnoses.
 Next, we compared the morbidity rates based on EPICON with the gold standard. In 
order to make this comparison, we distinguished between infrequent rates (less than 
one per 1000 patients per year according to the gold standard) and frequent rates (at 
least one per 1000 patients per year according to the gold standard), which divided the 
large number of rates into two approximately equal parts. The absolute differences were 
calculated for infrequent rates (absolute deviation), the relative differences, i.e., the 
per centages, for frequent rates (relative deviation).
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Selection
We used the calculated differences to select a number of deviating diagnoses for further 
qualitative analysis. The criteria for selecting deviating diagnoses are based on sole 
outliers or structural differences:
•  Criteria for deviating infrequent diagnoses:
  a. Absolute difference in at least one year < -0.2 or > 0.2 (sole outliers); or
  b. Absolute difference in all four years < -0.05 or > 0.05 (structural differences).
•  Criteria for deviating frequent diagnoses:
  a. Relative difference in at least one year < -15% or > 15% (sole outliers); or
  b. Relative difference in all four years < -5% or > 5% (structural differences).
Qualitative Analysis
To clarify the causes of the observed differences, we con ducted a qualitative analysis of 
these deviating diagnoses. The analysis included a detailed examination of both the 
documented grouping rules used by the GPs and the group ing methods used by EPICON 
(i.e., the algorithm, the decision table, and the cases). In addition, we interviewed one 
of the GPs and the coordinator of the registration network. 
RESULTS
Morbidity Rates
Figure 4.1 shows the 2002 morbidity rates based on EPICON compared with the gold 
standard. Each scatter plot shows some hundreds of morbidity rates, named according 
to the ICPC.14 (Because of the large number of rates, the plots show only part of all code 
names). For example, the prevalence of “other cardiovascular symptoms/com plaints” (K29) 
in Figure 4.1a is 0.45 per 1000 patients per year in the gold standard (shown at the 
x-axis). The prevalence based on EPICON is 0.62 per 1000 patients per year which is a 
difference of 0.17 with the gold standard (shown at the y-axis).
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• A morbidity rate, per 1000 pati ents per year, with corresponding code name from the 
 Internati onal Classifi cati on of Primary Care14
- - Limit for sole outliers (a morbidity rate beyond this line is considered as deviati ng)
Fig. 4.1 Deviati on of morbidity rates (based on EPICON-grouped episodes) from the gold standard 
   (i.e., morbidity rates based on GP-grouped episodes), 2002.
Fig. 4.1.a Deviati on from the gold standard for 
infrequent prevalence rates.
Fig. 4.1.c Deviati on from the gold standard for 
infrequent incidence rates.
Fig. 4.1.b Deviati on from the gold standard for 
frequent prevalence rates.
Fig. 4.1.d Deviati on from the gold standard for 
frequent incidence rates.
71
External validation of EPICON
Figures 4.2-4.5 (Appendix) show the results for the morbidity rates of 2003 through 
2005. The fi gures show a similar pattern in each category. In general, the infrequent 
morbidity rates based on EPICON (fi gures 4.1a, 4.1c, 4.2, and 4.4) deviate only slightly 
from the gold standard; the deviation of most rates is either 0 or close to 0. There are 
just a few deviating diagnoses, i.e., sole outliers (rates beyond the dotted lines) or 
structural differences (not clearly visible in the fi gures, but listed in the last column of 
Table 4.1). Although the frequent morbidity rates (Figures 4.1b, 4.1d, 4.3, and 4.5) show 
more deviating diagnoses, with most of them occurring among the frequent incident 
rates (Figures 4.1d and 4.5), the large majority of the frequent morbidity rates deviates 
not at all or just a few percent. With the exception of the diagnoses that comply with 
the selection criteria, there is no systematic bias, because the rates are proportionally 
distrib uted above and below the x-axis.
 Out of all 675 analyzed diagnoses, 36 diagnoses (5%) were deviant. Five of these 
diagnoses were not further scrutinized because they included fewer than fi ve mis-
classifi cations in a three year period; i.e., “haematemesis/vomiting blood” (D14), “fear 
of pregnancy” (W02), “unwanted pregnancy” (W79), “benign neoplasm female genital” 
(X80), and “genital herpes female” (X90). The remaining 31 diagnoses were analyzed in 
detail.
Causes of Deviations
Table 4.1 shows all deviating diagnoses. Similar diagnoses that deviate for the same 
reason are grouped together into one category. We found two main causes for devia-
tions: differences in rules for grouping, and inadequate perfor mance of EPICON.
Diﬀ erences in Rules
Differences in the rules for grouping used by GPs and EPICON was the reason for the 
deviations found in the categories “diagnoses related to death,” “diagnoses related to 
pregnancy,” and some of the “unrelated diagnoses” (i.e., “elevated blood pressure” (K85), 
“hypertension compli cated” (K87), and “chronic obstructive pulmonary disease” (R95)).
 For instance, when looking at the incidence rates of “death” (A96) and “pregnancy” 
(W78), it becomes clear that the rates based on EPICON are higher than the gold 
standard, whereas the incidences of some causes of death (cardiovas cular diseases and 
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In all 
4 years
I>5%
I>5%
I<0.05
I<-5%
I<-5%
I<-5%
I<-0.05
I<-0.05
I<-0.05
I<-0.05
PI>5% 
I<-5%
I<-5%
I<-5%
I<-0.05
P>5%
I>5%
P>5%
P>5%
I>5%
I>5%
I>5%
I<-5%
I<-0.05
P<5%
I>5%
I<-0.05
 Deviati ng diagnoses (ICPC)
Diagnoses related to death
   Euthanasia request/discussion (A20)
   Death (A96)
   Suicide/suicide att empt (P77)
   Cardiovascular diseases
      Acute myocardial infarcti on (K75)
      Heart failure (K77)
      Stroke/cerebrovascular accident (K90)
   Neoplasms
      Malignant neoplasm colon/rectum (D75)
      Malignant neoplasm digesti ve other (D77)
      Malignant neoplasm bronchus/lung (R84)
      Malignant neoplasm breast female (X76)
      Malignant neoplasm prostate (Y77)
Diagnoses related to pregnancy
   Pregnancy (W78)
   End points of pregnancy
      Aborti on spontaneous (W82)
      Aborti on induced (W83)
      Uncomplicated labour/delivery livebirth (W90)
      Complicated labour/delivery livebirth (W92)
Adverse eﬀ ects
   Adverse eﬀ ect medical agent (A85)
   Possible symptoms
      Sweati ng problem (A09)
      Nausea (D09)
      Rash generalized (S07)
General diagnoses
   General deteriorati on (A05)
   General symptom/complaint other (A29)
   Complicati on of medical treatment (A87)
   Disease digesti ve system, other (D99)
   Other arterial obstructi on/PVD (K92)
   Cardiovascular disease other (K99)
Unrelated diagnoses
   Elevated blood pressure (K85)
   Hypertension complicated (K87)
   Epilepsy (N88)
   Chronic obstructi ve pulmonary disease (R95)
   Syphilis male (Y70)
2002
I>15%
I<-15%
I<-15%
I<-0.2
I<-0.2
I<-15%
I<-15%
I<-15%
P>15%
P>15%
I>15%
I<-15%
I>15%
2003
I>15%
I<-15%
I<-15%
I<-15%
I<-15%
I<-15%
I<-15%
P>15%
P>15%
I>15%
I<-15%
I>15%
I>0.2
2004
I>15%
I>15%
I<-15%
I<-15%
I<-0.2
I<-0.2
I<-15%
I<-15%
I<-15%
P>15%
I>15%
I<-15%
2005
I>0.2
I>15%
I<-15%
I<-15%
I<-0.2
PI>15%
I<-15%
I<-0.2
I<-15%
I<-0.2
P>15%
I>15%
Selecti on criteria*
Sole outliers
Table 4.1 Deviati ng diagnoses per category
* P=Prevalence, I = Incidence
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neoplasms) and end points of pregnancy are lower than the gold standard. This difference 
can be attributed to the fact that GPs use the rule that “death” (A96) or “pregnancy” 
(W78) should be linked to the cause of death or the end point, whereas EPICON uses 
the opposite rule, classifying “death” (A96) or “pregnancy” (W78) as a separate, new 
episode.
 The main cause for differences in the morbidity rates of “adverse effect medical agent” 
(A85) is a difference in the rule for naming the episodes. The EPICON rule is that the last 
disease code (ICPC codes 70–99) in time is used as the episode name for that episode. 
When there is no disease code in the episode, the last symptom code (ICPC codes 1–29) 
is used as the episode name. GPs can choose every diagnosis as the episode name.
 Furthermore, the interviews revealed that there are differ ences in handling the rules. 
The GPs, who group manually, vary in their use of the grouping rules, whereas EPICON 
groups automatically, and consequently, EPICON has no inter-doctor variation.
Inadequate Performance of EPICON
Differences in the category “general diagnoses,” “possible symptoms of adverse effects,” 
and some of the “unrelated diagnoses” (i.e., “epilepsy” (N88) and “syphilis male” (Y70)) 
are mainly due to problems in EPICON’s performance. In some cases, EPICON displays 
linking problems, for in stance, EPICON frequently failed to link possible symptoms of 
adverse effects, such as “nausea” (D09) to “adverse effect medical agent” (A85). In other 
cases, EPICON both displays link failures and creates false links. The main reason for 
this problem is that many different diagnoses can be linked to unspecifi ed and general 
diagnoses. Moreover, the inter views showed that within the category of “general 
diag noses,” a large inter-doctor variation exists in recording diagnoses as they are 
drawn from a reservoir of unknown or infrequently occurring diagnoses.
DISCUSSION
In this study, we examined the external validity of EPICON, a system for grouping 
diagnoses into episodes whose pur pose is to estimate morbidity rates in general 
practice. We used an independent dataset derived from GPs who record diagnoses 
using episode-oriented EMRs. Morbidity rates based on the GP-grouped episodes 
were considered the gold standard and compared to morbidity rates based on 
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EPICON-grouped episodes. The results indicate that EPICON performs well for the large 
majority of diagnoses.
 Only 5% (n = 36) of all analyzed diagnoses (n = 675) shows a substantial deviation in 
at least one year or a structural small deviation over four years. We found more deviations 
in rates for frequent than for infrequent diagnoses, because differences in episode 
construction have more effect on frequent than on infrequent rates. Except for these 
deviating diagnoses, we did not observe any systematic bias.
 An explanation for part of these deviating diagnoses is a difference in grouping rules. 
Some of the rules used by EPICON for grouping diagnoses differ from those utilized by 
GPs. For instance, the GPs linked “death” (A96) to the cause of death, whereas EPICON 
is based upon a dataset in which it was decided to link “death” not to the cause of 
death. Both decisions have their advantages and disadvan tages and it is not possible to 
claim that one rule is more valid than the other. In addition, we found differences in 
handling the rules and in naming the episodes.
 Other deviating diagnoses are explained by inadequate performance of EPICON. This 
accounts, in particular, for deviations in unspecifi ed and general diagnoses since many 
symptoms can be grouped within these diagnoses. The EPICON application is based on 
the probability that the ca ses in the training set were grouped. It does not use the same 
information in the grouping process as the GP does, such as age, gender, and the duration 
of the disease, which may cause misclassifi cations. Furthermore, it is possible that some 
cases did not occur in the training set. In all likelihood, however, EPICON will not be 
used for these unspecifi ed and general diagnoses, because they are considered less 
impor tant for epidemiological research. Should EPICON be used for these diagnoses, 
the resulting morbidity rates should be interpreted with caution. The EPICON application 
might be adjusted for these insuffi ciencies by: a) adding cases, and b) including variables 
such as gender, age, and duration of the disease into EPICON.
 The strength of this study is that we used an independent dataset to examine the 
external validity of a prognostic model. There is not much research describing an external 
validation of a prognostic system.15 Another strength is that we performed a quantitative 
as well as a qualitative analysis, providing insight into both the number of deviating 
rates and the main causes of these deviations.
 A limitation of this study is that the criteria for defi ning deviating diagnoses are to 
some extent arbitrary, so should the criteria be altered, we will fi nd less or more deviating 
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codes. In addition, our judgement that the large majority of the morbidity rates deviates 
only slightly, is also subjective, although with the fi gures we provided, it is possible to 
judge deviations for oneself. Furthermore, our conclusions about the external validity of 
EPICON are based upon one test that was carried out in one setting.
 This one test does provide some insight into the histori cal, geographical, and method-
ological transportability of EPICON. Regarding the historical transportability, EPICON 
was originally developed using data from 2001, and in this study, was applied to data 
from 2002 through 2005. The historical transportability of EPICON seems adequate as 
we did not observe any problem in the application to another time period. In the long 
run, however, changing medical insights that affect grouping rules may reduce the 
historical transportability.
 Regarding the geographical transportability, EPICON is based on data from a nationally 
representative patient population, derived from 89 general practices throughout the 
Netherlands.3 The six practices that were used for the external validation are located in 
the Northern part of the Netherlands. The patient population of these six practices is 
quite similar to the nationally representative population and we encountered no differ-
ences in episode-construction that could be attributed to the difference in geographical 
loca tion. This cautiously indicates that EPICON is transportable to similar datasets in 
other regions or countries. We need more evidence, however, before we can draw any 
fi rm conclusions. If EPICON is applied to data from another geographical area, this 
ungrouped dataset should be com pared fi rst to the dataset upon which EPICON is 
based. For instance, the similarity of the age and gender distributions of both populations, 
and the frequencies of ungrouped diag noses could be examined. The EPICON application 
should not be used if this comparison reveals large differences, such as many diagnoses 
of diseases that do not occur in the Netherlands.
 Additionally, this study provides some insight into method ological transportability, 
because two different methods of collecting data were used. In this study we applied 
EPICON to data from episode-oriented EMRs whereas it was origi nally developed using 
data from contact-oriented EMRs. The EPICON tool is thus applicable to both contact-
oriented and episode-oriented EMRs. A possible application for EPICON in episode-
oriented EMRs is to discover differences in (handling) the rules used by different GPs. 
However, a limitation of the application of EPICON to contact-oriented EMRs is that the 
characterization of a diagnosis as either “new” or “ongoing” might be lacking. Although 
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this fi eld can be easily added to an existing EMR system, this solution does require 
extra recording for the GP. 
 These results regarding the generalizibility of EPICON need to be con fi rmed in cumu-
lative tests across diverse settings. Further more, an important topic for future research is 
the extent to which differences in (the design of) EMRs affect the morbid ity rates derived 
from these EMRs.
CONCLUSION
This study shows that the external validity of EPICON is suffi cient for the purpose of 
estimating morbidity rates in general practice. Only a limited number of diagnoses (5%) 
deviates from the gold standard. There are two main causes for these deviations: 
inadequate performance of EPICON, and differences in rules. The latter cause seems 
particularly to apply to deviations in diagnoses related to death and pregnancy. The 
EPICON application performs less well when it comes to unspecifi ed and general 
diagnoses, and hence caution is required when EPICON is used for these rates.
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Fig. 4.2 Deviati on from the gold standard 
   for infrequent prevalence rates.
Fig. 4.3 Deviati on from the gold standard 
   for frequent prevalence rates.
Fig. 4.4 Deviati on from the gold standard 
   for infrequent incidence rates.
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Fig. 4.5 Deviati on from the gold standard 
   for frequent incidence rates.
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ABSTRACT
Background: This study aimed to detect striking trends based 
on a new strategy for monitoring public health.
Methods: We used data over four years from electronic 
medical records of a large, nationally representative network 
of general practices. Episodes were either directly recorded 
by general practitioners or were constructed using a new 
record linkage method (EPICON). The episodes were used to 
estimate raw morbidity rates for all codes of the International 
Classifi cation of Primary Care. Multilevel Poisson regression 
models were used to analyse the trend over time for 15 
health problems that showed an obvious change over time. 
Based on these models, we calculated adjusted incidence 
rates corrected for clustering, sex, and age.
Results: During 2002-05, both men and women increasingly 
consulted the general practitioner because of concern about 
a drug reaction, a change in faeces/bowel movements, and 
urination problems. Men showed an increase in consultations 
for prostate problems and venereal diseases. The incidence 
of chronic internal knee derangement decreased for both 
sexes. Women consulted their general practitioner less 
frequently about sterilization and fear of being pregnant.
Conclusion: The strategy developed proved to be useful to 
detect trends across a short period of time. Changes in the 
health care market, such as the increasing availability of 
over-the-counter drugs and various large advertising cam-
paigns for medications may explain some of the fi ndings. 
The increasing incidence of health problems in the urogeni-
tal area deserves attention as it could refl ect increases in the 
incidence of sexually transmitted diseases and urinary tract 
infections.
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INTRODUCTION
Morbidity trends in general practice provide important information for public health 
agencies, because they refl ect, to some extent, morbidity trends in the general population. 
In particular, this holds for countries that use a gatekeeping system, because these systems 
utilize general practices as the main pathway to medical care. In countries where patients 
have free access to specialist care, trends in general practice could still provide an indi-
cation of morbidity changes in the population, although there is a higher chance of 
morbidity ‘leaking’ to other health care providers.
 Electronic medical records (EMRs) in general practice can be a valuable source for 
estimating these trends, because they can provide the large and longitudinal datasets 
that are needed to observe morbidity over time. In the past, this routine data has been 
widely used to estimate morbidity trends of specifi c diseases. However, using this data 
to signal striking and unusual changes in a large range of health problems, is only just 
emerging.1 This can probably be attributed to the complexity of this type of research, 
which has various requirements.
  For starters, it calls for a suffi ciently large registration network of general practitioners 
(GPs) who accurately code diagnoses of their patients using a coding system. Next, 
morbidity rates (i.e. incidence and prevalence rates) over specifi c time periods have to 
be computed. In order to estimate the numerators of these rates, contact diagnoses have 
to be grouped into episodes of care. An episode of care includes “all encounters for the 
management of a specifi c health problem”.2 An episode could be either one diagnosis 
or a sequence of diagnoses that refl ects the course of a disease over time. To be able to 
distinguish between incidence and prevalence, we also need an indication whether the 
presented health problem represents the start of a new episode or is part of an episode 
that started in the past.
 Generally, two approaches for constructing episodes can be distinguished. The fi rst 
approach involves the use of episode-oriented EMRs. In this new generation of EMRs, the 
GP records diagnoses directly into episodes.3 In the second approach, diagnoses from 
contact-oriented EMRs are grouped afterwards, through manual review or use of a com-
puterised method. In a previous paper, we presented EPICON, an application for automat-
ically grouping diagnoses from contact-oriented EMRs into episodes of care. Both the 
development and the evaluation of EPICON have been described in detail elsewhere.4-6
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In addition, the size of the population at risk in the denominator has to be determined. 
In countries where every patient is registered with a GP (so called list system), the 
denominator can easily be determined, while more complicated approaches are avail-
able for countries without a list system.7 Finally, a method has to be developed to 
detect trends in morbidity rates over time that takes into account that count data are 
used which are clustered within patients and within practices.
 In this study, we developed a strategy that met all these requirements, and involved 
the application of EPICON to yearly data from a very large, nationally representative 
computerised network of Dutch general practices,8;9 and the use of multilevel poisson 
regression models. The Netherlands has favourable conditions for monitoring public 
health based on data from EMRs in general practice, because it utilises both a gatekeep-
ing and a list system. The aim of our research is to detect striking trends in the incidence 
of health problems in the Netherlands during 2002-2005.
METHODS
Dataset
We used data from practices participating in the Netherlands Information Network of 
General Practice (LINH).8;9 This network consists of a large and dynamic pool of prac-
tices, which differs from year to year as some practices leave the network and others 
join up. The GPs within this network assign codes from the International Classifi cation 
of Primary Care (ICPC) to consultations, prescriptions, and referrals.10 Medical informa-
tion about out of hours care is transferred to the GPs’ offi ces, coded, and included in 
the database as well. The majority of the practices uses contact-oriented EMRs and a 
minority uses episode-oriented EMRs. In a previous study, we compared morbidity rates 
between EPICON-grouped and GP-grouped diagnoses. The results of that study indicate 
that morbidity rates based on EPICON-grouped diagnoses from contact-oriented EMRs 
can be used in conjunction with morbidity rates based on GP-grouped diagnoses from 
episode-oriented EMRs provided that the same grouping rules are used.6 The present 
study includes only health problems (15 in total) for which the rules used by EPICON 
for grouping diagnoses in the contact-oriented EMRs are similar to those utilised by the 
GPs in the episode-oriented EMRs.
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In this study, we included data from 2002 (the fi rst year in which EPICON could be 
applied) through 2005 (the last year for which data were available at the time of analyses). 
The total number of LINH-practices was 83 in 2002, 80 in 2003, 61 in 2004 and 71 in 
2005, but only practices were included that met certain criteria for accuracy and com-
pleteness. This resulted in the following number of practices in the analyses: 69 in 
2002, 66 in 2003, 43 in 2004, and 42 in 2005 (220 practice-years in total).
 The included practices are representative of all Dutch practices in terms of urbanisation 
level and practice type (i.e. solo or group practice), but practices in the northern part of 
the country are slightly overrepresented at the expense of practices in the western 
part.11 For each year, the total patient population of these practices provides a represen-
tative sample of at least 1% of the Dutch population regarding age and gender.12
Raw morbidity rates
Several steps were taken to compute raw morbidity rates. For contact-oriented practices, 
episodes were constructed using EPICON. For episode-oriented practices, (6 in 2002, 
6 in 2003, 6 in 2004, and 5 in 2005), we used the episodes that were recorded by the 
GP. The episodes were weighted for the length of recording of a practice within one 
year, to account for vacation, sick leave, etc. (198 of the 220 included practice-years 
covered a complete year and 22 covered slightly less than a year).
 Next, we estimated the yearly morbidity rates. For the numerators, we counted, 
per episode name, the number of patients with at least one episode (prevalence) and 
the number of new episodes (incidence). For the denominators, we used the mid-year 
population (i.e. the average of the population at the beginning and the end of a year). 
The total mid-year population varied from 174138.5 in 2005 to 296716.0 in 2002.
 We then computed raw incidence rates for the total population, for men and women 
separately, and for various age groups (0, 1-4, 5-14, 15-24, 25-44, 45-64, 65-74, 75+). 
These raw morbidity rates are comparable to the rates in the second Dutch National 
Study of General Practice.13;14 
 Out of the raw incidence rates for all ICPC codes (N=683), we selected 15 health 
problems that showed an obvious increase or decrease over time for further investigation.
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Crude and adjusted incidence rates
We used multilevel Poisson regression models to analyse the trend over time for the
 selected health problems.15;16 Because of the large number of dependent variables 
(15), we developed general models that could be applied to each outcome. For all models, 
the dependent variable is the number of new episodes of a health problem in a year for 
one patient.
 These multilevel analyses were used, because the data is clustered within levels: 
repeated observations of a health problem are clustered within patients (level one) who 
are clustered within general practices (level two). We modelled (i.e., corrected for) the 
variance due to clustering within levels in the random part of all models. The fi xed part 
of all models includes the four years which is necessary to test for a trend over time. For 
the total population, we used a crude and an adjusted model. The crude model, which 
corrects just for clustering, includes only the four years. The adjusted model includes 
the four years controlling for sex and age.
 For each health problem, we stratifi ed by sex, and used the adjusted model (without 
controlling for sex) to test for a linear trend over time. The adjusted model was also used 
for the total population to test whether the age effect differed between two years. Statis-
tical signifi cance was set at p<0.05. 
 Based upon the crude and the adjusted model, we calculated incidence rates for the 
total population and for men and women separately.
RESULTS
Looking at the raw incidence rates, eight health problems increased and seven health 
problems decreased considerably over the 2002-2005 period. Table 5.1 shows the 
results of the analyses over time. Nine of the 15 selected health problems show a 
signifi cant increase (6) or decrease (3) over time.
a: Internati onal Classifi cati on of Primary Care
* Stati sti cally signifi cant at p < 0.05
Males
0.0008*
0.0015*
0.1797
0.0261*
0.0004*
n/a
0.0003*
0.0001*
0.1821
0.0028*
0.1738
0.0719
0.6315
n/a
n/a
Females
0.0039*
0.0010*
0.1049
0.0013*
0.0005*
0.1573
n/a
n/a
0.1229
0.0547
0.3482
0.4237
0.4708
0.0113*
0.0000*
Table 5.1 Results of tests for a linear trend over ti me 2002-2005 (p-values)
Health problems (ICPC code)a
Increasing based on raw incidence rates
Concern about drug reacti on (A13)
Change in faeces/bowel movements (D18)
Hypertension with involvement target organs (K87)
Frequent/urgent urinati on (U02)
Other urinati on problems (U05)
Family planning/other (W14)
Symptoms/complaints prostate (Y06)
Fear of venereal disease (Y25)
Decreasing based on raw incidence rates
Sprains & strains of other joints (L79)
Chronic internal knee derangement (L97)
Other head injury without skull fracture (N80)
Hypertrophy/chronic infecti on tonsils/adenoids (R90)
Diaper rash (S89)
Fear of being pregnant (W02)
Family planning/sterilizati on (W13)
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Concern about drug reacti on 
(A13)
Hypertrophy/chronic infecti on 
tonsils/adenoids (R90)
Fear of being pregnant 
(W02)
Fear of veneral disease 
(Y25)
Change in feces/bowel 
movements (D18)
Frequent/urgent urinati on 
(U02)
Family planning/sterilizati on 
(W13)
Other urinati on problems 
(U05)
Chronic internal knee 
derangement (L97)
Symptoms/complaints prostate
(Y06)
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Figure 5.1 shows the adjusted incidence rates for all signifi cantly changing health 
problems and for ‘hypertrophy/chronic infection tonsils/adenoids (R90)’.
Fig. 5.1 Incidence rates per 1000 per year, the Netherlands, 2002-
2005. All rates are corrected for clustering and age (adjusted model). 
Rates for men or women only (W02, W13, Y06, Y25) are compared to 
raw rates, and to rates corrected for clustering only (crude model).
93
Striking trends
‘Concern about drug reaction (A13)’ is a common problem in general practice, especially 
among women and the elderly. Within the ICPC coding system, the symptom-diagnosis 
‘concern about drug reaction (A13)’ is distinguished from the disease-diagnosis 
‘adverse effect medical agent proper dose (A85)’. Both men and women increasingly 
consulted the GP because of concern about a reaction to drugs, especially in 2005. The 
increase occurs mainly among patients of 45 years of age and older, which results in a 
highly signifi cant change of the effect of age over time (p = 0.0000).
 GPs use the uncommon diagnosis ‘change in faeces/bowel movements (D18)’ for a 
change in the pattern of defecation. Separate ICPC-codes exist for ‘diarrhoea (D11)’ and 
‘constipation (D12)’. In particular, infants and elderly patients are bothered by changes 
in faeces/bowel movements. The increase, however, did not occur among the youngest 
and oldest, but among people in the age range of 15 through 74.
 ‘Chronic internal knee derangement (L97)’ starts to occur at the age of fi ve and is a 
frequent problem in the age group of 15 through 64. Chronic internal knee derangement 
decreased for men and women in the examined time period. The effect of age over time 
changed signifi cantly (p = 0.0002) for this health problem due to a remarkable decrease 
among young people (15 through 24 years of age).
 ‘Hypertrophy/chronic infection tonsils/adenoids (R90)’ shows borderline signifi cance 
for men, but not for women. This health problem, which occurs mainly in infants and 
children, decreased especially in male infants and young boys (the raw incidence 
decreased from 18.5 to 1.6 for male infants and from 27.0 to 21.1 per 1000 per year for 
boys from one through four years of age). For female infants and young girls, the trend 
also decreases, but it fl uctuates more over time.
 ‘Frequent/urgent (U02) and other urination problems (U05)’ are common problems 
among the elderly. ‘Other urination problems (U05)’ refers to problems other than ‘painful 
urination (U01)’ and ‘incontinence (U04)’ for which separate ICPC-codes exist. Frequent, 
urgent, and other urination problems show an increase in various age groups, but in 
particular in people aged 75 and over. 
 Women who consult the GP for ‘fear of being pregnant (W02)’ are usually between 
15 and 44 years of age. In the 2002-2005 period, the number of consultations for fear 
of pregnancy decreased, especially among young women (15 through 24 years of age).
 Consultations for ‘family planning/sterilization (W13)’ among women start at the age 
of 20, increase until the age of 40, and then decline to zero at 50 years of age. Starting 
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in the year 2003, women decreasingly consulted their GP about sterilization, a decline 
which occurred especially among women in their thirties.
 We found a considerable increase for ‘symptoms/complaints prostate (Y06)’, a health 
problem which commences among men at the age of 25 and is a common problem 
among elderly males. Prostate symptoms/complaints increased for both middle-aged 
and older men.
 Starting at age 15, young men frequently consult their GP about ‘fear of venereal disease 
(Y25)’. These consultations peak among men in their twenties, and then decline slowly 
to zero among the elderly. This health problem shows a considerable increase among 
men between 15 and 44 years of age.
 To illustrate the effect of clustering on the incidence rates, we added both the raw 
rates (no corrections) and the crude rates (corrected for clustering only), to four health 
problems in fi gure 5.1. The differences between the raw rates and the crude rates clearly 
show that clustering may have considerable impact on incidence rates in general practice. 
The crude rates are generally lower than the raw rates, because part of the variance of 
the raw incidence is attributable to the fact that these data are clustered within patients 
and within practices. The adjusted rates (corrected for clustering and age) are usually 
higher than the crude rates because they show the incidence of a patient with a mean 
age (i.e. the age variables were centered).
DISCUSSION
In this study, we monitored trends in the incidence of health problems in general practice 
through the application of a new method for record linkage and the use of multilevel 
Poisson regression models for analysing trends in clustered data. The results show that 
the incidence of nine health problems changed signifi cantly over the 2002-2005 period 
in the Netherlands.
Dataset
Our results are based on data obtained from a large network of computerised general 
practices in the Netherlands, a dataset which has several advantages. First, the patient 
population of the included practices forms a representative sample of the Dutch 
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population regarding age and gender. Second, the health of this patient population 
refl ects the health status of the general population because the Netherlands uses a gate 
keeping system. Third, the dataset is large enough to fi nd trends across time, and fi nally, 
the use of routine data is effi cient and reduces the risk of information bias.
 A limitation of the dataset is that some practices had to be excluded from the analyses 
because their record keeping was not suffi ciently, which resulted in a considerable loss 
of practices for 2004 and 2005. Furthermore, the selected practices record not always 
100% completely, which could mean that the calculated rates underestimate the true 
rates to a limited extent. Recently, the network developed an application to improve the 
quality of recording. The application uses a number of indicators to measure the quality 
of recording of a practice. These measurements are used to provide the practice with 
automatic feedback on its quality of recording.
METHODS
We used EPICON, a new application to disclose data from EMRs in general practice for 
estimating morbidity rates. EPICON constructs episodes from ICPC-codes, which can 
be used to estimate the numerator of morbidity rates. Results from studies assessing the 
internal and external validity show that EPICON performs adequate for the purpose of 
estimating morbidity rates.5;6 
 In our analyses, we correct for clustering of observations within patients and within 
practices through the use of multilevel Poisson regression models. The results show that 
this clustering may have considerable impact on the incidence rates. It is therefore ad-
visable to correct incidence rates for clustering when data is clustered within levels, for 
instance in incidence rates based on samples stratifi ed by general practice, hospital, or 
neighborhood.
Interpretation of findings
To interpret the fi ndings, the full range of factors that could affect the registration of 
patient data in EMRs in general practice has to be taken into account. In box 5.1, we 
distinguish between four categories of possible causes of changing incidence rates. The 
fi rst category falls within the domain of medical informatics, which comprises aspects 
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of the validity of using EMRs in general practice for the purpose of estimating morbidity 
rates. In the previous paragraphs, we discussed our fi ndings from this perspective. The 
second and third categories are related to the area of health policy; the fourth category 
is the area of epidemiologic research. Before considering a real change in the incidence 
of disease, possible causes that fall into the fi rst three categories should be excluded.
Box 5.1 Possible causes of changing incidence rates
Category 1: Changes in recording as a result of
a)  change in GPs’ perspecti ve of disease;
b) change in rules for coding diagnoses;
c)  change in rules for grouping diagnoses into episodes;
d) change in quality of recording;
e) change in general practi ce soft ware;
f)  unknown change in recording.
Category 2: Changes in supply of care as a result of
a)  change in organizati on of care;
b) change in availability of drugs including
  - introducti on of a new drug;
  - change in reimbursement of medicati on;
  - change in availability of prescripti on versus over-the-counter drugs;
c)  unknown change in supply of care.
Category 3: Changes in demand for care as a result of
a)  media att enti on including adverti sing;
b) change in pati ents’ perspecti ve of disease;
c)  change in pati ents’ expectati ons of general practi ce;
d) unknown change in demand for care.
Category 4: Changes in incidence of disease as a result of
a)  natural course of disease;
b) medical interventi on;
c)  change in lifestyle behaviour;
d) change in compilati on of the pati ent populati on; 
e) change in environment; 
f)  unknown cause that changes incidence of disease.
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We discussed the causes listed in box 5.1 with three experts in the fi eld of general practice 
registration networks (see acknowledgements) in order to interpret the fi ndings of our 
study. The most plausible explanations are described below. Note that we did not study 
these explanations; they are merely hypotheses. We also compared our fi ndings to the 
annual incidence rates of a similar general practice network in England and Wales 
(Weekly Returns Service).17 This comparison is limited to ICPC-codes that could be 
mapped to corresponding ICD-9 related Read codes from the Weekly Returns Service.
 The increasing ‘concern about drug reaction (A13)’ might be due to a change in 
the availability of over-the-counter drugs. In 1999, a large number of drugs that was 
previously available on prescription only became available over-the-counter, although 
chronic users still received a reimbursement on presentation of a prescription. Subse-
quent legislation (starting from January 1, 2004) limited the reimbursement for chronic 
users considerably.18 The use of over-the-counter drugs shows a steady increase in 
2002-2005 period.19 The observed increase of ‘concern about drug reaction (A13)’ 
could thus be caused by patients who consulted their GP about possible adverse effects 
of over-the-counter drugs.
 An explanation for the increase of ‘change in faeces/bowel movements (D18)’ might 
be a very successful, broad campaign on colon cancer in 2004 by a large non-profi t 
organization. Among other things, the campaign explained that a change in faeces/
bowel movements is one of the possible signs of colon cancer.20;21
 We have no explanation for the observed decrease of ‘chronic internal knee derange-
ment (L97)’. In English and Welsh practices, the incidence of ‘internal derangement of 
knee’ (ICD-9 code 717) decreased also in the study period.17
 The decrease of ‘hypertrophy/chronic infection tonsils/adenoids (R90)’ might be part 
of an ongoing decline that started decades ago. Another Dutch registry in general 
practice noticed a decrease in the incidence of this disease starting in the 1970s. This 
decline is possibly related to the simultaneous decreasing trend in tonsillectomy.22 
Furthermore, in 1993 the haemophilus infl uenza type b vaccine was added to the 
routine childhood immunization schedule, which could have caused a further decrease 
in this disease. In England and Wales, the incidence of ‘chronic disease of tonsils and 
adenoids’ (ICD-9 code 474) remained more or less the same between 2002-2005.17
 We found a decrease in consultations for ‘fear of being pregnant (W02)’, especially 
among young women, a fi nding which could be partly explained by the increased use 
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of contraceptives among young people. Results of a 2005 study on sexual health among 
young people show an increased use of contraceptives among sexually active school 
going youth compared to 1995.23 
 The decrease in consultations for sterilization among women (W13) is possibly related 
to the increase in childbearing age. Results of a study comparing different birth cohorts 
indicate that sterilizations are postponed (delay effect), whereas no catch-up effect is 
observed yet.24 Furthermore, in 2004 new legislation excluded sterilization from the 
basic health insurance plan25 and since then, only supplemental plans cover sterilization. 
This health policy measure may have attributed to a decrease in consultations for 
sterilization in the period after June 1, 2004.
 The increase in ‘symptoms/complaints prostate (Y06)’ might be due to the fact that 
new drugs for benign prostate hyperplasia became available in the period under study. 
This medical condition causes urination problems, and between 2002 and 2005, the 
pharmaceutical industry launched a broad advertising campaign focusing on urinary 
problems. The availability of these new drugs accompanied by the advertising 
campaign may have resulted in an increase in consultations for both prostate and urination 
problems in general practice.
 The increased ‘fear of venereal disease (Y25)’ is not limited to men. We found an 
increased ‘fear of venereal disease (X23)’ among women as well, but this health 
problem was not selected for further investigation (the raw incidence increased from 
10.0 to 19.6 among young women (15 through 24 years of age) and from 2.7 to 6.5 
among women aged 25 through 44 years of age). The increased fear is probably 
explained by a considerable rise in the number of sexually transmitted diseases (STDs) 
in the examined period. In particular, Chlamydia, gonorrhoea and Lues showed an 
increase among both men and women. This trend is attributed to the availability of 
effective therapy for AIDS (Highly Active Antiretroviral Therapy) which resulted in an 
increase in unprotected sexual behaviour.26;27
 We found an increase in ‘frequent/urgent (U02)’ and ‘other urination problems (U05)’ 
for both men and women. The availability of, and campaign for, new drugs for benign 
prostate hyperplasia as well as the increase in STDs provide a partial explanation for the 
observed increase in urination problems since both urinary tract infections and sexually 
transmitted diseases may cause urination problems. Furthermore, these diseases share 
similar risk factors such as recent sexual activity.28 The increase in urination problems 
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among middle-aged and older women might be due to another, unknown cause of 
increasing urinary tract infections. Results of our study show an increase in ‘urinary tract 
infections (U71)’ among women of 25 years of age and older, but this health problem was 
not selected for further investigation (the raw incidence for all women increased from 
69.0 in 2002 to 77.6 in 2005).
 We could provide plausible explanations for most of our fi ndings. These presumed 
causes, however, were not investigated in this study and no causal relationships were 
assessed. Therefore, these interpretations should be considered as hypotheses for further 
investigation.
Implications of findings
This study shows that data from EMRs can be a valuable source to monitor trends in the 
incidence of health problems in general practice over a relatively short time period. 
Extracting diagnoses from EMRs, provided that they are recorded accurately, is an effi -
cient method to obtain a dataset that is large enough to pick up both usual and unusual 
changes over time. In this paper we provide an example of a strategy for processing, 
analysing and interpreting such data. This strategy is essentially applicable to all databases 
of routinely collected data in general practice. These new possibilities are relevant for 
future research, not only in the Netherlands, but in all countries with a high degree of 
Information Technology. Future research should aim to develop methods that disclose 
and use data from EMRs for research purposes, in particular methods for ensuring the 
quality of this data.
 Results of this study regarding time trends in morbidity point at three important issues. 
First, attention should be paid to the increasing concern about reactions to drugs and 
the possible relation with the availability of over-the-counter drugs. Second, our fi ndings 
indicate that advertising campaigns may have considerable impact on incidence rates 
in general practice. More research is needed to investigate the effect of advertising 
campaigns on the health care market. Third, the increasing incidence of urination 
problems and fear of venereal diseases is a cause for concern. Both health problems are 
probably related to an increase in the incidence of STDs and urinary tract infections.
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SUPPLEMENTARY MATERIAL
The supplementary material provides further details on the selection procedures, the 
analyses, and an overview of all adjusted rates with 95% confi dence limits.
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INTRODUCTION
The following sections provide details on the article ‘Striking trends in the incidence of 
health problems in the Netherlands (2002-05). Findings from a new strategy for sur-
veillance in general practice’. In particular, we elaborate on the selection of general 
practices, the selection of 15 health problems for further investigation, and the multi-
level analyses. In addition, we present a tabular overview of the adjusted rates with 
95% confi dence limits.
SELECTION OF GENERAL PRACTICES
In the study, we included only general practices that met certain criteria for accuracy 
and completeness. This selection procedure is based on the following criteria:
(a)  at least 60% of the ICPC-codes assigned to consultations had to be fi lled out, and 
(b)  consultation, and
(c)  prescription records had to be recorded adequately throughout the year (at least  
10% of all consultation and 10% of all prescription records in each quarter), and
(d)  at least 75% of the fi eld ‘new’ or ‘ongoing’ in contact-oriented EMRs had to be fi lled 
out. Within LINH, this fi eld is added to contact-oriented EMRs. General practitioners 
have to characterize each consultation diagnosis either as ‘new’, which refers to a 
newly presented/recurrent health problem, or ‘ongoing’, which refers to a continuing 
health problem.
SELECTION OF 15 HEALTH PROBLEMS
Out of the raw incidence rates for all ICPC codes (N=683), we selected 15 obviously 
changing health problems for further investigation. Figure 5.2 shows a fl owchart of this 
selection process. We excluded rare health problems (prevalence ≤ 0.5 per 1000 
patients in 2002-2005) and rest group health problems (ICPC-codes 29 and 99). We 
included all health problems that displayed a substantial increase (or decrease) 
between 2002 and 2005 (absolute difference ≥| 0.3 |and relative difference ≥ | 30%|).
Subsequently we checked for outliers. For three health problems, the changes over 
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time could mainly be attributed to one or two practices (‘other symptoms/complaints 
multiple/unspecified muscles (L19)’, ‘meningitis/encephalitis (N71)’, and ‘painful 
urination (U01)’). These health problems were excluded, leaving a selection of 15 health 
problems.
Fig. 5.2 Selecti on of health problems
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MULTILEVEL ANALYSES
To analyse the data, we used multilevel multivariate repeated measurements models 
for count data (poisson error distribution allowing for overdispersion, with a log link 
function, MLwiN specifi cs estimation was penalized quasi-likelihood with fi rst order). 
For every year we specified the same equation, all four equations were estimated 
simultaneously. We did not estimate the covariances between the different years, 
neither at the level of the practice nor at the level of the individual patients. This was 
due to sparseness of the data: less than 0.5% of the patients have the specifi c episode 
and almost none have new specifi c episodes in two or more years. 
The equation for one year is as follows:
 on)distributi poisson (extra practice within variancepatient  between 
on)distributi (normal variance practice between 
1....N practice   j
n ..... 1patient     i
)length()age()age()age()sex()intercept(y
ji
j
jijji5ji
3^
4ji
2^
3ji2ji10ji
ε
μ
ε+μ+β+β+β+β+β+β=
The models are restricted to the ages upon which a health problem occurs (we included 
only those fi ve-year ages for which at least 5 new episodes of a health problem 
occurred in the period 2002-2005. Table 5.2 shows the age range used in the analyses 
as well as the raw prevalence, the mean age, and the male/female proportion for each 
of the examined health problems.
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The age and sex variables were centered, i.e. the adjusted model estimates the incidence 
for a patient with an average age and an average male/female proportion. This centering 
differed between the dependent variables, for an overview of these values see table 5.2 
(mean age and males %). The variable length corrects for the length of recording of a 
patient within a practice within one year.
 For testing the trends over the years we used linear contrast tests for the fi xed parameters, 
the intercept, sex and the three age variables. For testing the sex trends a model was fi tted 
in which the intercept was removed and a separate yearly average was estimated for 
male and female, both 0,1 coded. The data were analysed using MLwiN 2.02.
Table 5.2 Overview of selected health problems
Health problems (ICPC code)a
Increasing based on raw incidence rates
Concern about drug reacti on (A13)
Change in feces/bowel movements (D18)
Hypertension with involv. target organs (K87)
Frequent/urgent urinati on (U02)
Other urinati on problems (U05)
Family planning/other (W14)
Symptoms/complaints prostate (Y06)
Fear of venereal disease (Y25)
Decreasing based on raw incidence rates
Sprains & strains of other joints (L79)
Chronic internal knee derangement (L97)
Other head injury without skull fracture (N80)
Hypertro./chronic infect. tonsils/adenoids (R90)
Diaper rash (S89)
Fear of being pregnant (W02)
Family planning/sterilizati on (W13)
a: ICPC, Internati onal Classifi cati on of Primary Care
Prev. 
(raw) 
2005
5.7
1.7
9.4
4.3
2.6
11.5
7.3
3.9
2.1
3.6
0.8
2.0
1.1
1.8
0.9
Mean 
age   
02-05
54.9
49.9
65.7
47.5
53.7
30.2
62.9
29.7
30.4
38.8
26.2
8.1
2.0
28.2
36.4
Age 
range
0-99
0-94
30-94
1-99
0-99
10-59
25-94
15-64
0-94
5-89
0-94
0-64
0-9
10-54
20-49
Males 
(%)
02-05
31.5
44.6
55.8
44.9
61.3
0.0
100.0
100.0
49.9
48.5
52.3
50.5
36.3
0.0
0.0
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OVERVIEW OF THE ADJUSTED RATES
Table 5.3 provides an overview of the adjusted rates of the 15 selected health problems 
with confi dence limits.
Table 5.3 Adjusted incidence rates (corrected for clustering and age) per 1000 per year with 95% 
Confi dence Intervals
Health problems (ICPC code)a
Concern about drug reacti on (A13)
   2002
   2003
   2004
   2005
Change in feces/bowel movements (D18)
   2002
   2003
   2004
   2005
Hypertension with involvement target organs (K87)
   2002
   2003
   2004
   2005
Sprains and strains of other joints (L79)
   2002
   2003
   2004
   2005
Chronic internal knee derangement (L97)
   2002
   2003
   2004
   2005
Other head injury without skull fracture (N80)
   2002
   2003
   2004
   2005
Hypertrophy/chronic infecti on tonsils/adenoids (R90)
   2002
   2003
   2004
   2005
Men
2.0 (1.5 - 2.7)
2.5 (1.8 - 3.4)
2.7 (1.8 - 4.2)
4.5 (3.2 - 6.5)
0.7 (0.5 - 0.9)
0.8 (0.6 - 1.1)
0.9 (0.6 - 1.2)
1.3 (1.0 -1.7)
4.1 (3.0 - 5.6)
4.6 (3.3 - 6.4)
6.5 (4.8 - 8.9)
5.1 (3.5 - 7.4)
3.1 (2.4 - 4.0)
2.9 (2.2 - 3.8)
2.5 (1.8 - 3.6)
2.4 (1.6 - 3.4)
5.3 (4.3 - 6.5)
4.3 (3.4 - 5.3)
4.3 (3.1 - 5.9)
2.9 (2.1 - 4.0)
0.7 (0.5 - 0.9)
0.5 (0.3 - 0.6)
0.6 (0.4 - 0.9)
0.5 (0.3 - 0.7)
6.7 (5.1 - 8.9)
5.7 (4.4 - 7.4)
5.0 (3.8 - 6.6)
4.4 (2.9 - 6.7)
Women
4.1 (3.1 - 5.5)
4.9 (3.6 - 6.7)
5.6 (3.7 - 8.4)
7.9 (5.6 - 11.2)
0.9 (0.7 - 1.1)
0.9 (0.7 - 1.1)
1.0 (0.7 - 1.3)
1.6 (1.2 - 2.1)
2.6 (1.9 - 3.6)
3.6 (2.5 - 5.0)
3.0 (2.1 - 4.2)
4.2 (2.9 - 6.1)
3.1 (2.4 - 4.0)
2.9 (2.2 - 3.8)
2.8 (2.0 - 4.0)
2.2 (1.5 - 3.1)
5.5 (4.5 - 6.7)
4.4 (3.6 - 5.5)
4.5 (3.3 - 6.2)
3.7 (2.7 - 5.1)
0.6 (0.5 - 0.8)
0.4 (0.3 - 0.6)
0.4 (0.3 - 0.7)
0.5 (0.3 - 0.7)
5.8 (4.4 - 7.6)
6.7 (5.2 - 8.7)
4.9 (3.7 - 6.4)
5.2 (3.4 - 7.9)
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Table 5.3 Conti nued
Health problems (ICPC code)a
Diaper rash (S89)
   2002
   2003
   2004
   2005
Frequent/urgent urinati on (U02)
   2002
   2003
   2004
   2005
Other urinati on problems (U05)
   2002
   2003
   2004
   2005
Fear of being pregnant (W02)
   2002
   2003
   2004
   2005
Family planning/sterilizati on (W13)
   2002
   2003
   2004
   2005
Family planning other (W14)
   2002
   2003
   2004
   2005
Symptoms/complaints prostate (Y06)
   2002
   2003
   2004
   2005
Fear of venereal disease (Y25)
   2002
   2003
   2004
   2005
a: Internati onal Classifi cati on of Primary Care
Men
7.8 (5.4 - 11.2)
7.2 (4.9 - 10.5)
5.5 (3.6 - 8.3)
6.6 (2.5 - 17.3)
1.9 (1.5 - 2.3)
2.2 (1.7 - 2.7)
2.4 (1.9 - 3.2)
2.6 (2.1 - 3.3)
1.7 (1.3 - 2.2)
1.7 (1.4 - 2.2)
2.6 (2.0 - 3.5)
2.9 (2.3 - 3.9)
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
4.3 (3.5 - 5.3)
5.0 (4.0 - 6.3)
6.6 (5.2 - 8.3)
7.4 (5.7 - 9.5)
1.9 (1.4 - 2.6)
2.4 (1.8 - 3.2)
3.3 (2.4 - 4.4)
4.2 (3.1 - 5.6)
Women
15.7 (11.5 - 21.5)
12.9 (9.2 - 18.0)
9.5 (6.5 - 14.0)
12.6 (5.5 - 28.5)
2.0 (1.6 - 2.4)
2.4 (1.9 - 3.0)
2.8 (2.1 - 3.6)
3.2 (2.5 - 3.9)
0.9 (0.6 - 1.1)
1.0 (0.7 - 1.3)
1.4 (1.0 - 1.9)
1.6 (1.2 - 2.2)
2.5 (1.9 - 3.2)
2.0 (1.6 - 2.7)
2.0 (1.4 - 2.8)
1.5 (1.1 - 2.0)
2.7 (2.2 - 3.4)
2.8 (2.2 - 3.6)
1.9 (1.4 - 2.7)
1.1 (0.7 - 1.7)
4.9 (3.7 - 6.4)
6.4 (4.9 - 8.4)
6.1 (4.9 - 7.5)
6.6 (5.0 - 8.7)
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
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ABSTRACT
Background: The incidence of hypertrophy and recurrent 
infections of tonsils/adenoid in the Netherlands appears to be 
decreasing: is this a real decrease in the incidence of disease or 
an artefact?
Aim: To investigate possible causes of the decreasing incidence 
of adenotonsillar problems among Dutch children.
Design: Observational study.
Setting: A nationally representative general practice database.
Method: Incidence rates were calculated over 2002-2005 
among children aged 0-14 years. Multilevel Poisson regression 
analyses were used to examine the following possible causes of 
changing incidence rates: change in recording (i.e. more substi-
tution codes), change in the demand for care (i.e. fewer visits to 
the general practitioner), and change in the supply of care (i.e. 
fewer antibiotic prescriptions and referrals). Indications for a real 
change in the incidence of disease were examined by calculating 
incidence rates of other clinical manifestations of microbial 
pathogens that may cause adenotonsillar problems.
Results: The incidence rate decreased signifi cantly (p=0.02) 
from 3.0 to 1.3 per 1000 children per year. Correcting for 
demand for and supply of care led to a smaller decline in yearly 
incidence, from 2.9 to 1.7 per 1000 children per year (p=0.11). 
No clearly similar trend was found in other clinical manifestations 
of viruses and bacteria that may cause adenotonsillar problems.
Conclusion: Part of the declining trend can be explained by a 
change in the demand for and supply of care, but no apparent 
causal clue emerged for the residual declining trend in the inci-
dence of disease.
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INTRODUCTION
Adenotonsillar problems, notably obstructive hypertrophy and infection, are very 
common in early childhood and an important reason for parents to visit the general 
practitioner (GP) with their child. Recurrent infections of the tonsils or adenoid can be 
a source of both upper and lower respiratory tract infections. Hypertrophy can lead to 
sleep-disordered breathing, eating disorders, and even growth problems.1-5
 The relation between hypertrophy and recurrent infections of adenotonsillar tissue is 
unclear. Although hypertrophy is associated with recurrent infections of adenotonsillar 
tissue, many children present hypertrophy in the absence of infection.1;6-8 Some 
suggest that tonsils and adenoid may only appear to be large due to their prominence 
or relative size in the throat during childhood.7 Recent MRI studies, however, indicate 
that tonsils and adenoid grow proportionally to the skeletal structures during normal 
child development.9;10
 Treatment options for adenotonsillar problems in general practice include watchful 
waiting, symptomatic medication, antibiotics, or referral to an otorhinolaryngologist. 
Recurrent tonsillitis, as well as obstructive sleep apnoea due to adenotonsillar hypertrophy, 
are important indications for (adeno)tonsillectomy, a common surgical procedure 
onchildren. There is an ongoing debate, however, about the proper indications for 
(adeno)tonsillectomy resulting in widely varying surgical rates.11
 The few studies that examined the incidence of this health problem in general 
practice indicate, at least for the Netherlands, that the incidence of hypertrophy and 
recurrent infections of tonsils/adenoid among the total population is decreasing.12,13 
Considering the differing opinions on diagnostics and treatment consequences for this 
health problem, the question arises whether there is a ‘real’ decrease in the incidence 
of this disease, or one originated by ‘artefacts’. 
 In an earlier paper, we distinguished between four categories of possible causes of 
changing incidence rates in general practice: changes in recording, changes in the 
demand for care, changes in the supply of care, and ‘real’ changes in the incidence of 
a disease.13 Based on this categorization, we composed the following hypotheses.
Changes in recording
A shift in recording might explain the decrease in hypertrophy and recurrent infections 
of tonsils/adenoid. GPs might have replaced the diagnostic code for this particular 
health problem by other codes.
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Changes in the demand for care
The overall consultation frequency of Dutch children aged 0-14 years decreased during 
1987 to 2001.14 This trend may have continued and may explain the decrease in 
adenotonsillar problems.
Changes in the supply of care
Dutch GPs usually work according to guidelines. In 1999 the guideline ‘Acute sore 
throat’ was revised, advocating restraint in prescribing antibiotics. Recommendations 
for referring to an otorhinolaryngologist also changed, now requiring four (instead of 
three) severe episodes of tonsillitis per year.15 These policy changes might have 
reduced the number of consultations for this specifi c health problem. The less children 
are treated with antibiotics or (adeno)tonsillectomy, the less parents are inclined to visit 
the GP with their child for these treatments.
Changes in the incidence of a disease
Viruses and bacteria are important pathogens in the aetiology of infections and hyper-
trophy of the tonsils and adenoid. Viruses dominate in pre-school children.16 Viral 
pathogens are: adenovirus, parainfl uenza virus, respiratory syncytial virus (RSV), rhino-
virus, Epstein-Barr virus (EBV), and herpes simplex virus (HSV). Bacterial species that 
have been isolated are: Haemophilus infl uenzae, Streptococcus pyogenes, Streptococ-
cus pneumonia, and Staphylococcus aureus.16-28 A decrease in the incidence of these 
pathogens could explain a decrease in adenotonsillar problems.
 The present study examines (causes of) the trend in the incidence of hypertrophy and 
recurrent infections of tonsils/adenoid among children aged 0-14 years in the Nether-
lands, based on the available evidence in a national GPs’ database.
METHOD
Dataset
We used data from the electronic medical records (EMRs) of Dutch general practices 
participating in the Netherlands Information Network of General Practice (LINH) during 
2002-2005.29,30 The GPs within this network code consultations, prescriptions, and 
referrals on a routine basis using the International Classifi cation of Primary Care (ICPC).31 
All ICPC codes were grouped into episodes, either by EPICON, a new record linkage 
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method (for contact-oriented EMRs) or by GPs (for episode-oriented EMRs). 32,33 Only 
practices that met predefi ned criteria for accuracy and completeness were included in 
the analyses; this resulted in 69 practices in 2002, 66 in 2003, 43 in 2004 and 42 in 
2005. The included practices are considered representative for all Dutch practices 
regarding urbanization, practice type (i.e. single-handed or group practice), and 
region.13
Study population
A total of 80836 patients, boys and girls aged 0-14 year, was available for this analysis. 
Age was measured on the fi rst of July in the year concerned. The population is represen-
tative for the total Dutch population regarding age and sex.34
Outcome
The main outcome variable was the yearly incidence of hypertrophy and recurrent 
infections of tonsils/adenoid (ICPC code R90). Indications for a ‘real’ change in the 
incidence of disease were examined by estimating incidence rates of clusters of other 
diseases that share the same pathogens with adenotonsillar problems. These clusters 
were composed as follows:
a) Based on the literature, we listed the major microbial pathogens of hypertrophy and 
infections of the tonsils and adenoid.16-28 
b) We then looked for other frequent clinical manifestations of these pathogens and 
selected the corresponding ICPC codes. Clinical manifestations involving a general 
ICPC code, such as coughing (R05), were excluded. 
c) For each pathogen a cluster of ICPC codes was composed (see Appendix I).
Explanatory variables
Possible changes in recording were examined by composing a cluster of possible sub-
stitution codes for ICPC code R90 (see Appendix II). The overall consultation frequency 
was used as a measure for the demand for care, whereas changes in the supply of care 
were measured by referrals to an otorhinolaryngologist and prescriptions of antibiotics. 
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Table 6.1 gives a detailed description of these explanatory variables.
Incidence rates
Raw and adjusted incidence rates were calculated. The raw rates were computed as the 
total number of new episodes of a (cluster of) health problem(s) divided by the mid-year 
population (i.e. the average of the population aged 0-14 years at the beginning and the 
end of a year). The episodes were weighted for the recording period of each practice 
within each year to account for holidays, etc. 
 The adjusted incidence rates were corrected for clustering and for age, sex, and 
recording period. For this, we designed a basic model that includes the four years and 
corrects for variance due to clustering within levels (which is necessary because repeated 
observations of a health problem are clustered within patients, who are clustered within 
practices) and for age, sex and the length of recording of a practice within one year. The 
age and sex variables were centred at 8.1 years and 50.5% males (the mean age, and 
the average male/female proportion of this health problem in the population),13 i.e. the 
model estimates the incidence for an eight year old patient.
Table 6.1. Explanatory variables
Variable
Raw incidence of 
substi tuti on cluster
Consultati on 
frequency
Referral 
frequency
Anti bioti cs 
frequency
a The number of consultati ons was measured as the number of valid ICPC-codes entered during   
 consultati ons, excluding ICPC-codes derived from referrals and prescripti ons.
Descripti on
Total number of new episodes of substi tuti on codes in 
one year per pati ent/total mid-year populati on
Total number of consultati onsa per practi ce per year/
practi ce mid-year populati on
Total number of referrals to an otorhinolaryngologist for a 
new episode of ‘hypertrophy/recurrent infecti ons of tonsils/
adenoid’ per practi ce per year/practi ce mid-year populati on
Total number of anti bioti c prescripti ons for a new 
episode of ‘hypertrophy/recurrent infecti ons of tonsils/
adenoid’ per practi ce per year/practi ce mid-year populati on
Range
288.12 - 364.78 
(per 1000 children
per year)
0.54 - 3.68
(per child 
per practi ce per year)
0.00 - 21.05
(per 1000 children 
per practi ce per year)
0.00 - 75.79
(per 1000 children 
per practi ce per year)
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In order to explain the trend over time for hypertrophy and recurrent infections of 
tonsils/adenoid, the explanatory variables were then entered stepwise into the basic 
model. We only included variables that a) increased or decreased over time in the 
expected direction based on the raw analyses, and b) were signifi cantly associated with 
hypertrophy and recurrent infections of tonsils/adenoid (according to the 95% 
confi dence intervals (CIs) of the rate ratio (RR)). For each of these models, we tested for 
a linear trend over time. In the fi nal model, the consultation, referral, and frequency of 
antibiotic prescriptions were added (in this order) to the basic model. Multilevel Poisson 
regression models (MLwiN 2.02) were used to estimate the adjusted incidence rates.
RESULTS
Overall trend
Figure 6.1 shows the annual adjusted incidence rates of hypertrophy and recurrent 
infections of tonsils/adenoid among children aged 0-14 years. Between 2002 and 2005, 
this rate decreased from 2.96 (95% CI 2.16-4.07) to 1.27 (95% CI 0.67-2.41) per 1000 
children per year. The decrease is signifi cant for the total group of children (p=0.0171), 
and for boys (p=0.021) and girls (p=0.022) separately.
Fig. 6.1 Adjusted incidence rates (basic model) of hypertrophy and recurrent 
   infecti ons of tonsils/adenoid among children aged 0-14 years.
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Raw rates
The raw rates of consultations, referrals, and antibiotic prescribing declined over 
2002-2005. For instance, the total annual consultation frequency decreased from 1.98 
in 2002 to 1.79 in 2005. Instead of the hypothesised increase of substitution codes, 
however, we found a decrease in the incidence rate of the cluster of substitution codes. 
Even when we computed a cluster of only upper respiratory codes, we noticed a decrease 
(Figure 6.2). Based on these raw rates, we could reject the hypothesis that the decrease 
was caused by a shift in recording. Therefore, this variable was not included in the multi-
level Poisson regression analyses.
Adjusted rates
Table 6.2 shows the RRs for the other explanatory variables. These RRs can be interpreted 
in such a way that a mean decrease of one consultation per child per practice per year 
(for instance, when the consultations per child decrease from three to two per year) is 
associated with a 23% decrease in risk of new episodes of hypertrophy and recurrent 
infections of tonsils/adenoid over the examined four-year period. All three variables are 
signifi cantly associated with hypertrophy and recurrent infections of tonsils/adenoid 
(i.e. the 95% CIs exclude unity).
Fig. 6.2 Raw incidence rates of clusters of substi tuti on codes and upper 
   respiratory diseases among children aged 0-14 years.
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Thus, these three variables have the potential to explain the decrease in adenotonsillar 
problems, because a) they declined, and b) they are associated with these problems. 
Figure 6.3 shows the impact of each of the variables on the adjusted incidence rate of 
hypertrophy and recurrent infections of tonsils/adenoid. Each variable explains a small 
part of the decrease of this incidence rate. The linear trend over time was no longer 
signifi cant after referral (p=0.075) and antibiotics frequency (p=0.105) were entered 
into the model.
Table 6.2. Associati ons between the explanatory variables and new episodes 
 of hypertrophy and recurrent infecti ons of tonsils/adenoid
Variable
Consultati on frequency
Referral frequency
Anti bioti cs frequency
a Based on the fi nal model
RRa (95% CI)
1.23 (1.02-1.48)
1.09 (1.07-1.12)
1.03 (1.02-1.04)
Fig. 6.3 Adjusted incidence rates (various models) of hypertrophy and recurrent 
   infecti ons of tonsils/adenoid among children aged 0-14 years.
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Clinical manifestati ons of pathogens found in hypertrophy/recurrent tonsilliti s
Figure 6.4 shows the clusters of other clinical manifestations related to the same microbial 
pathogens held responsible for adenotonsillar problems, which show no linear decrease 
over time. The shape of the trend over time corresponds to the trend observed in the 
cluster of respiratory diseases (Figure 6.2) and to the decline in adenotonsillar problems 
over 2002-2004, whereas the rise of clinical manifestations in 2005 is opposed to the 
decrease of adenotonsillar problems in 2005 (Figure 6.3).
DISCUSSION
Summary of main findings
The incidence of recurrent infections and hypertrophy of tonsils/adenoid among Dutch 
children decreased over the years 2002-2005. Part of the decline can be explained by 
changes in the demand for and supply of care during this period, whereas no indications 
were found for a change in recording. We found no clear indications for a ‘real’ change 
in the incidence of disease.
Fig. 6.4 Adjusted incidence rates (basic model) among children aged 0-14 years of clusters of clinical 
   manifestati ons of pathogens found in hypertrophy and recurrent infecti ons of tonsils/adenoid.
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Strengths and limitations of the study
This study illustrates the potential use of data derived from EMRs in general practice. 
A strength of the study is that a large network of general practices, and therefore a 
large number of patients, were included in the analyses. The study population was 
representative for the Dutch population regarding age and sex. Furthermore, the 
database enabled to study the most obvious hypotheses for the observed decrease in 
adenotonsillar problems.
 The study was limited, however, to the available evidence in the database. Hence, the 
decrease might be explained by other factors that were not measured in this study, such 
as changes in day-care attendance. Furthermore, the study was limited to a four-year 
period, whereas changes that occurred before this time frame may have caused the 
decrease. In particular, the large decrease in (adeno)tonsillectomy rates during the 
1970s and 1980s in the Netherlands11 may have caused a general decrease in attention 
for adenotonsillar problems among parents, GPs and otorhinolaryngologists. This his-
torical change in supply may still have a lingering effect on the current incidence rates.
 Furthermore, we did not measure the change in actual pathogens that cause the 
disease. Instead, we used a proxy consisting of clusters of clinical manifestations of 
pathogens found in hypertrophy and infections of tonsils/adenoid, which has several 
disadvantages. First, we cannot be certain that the identified viruses and bacteria 
actually cause adenotonsillar problems, because the presence of an organism in a 
patient’s throat and its culture from a swab does not mean that it is pathogenic.5 
Second, other microbial pathogens may also cause the clinical manifestations that were 
used in this study. The incidence rates of these clusters of clinical manifestations should 
therefore be interpreted cautiously; they only give an indication and cannot provide any 
evidence of a change in the incidence of major pathogens held responsible for 
adenotonsillar problems.
 Finally, not all referrals and prescriptions were linked to an ICPC code by the GPs. 
Each year, ICPC codes were missing for 3-5% of the referrals to otorhinolaryngologists 
and for 7-10% of the antibiotic prescriptions. Therefore, we might have underestimated 
the referral and antibiotics frequency, but we have no reason to believe that higher 
estimates would have changed our conclusions.
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Comparison with existing literature
The fi ndings of this study raise the question whether the decrease of adenotonsillar 
problems is related to an overall decline in upper respiratory tract diseases. Both 
adenotonsillar problems and other upper respiratory tract diseases declined over 
2002-2004, whereas opposite trends were observed over 2005. Several studies report 
that the incidence of various respiratory diseases, including acute tonsillitis, declined 
over the last decade.35-38 Some suggest that this decline is caused by a reduced inclination 
of patients to present respiratory illness to their GP36, whereas others suggest a ‘real’ 
decrease in the incidence of respiratory tract infections.38 The results of our study appear 
to be in favour of the last hypothesis, because the decrease in the overall consultation 
frequency had only little impact on the observed decline in adenotonsillar problems 
(Figure 6.3). The basic model, however, controls for clustering within practices, which 
may already reduce some of the variance caused by differences in consultation frequency. 
Hence, the actual impact of consultation frequency might be somewhat larger. Never-
theless, our fi ndings demonstrate that consultation frequency provides no conclusive 
explanation for the decline in adenotonsillar problems.
 In the present study, we observed a decline in both the antibiotics and the referral 
frequency for hypertrophy and recurrent infections of tonsils/adenoid among children 
over the years 2002-2005. This fi nding corresponds with declining antibiotic prescribing 
trends for acute tonsillitis, and with decreasing referral rates for hypertrophy and recurrent 
infections of tonsils/adenoid among Dutch children during 1987 to 2001.35;39;40
Implications for future research
We observed a substantial decline in adenotonsillar problems among children over 
2002-2005, partly explained by factors that are not causally linked to the aetiology of 
the disease itself. For the residual decline, no causal clue has yet emerged. Future 
research should focus on the question whether the observed decrease is part of an 
overall decline in upper respiratory tract infections resulting from a changing pattern in 
the occurrence of major pathogens in the population.
123
Adenotonsillar problems
REFERENCES
1. Kara CO, Ergin H, Koçak G, Kiliç I, Yurdakul M. Prevalence of tonsillar hypertrophy and associated 
oropharyngeal symptoms in primary school children in Denizli, Turkey. Int J Pediatr Otorhinolaryngol. 
2002;66:175-179.
2.  Kvaerner KJ, Tambs K, Harris JR, Mair IWS, Magnus P. Otitis media: relationship to tonsillitis, sinusitis 
and atopic diseases. Int J Pediatr Otorhinolaryngol. 1996;35:127-141.
3.  Bonuck K, Parikh S, Bassila M. Growth failure and sleep disordered breathing: A review of literature. 
Int JPediatr Otorhinolaryngol. 2006;70:769-778.
4.  Tal A, Bar A, Leiberman A, Tarasiuka A. Sleep characteristics following adenotonsillectomy in children 
with obstructive sleep apnea syndrome. Chest. 2003;124:948-953.
5.  Cowan DL, Hibbert J. Acute and chronic infection of the pharynx and tonsils. In: Kerr AG, Hibbert J, 
editors. Scott-Brown’s Otolaryngology. Laryngology and head and neck surgery. 6th ed. Oxford: 
Butterworth-Heinemann; 1997. 5/4/1-5/4/24.
6.  Potsic, WP. Assessment and treatment of adenotonsillair hypertrophy in children. Am J Otolaryngol. 
1992;13:259-264.
7.  Cable HR, Batch AG, Stevens DJ. The relevance of physical signs in recurrent tonsillitis in children. 
A prospective study. J Laryngol Otol. 1986;100:1047-1051.
8.  Barr GS, Crombie IK. Comparison of size of tonsils in children with recurrent tonsillitis and in controls. 
BMJ. 1989;298:804.
9.  Arens R, McDonough JM, Corbin AM, Hernandez ME, Maislin G, Schwab RJ, et al. Linear dimensions 
of the upper airway structure during development. Am J Respir Crit Care Med. 2002;165:117-122.
10.  Vogler RC, Wippold FJ, Pilgram TK. Age-specifi c size of the normal adenoid pad on magnetic 
resonance imaging. Clin Otolaryngol. 2000; 25:392-395.
11.  Van den Akker EH, Hoes AW, Burton MJ, Schilder AGM. Large international differences in 
(adeno)tonsillectomy rates. Clin Otolaryngol. 2004;29:161-164.
12. Van de Lisdonk EH, van den Bosch WJHM, Lagro-Janssen ALM, editors. Ziekten in de 
huisartsenpraktijk (Diseases in General Practice). Maarssen: Elsevier gezondheidszorg; 2003.
13.  Biermans MCJ, Spreeuwenberg P, Verheij RA, De Bakker DH, De Vries Robbé, Zielhuis GA. 
Striking trends in de incidence of health problems in the Netherlands (2002-05). Findings from a 
new strategy for surveillance in general practice. Submitted.
14.  Van den Berg MJ, Kolthof ED, De Bakker DH, Van der Zee J. De werkbelasting van huisartsen 
(The workload of general practitioners). Utrecht: Nivel; 2004.
124
Chapter 6
15.  Dagnelie CF, Zwart S, Balder FA, Romeijnders ACM, Geijer RMM. NHG Standard ‘Acute sore throat’ 
from the Dutch College of General Practitioners, fi rst revision, 1999 [document on the internet]. 
[cited 2008 April 23]. Availablefrom: http://nhg.artsennet.nl/upload/104/guidelines2/E11.htm.
16.  Putto A. Febrile exudative tonsillitis: Viral or streptococcal? Pediatrics. 1987;80:6-12.
17.  Tosca MA, Riccio AM, Marseglia GL, Caligo G, Pallestrini E, Ameli F, et al. Nasal endoscopy in 
asthmatic children: assessment of rhinosinusitis and adenoiditis incidence, correlations with 
cytology and microbiology. Clin Exp Allergy. 2001;31:609-615.
18.  Bisno AL. Acute pharyngitis. N Engl J Med. 2001;344:205-211.
19.  Suvilehto J, Roivainen M, Seppänen M,Meri S, Hovi T, Carpén O, et al. Rhinovirus/enterovirus RNA 
in tonsillar tissue of children with tonsillar disease. J Clin Virol. 2006;35:292-297.
20.  Gaffney RJ, Timon CI, Freeman DF, Walsh MA, Cafferkey MT. Bacteriology of tonsil and adenoid 
and sampling techniques of adenoidal bacteriology. Respir Med. 1993;87:303-308.
21.  DeDio RM, Tom LWC, McGowan KLM, Wetmore RF, Handler SD, Potsic WP. Microbiology of the 
tonsils and adenoids in a pediatric population. Arch Otolaryngol Head Neck Surg. 1988;114:
763-765.
22.  Van Staaij BK, Van den Akker EH, De Haas van Dorsser EHM, Fleer A, Hoes AW, Schilder AGM. 
Does the tonsillar surface fl ora differ in children with and without tonsillar disease? Acta Otolaryngol. 
2003;123:873-878.
23.  Endo LH, Ferreira D, Montenegro MCS, Pinto GA, Altemani A, BortoletoJr AE, et al. Detection of 
Epstein-Barr virus in tonsillar tissue of children and the relationship with recurrent tonsillitis. Int J 
Pediatr Otorhinolaryngol. 2001;58:9-15.
24.  Brook I. Aerobic and anaerobic bacteriology of adenoids in children: a comparison between 
patients with chronic adenotonsillitis and adenoid hypertrophy. Laryngoscope. 1981;91:377-382.
25.  Gaffney RJ, Cafferkey MT. Bacteriology of normal and diseased tonsils assessed by fi ne needle 
aspiration: Haemophilus infl uenzae and the pathogenesis of recurrent acute tonsillitis. 
Clin Otolaryngol. 1998;23:181-185.
26.  Brook I, Yocum P, Foote PA. Changes in the core tonsillar bacteriology of recurrent tonsillitis: 
1977-1993. Clin Infect Dis. 1995;21:171-176.
27.  JeongJH, Lee DW, Ryu RA, Lee YS, Lee SH, Kang JO, et al. Bacteriologic comparison of tonsil core 
in recurrent tonsillitis and tonsillar hypertrophy. Laryngoscope. 2007;117:1-6
28.  Stjernquist-Desatnik A, Prellner K, Schalén C. High recovery of Haemophilus infl uenzae and group 
A streptococci in recurrent tonsillar infection or hypertrophy as compared with normal tonsils. 
J Laryngol Otol. 1991;105:439-441.
125
Adenotonsillar problems
29.  Verheij RA, Jabaaij L, Abrahamse H, Van den Hoogen H, Braspenning J, Van Althuis T. Netherlands 
Information Network of General Practice. Facts and fi gures on Dutch GP care 
[website on the internet]. [cited 2008 April 23]. Available from: http://www.linh.nl.
30.  Tacken MAJB. Quality of preventive performance in general practice: the use of routinely collected 
data [dissertation]. Radboud University Nijmegen; 2005.
31.  Lamberts H, Woods M, editors. International Classifi cation of Primary Care (ICPC). Oxford: 
Oxford University Press; 1987.
32.  Biermans MCJ, De Bakker DH, Verheij RA, Gravestein JV, Van der Linden MW, De Vries Robbé PF. 
Development of a case-based system for grouping diagnoses in general practice. Int J Med Inform. 
2008;77:431-439.
33.  Biermans MCJ, Verheij RA, De Bakker DH, Zielhuis GA, De Vries Robbé PF. Estimating morbidity 
rates from electronic medical records in general practice. Evaluation of a grouping system. Methods 
Inf Med. 2008;47:98-106.
34.  Statistics Netherlands [database on the internet]. Voorburg/Heerlen: Statistics Netherlands. 
[updated daily; cited 2008 March 27]. Available from: http://www.cbs.nl.
35.  Diepenhorst HIJ, Otters HBM, Van Suijlekom-Smit LWA, Schellevis FG, Van der Wouden JC. 
Tonsillitis acuta bij kinderen in de huisartsenpraktijk: verandering van incidentie en beleid? 
(Acute tonsillitis in children in the GP’s practice: changes in incidence and policy?). 
Huisarts Wet. 2004;47:399-404.
36.  Kuyvenhoven M, Van Essen G, Schellevis F, Verheij T. Management of upper respiratory tract 
infections in Dutch general practice: antibiotic prescribing rates and incidences in 1987 and 2001. 
Fam Pract. 2006;23:175-179.
37.  Gommer AM, Poos MJJC. Neemt het aantal mensen met infecties van de bovenste luchtwegen toe 
of af? (Is the number of people with upper respiratory tract infections increasing or decreasing?). 
[cited 2008 Feb 28]. Available from: http://www.rivm.nl.
38.  Fleming DM, Ross AM, Cross KW, Kendall H. The reducing incidence of respiratory tract infection 
and its relation to antibiotic prescribing. Br J Gen Pract. 2003;53:778-783.
39.  Otters HBM, Van der Wouden JC, Schellevis FG, Van Suijlekom-Smit LWA, Koes BW. Trends in 
prescribing antibiotics for children in Dutch general practice. J Antimicrob Chemother. 
2004;53:361-366.
40.  Otters H, Van der Wouden JC, Schellevis FG, Van Suijlekom-Smit LWA, Koes BW. Dutch general 
practitioners’ referral of children to specialists: a comparison between 1987 and 2001. Br J Gen 
Pract. 2004;54:848-852.
126
Chapter 6
APPENDIX I
Clusters of other clinical manifestations (and corresponding ICPC codes) of pathogens 
found in hypertrophy and recurrent infections of tonsils/adenoid:
•  Adenovirus: coryza (R74), otitis media (H71-H72), bronchitis (R78), pneumonia 
(R81), diarrhea (D73), pharyngitis (R74), conjunctivitis (F70), tonsillitis (R22/R76)
•  Parainfl uenza virus: laryngotracheobronchitis (R77), pneumonia (R81), bronchiolitis 
(R78), otitis media (H71-H72), sinusitis (R75), URI (R74), tonsillitis (R22/R76)
•  RSV: bronchiolitis (R78), pneumonia (R81), coryza (R74), sinusitis (R75), otitis 
media (H71-H72), tonsillitis (R22/R76)
•  Rhinovirus: coryza (R74), acute sinusitis (R75), otitis media (H71-H72), pharyngitis 
(R74), bronchitis (R78), asthma attack (R96), tonsillitis (R22/R76) 
•  EBV: otitis media (H71-H72), diarrhea (D73), URI (R74), infectious mononucleosis 
(A75), pneumonia (R81), tonsillitis (R22/R76)
•  HSV: gingivostomatitis (D82), oral leasions (S71), keratitis (F73), conjunctivitis 
(F70), blepharitis (F72), laryngitis (R77), tonsillitis (R22/R76)
•  H. Infl uenza: acute sinusitis (R75), otitis media (H71-H72), acute conjunctivitis 
(F70), exacerbation chronic bronchitis (R78), pneumonia (R81), meningitis (N71), 
epiglottis (R77), septic artritis (L70), osteomyelitis (L70), cellulitis (S10), tonsillitis 
(R22/R76)
•  S. pyogenes: sinusitis (R75), cellulitis (S10), otitis media (H71-H72), acute rheuma 
(K71), acute glomerulonefritis (U88), impetigo (S84), cellulitis (S10), meningitis 
(N71), tonsillitis (R22/R72)
•  S. pneumoniae: pneumonia (R81), meningitis (N71), sinusitis (R75), otitis media 
(H71-H72), tonsillitis (R22/R76)
•  S. aureus: furunkel (S10), impetigo (S84), pneumonia (R81), folliculitis (S11), 
tonsillitis (R22/R76)
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APPENDIX II
Cluster of possible substitution codes for hypertrophy and recurrent infections of tonsils/
adenoid (R90):
R01: pain attributed to respiratory system
R04: other breathing problems
R05: cough
R07: sneezing/nasal congestion
R08: other symptoms of nose
R09: symptoms/complaints sinus
R21: symptoms/complaints throath
R22: symptoms/complaints tonsils
R29: other symptoms respiratory system
R72: strep throath/scarlet fever *
R74: URI (head cold) *
R75: sinusitis acute/chronic *
R76: tonsillitis acute *
R83: other infections respiratory system
R97: hayfever, allergic rhinitis
R99: other disease respiratory system
A01: pain generalized/unspecifi ed
A02: chills
A03: fever
A75: infectious mononucleosis
A77: other viral diseases
A78: other infectious diseases
H71: acute otitis media/myringitis *
H72: serious otitis media, glue ear *
H74: chronic otitis media, other infections of ear*
* Codes included in the upper respiratory cluster in Figure 6.2

Chapter 7
General discussion
130
Chapter 7
In this fi nal chapter, we present the main fi ndings of this thesis, discuss methodological 
issues, and elaborate on the generalizability of the fi ndings. Finally, we address the 
implications of this thesis for public health, general practice, and future research.
MAIN FINDINGS
In this thesis, we developed a useful strategy for continuous surveillance of health 
problems based on data from electronic medical records (EMRs) collected in a national 
general practice database.1;2 This overall strategy entails four subsequent steps: 
a) constructing episodes, b) analyzing the data, c) interpreting the results, and d) follow-
up of detected trends. The following research questions were addressed, all of which 
refer to the use of data derived from EMRs in general practice. The term ‘useful’ in these 
questions denotes: effective, effi cient, and applicable.
1.  What is a useful design of an automated method for constructing episodes?
2.  What is the validity of this method for the purpose of estimating morbidity rates?
3.  What is a useful general strategy for constructing episodes, analyzing, and interpreting 
the dataset at large?
4.  What is a useful follow-up strategy for investigating causal clues to a detected trend 
in detail?
5.  Which striking trends in the incidence of health problems are detected by application 
of the developed overall strategy over subsequent years?
1. We designed an automated method to group diagnoses into episodes. This design 
was used to build EPICON, which appeared useful for estimating morbidity rates in 
general practice.
Diagnoses in general practice are not directly suitable for estimating morbidity rates. 
These diagnoses need to be grouped into episodes in order to estimate the numerators 
of these rates. An episode could be either one diagnosis or a sequence of diagnoses that 
refl ect the course of disease over time, for example a tension headache leading to 
migraine. In other words, we need to know which diagnoses of a patient refer to the 
same health problem in order to estimate morbidity rates. Generally, two approaches 
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for constructing episodes can be distinguished. In the fi rst approach, diagnoses from 
contact-oriented EMRs are grouped afterwards, through manual review or use of a 
computerized method. The second approach involves the new generation of episode-
oriented EMRs, in which the general practitioner (GP) records diagnoses directly into 
episodes.3 
 Chapter two describes the development of EPICON, an application for automatically 
grouping diagnoses from contact-oriented EMRs into episodes. Following the require-
ments, EPICON was designed as an extension of a semi-computerized method that was 
developed in previous research.4-6 EPICON is based on a combination of logical 
expressions, a decision table, and knowledge extracted from manually grouped cases 
by case-based reasoning, a problem-solving approach in the field of artificial 
intelligence.7-10 A case-based reasoner solves a problem by remembering previous 
similar situations and re-uses the information and knowledge from those situations. We 
used a dataset of manually grouped episodes, which contains implicit knowledge of the 
signs, symptoms, and the course of diseases, to solve the problem of grouping 
diagnoses.4-6 These manually grouped episodes were used to make case bases from 
which previous cases could be retrieved in order to group diagnoses from a new dataset 
automatically into episodes. Preliminary results indicated that EPICON’s performance 
would probably be adequate for estimating morbidity rates in general practice.
2. The validity of EPICON is adequate for the purpose of estimating morbidity rates in 
general practice. The implementation of EPICON to a national general practice data-
base yielded a nationwide, continuous registry of morbidity rates in general practice.
In chapter three, we examined the internal validity of EPICON by comparing morbidity 
rates based on EPICON with morbidity rates from the Dutch National Survey of General 
Practice (DNSGP-2), which we considered to be the gold standard.4-6 The dataset was 
divided into a training set, which was used to construct the case bases, and a test set 
that was used to test EPICON. Morbidity rates were calculated based on these episodes 
and compared with the morbidity rates found in the DNSGP-2. The results show that the 
internal validity of EPICON is adequate. We also examined the effect of case-based 
reasoning within EPICON. This effect is evident, the addition of case-based reasoning 
reduces both systematic and random error.
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Chapter four describes an investigation on the external validity of EPICON. In this study, 
we used an independent dataset derived from GPs who record diagnoses using episode-
oriented EMRs.11;12 This dataset contained diagnoses which were manually grouped by 
GPs. We ungrouped these diagnoses and regrouped them automatically into episodes 
using EPICON. Morbidity rates based on these EPICON-grouped episodes were compared 
with morbidity rates based on the GP-grouped episodes, which we considered to be the 
gold standard. The results show that EPICON performs well for the large majority of 
the morbidity rates. Some of the morbidity rates, however, deviated substantially or 
structurally from the gold standard. We found two main reasons for these deviations: 
‘differences in rules between the two methods of episode construction’ and ‘inadequate 
performance of EPICON’. The latter applies especially to unspecifi ed and general diag-
noses, and therefore caution is required when EPICON is used for these morbidity rates.
 We conclude that the internal as well as the external validity of EPICON is adequate 
for the purpose of estimating morbidity rates in general practice. Furthermore, morbidity 
rates based on EPICON-grouped diagnoses from contact-oriented EMRs can be used in 
conjunction with morbidity rates based on GP-grouped diagnoses from episode-oriented 
EMRs provided that the same grouping rules are used.
 EPICON has been brought into use to generate episodes from diagnoses of practices 
with contact-oriented EMRs that provide data for a national general practice database.1;2 
Because of this implementation, we now have a continuous national registry of morbidity 
rates in general practice. This registry is a substantial addition to the existing GP registries, 
which are either not continuous or are regional.13 Furthermore, the large size of this 
registry allows to calculate general morbidity rates of rare diseases and precise morbidity 
rates of common diseases.
3. We developed a general strategy, including the construction of episodes, the analysis 
of data, and the interpretation of fi ndings, for surveillance of health problems based 
on EMRs in general practice.
Chapter fi ve presents a general strategy for constructing episodes, and for analyzing and 
interpreting data from a national general practice database.1;2 This database contains 
data from both contact-oriented and episode-oriented EMRs. For contact-oriented 
practices episodes were constructed using EPICON, whereas for episode-oriented 
practices we used the episodes recorded by GPs.
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Analyses of data derived from EMRs in general practice have to take into account that 
this data is clustered within patients and within practices, which requires the use of 
multilevel analyses.14;15 Prevalence rates, which are dichotomous data (i.e. one counts 
whether or not a patient has a particular health problem) can be estimated with multilevel 
logistic regression analyses, while incidence rates, which are count data (i.e. one counts 
the number of new episodes of a particular health problem) require multilevel Poisson 
regression analyses. Furthermore, analyses of this data for surveillance purposes have to 
deal with the large range of health problems covered.
 Therefore, we developed general multilevel regression models that can be applied to 
each health problem. These models are useful to detect striking trends in the abundance 
of available data. The analyses result in adjusted morbidity rates that are corrected for 
clustering, age, sex, and recording period. We also calculated raw morbidity rates (i.e. 
common rates) and crude morbidity rates (i.e. rates corrected for clustering only) to acquire 
insight into the results of the general models. The comparison between raw and crude 
rates showed that clustering may have considerable impact on morbidity rates in general 
practice. Therefore, it is advisable to correct morbidity rates for clustering when data is 
clustered within levels, for instance in morbidity rates based on data from different general 
practices or from different hospitals.
 In order to interpret the results of the analyses, the full range of factors that could affect 
registration of patient data in EMRs in general practice has to be taken into account. 
Possible causes of changing incidence rates were listed and grouped into four categories: 
changes in recording, changes in the demand for care, changes in the supply of care, 
and ‘real’ changes in the incidence of disease. Before considering a ‘real’ change in the 
incidence of disease, possible causes that fall into the fi rst three categories should be 
excluded. The developed list can be used to check whether all factors have been taken 
into consideration, and the list can serve as a starting point for more detailed studies.
4. We developed a follow-up strategy to investigate causal clues to a detected trend. 
Application of this strategy to the database permits further exploration whether detected 
trends are due to ‘artefacts’ or might refl ect a ‘real’ change in the incidence of disease.
In chapter six, we studied a detected trend in detail, i.e. the decreasing incidence of 
adenotonsillar problems, based on the available evidence in the general practice 
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database. Specifi c hypotheses were formulated about the cause of the decrease based 
on the developed list of possible causes of changing incidence rates. The main aim of 
this study was to examine whether the decline refl ects a ‘real’ decrease in the incidence 
of disease or is merely originated by ‘artefacts’, like a change in recording. Indications 
for a ‘real’ change in the incidence of disease were examined by estimating incidence 
rates of clusters of other diseases that share the same pathogens with adenotonsillar 
problems. The artefact hypotheses were tested by constructing explanatory variables 
from the available data that is recorded in the EMRs, such as prescriptions and referrals. 
These explanatory variables were then entered stepwise into the general multilevel 
regression models. The available evidence enabled to study the most obvious hypotheses 
for the observed decrease over time.
5. Application of the developed strategy over subsequent years revealed several striking 
trends in the incidence of health problems, which provided insights that were not 
available otherwise.
The developed general strategy was used to monitor the incidence of health problems 
in general practice over subsequent years (chapter fi ve). In the period 2002-2005 several 
striking trends emerged in the Netherlands. In particular, we found increasing concern 
about reactions to drugs among middle-aged and elderly patients. This increase might 
be related to the simultaneous increase in the use of over-the-counter drugs.16;17 In 
addition, we found an increase in ‘a change in feces/bowel movements’, which might 
be due to a nationwide campaign explaining that a change in feces/bowel movements 
is one of the possible signs of colon cancer.18;19 In addition, we detected an increase in 
the incidence of urogenital problems (including urination problems) among men and 
women, fear of veneral disease among men aged 15-44 years, and prostate problems 
among middle-aged and older men. Some of these problems might be explained by the 
availability of, and campaign for, new drugs for benign prostate hyperplasia in the 
period under study, whereas others could refl ect an increase in the number of sexually 
transmitted diseases and urinary tract infections.20-22
 The study also revealed a decrease in the incidence of hypertrophy and recurrent 
infections of tonsils/adenoid among the total population, which was explored in more 
detail in chapter six. In this study, we examined (possible causes of) this health problem 
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among children aged 0-14 years. The results show that the incidence rate decreased 
signifi cantly (p=0.02) from 3.0 to 1.3 per 1000 children per year. Part of this decline can 
be explained by changes in the demand for and supply of care during this period, 
whereas no indications were found for a change in recording. Although unmeasured 
factors in demand or supply may further explain the decrease, a ‘real’ decline in the 
incidence of disease, possibly related to an overall decline in upper respiratory tract 
diseases, cannot be ruled out.
METHODOLOGICAL CONSIDERATIONS
A broad approach was used to develop an overall strategy for continuous surveillance 
that combines elements from epidemiology, public health, medical informatics, and 
general practice. This broad approach enabled us to develop a strategy that entails four 
subsequent steps: the construction of episodes, the analysis of data, the interpretation 
of data, and the follow-up of detected trends. The main drawback of this broad 
approach is that we could not elaborate on all elements in great detail.
Development of EPICON
We started with the development of EPICON, an application for grouping diagnoses 
into episodes. The major strength of EPICON is that it enables the automated construction 
of episodes from diagnoses recorded in contact-oriented EMRs. This method is very 
effi cient compared to the time-consuming and expensive manual grouping method that 
was used in the DNSGP-2.6 This manual grouping method, which was used to group 
diagnoses from 89 practices for one year only, took about one year and cost approxi-
mately 200,000 euro. Because of these high annual costs, the manual grouping method 
was not performed on a yearly basis. In comparison: EPICON runs for about half a day 
to construct episodes for an annual dataset, while the costs for developing and main-
taining EPICON are relatively low. Thus, EPICON is an effi cient method that allows to 
generate morbidity rates that would not have been available otherwise.
 In line with the requirements, EPICON was built on the grouping methods that were 
developed in the DNSGP-2. This choice was effi cient; we could extend the semi-
computerized method and use the manually grouped diagnoses as a case library. The 
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DNSGP-2 was consider to be the gold standard, which is plausible taking into account 
the careful data collection and processing procedures as well as the widespread use of 
this data. There is no evidence, however, to support this assumption. Consequently, pos-
sible fl aws in the DNSGP-2 might have been passed on to EPICON.
 We developed a practical, case-based application using a simple and transparent 
design. We selected case-based reasoning as an approach, because the domain 
knowledge that is needed to group diagnoses into episodes is implicit knowledge, 
which lends itself more to reasoning based on analogy (i.e. resemblance to previous 
cases) than to formulating ‘if-then’ rules, or for constructing a causal or functional 
model. Furthermore, ample cases were available because the DNSGP-2 dataset provided 
an extensive case library. However, because we ceased designing after we had developed 
the fi rst workable application, EPICON could be improved further. Suggestions for further 
development are described in the fi nal section under ‘Future research’.
Evaluation of EPICON
We then evaluated EPICON extensively, which is one of the strengths of this thesis. 
During the development phase, misclassifi ed diagnoses were explored which provided 
feedback about the actual grouping process. This can be considered a formative 
evaluation. We also performed two summative evaluations in which we examined 
whether EPICON fulfi lls its purpose, i.e. whether it is useful for estimating morbidity 
rates in general practice. Both the internal and external validity were examined. A 
limitation of both these studies is that we performed the evaluation ourselves, whereas 
an evaluation by independent researchers would have been more objective. Further-
more, the evaluations are based on subjective judgment as to whether deviations from 
the gold standard are considered small or large. The fi gures provided in chapters three 
and four, however, allow to judge for oneself.
Dataset used for surveillance
Subsequently, EPICON was implemented in the Netherlands Information Network of 
General Practice (LINH), which enabled us to actually monitor health problems over 
time.1;2 The dataset derived from this network has several strengths and limitations. First 
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of all, this dataset contains the necessary information to study morbidity rates in general 
practice, namely:
a)  Coded diagnoses of consultations, prescriptions, and referrals. Diagnoses of consul-
tations, prescriptions and referrals are not only necessary to estimate the numerator 
of the morbidity rates, but they also provide important information on the demand 
for and supply of care.
b)  Information whether or not a recorded diagnosis represents the start of a new 
episode, which is necessary to distinguish between incidence and prevalence rates.
c)  Information about the size of the population at risk, which is needed to determine 
the denominator of the morbidity rates.
d)  Basic patient characteristics, such as age and sex, which enable analysis at the 
patient level.
e)  Basic practice characteristics, such as region of residence and degree of urbanization, 
which allow analyses at the practice level.
Second, the secondary use of data from EMRs in general practice is effi cient and 
prevents or reduces certain forms of bias that may occur in primary data collection, 
such as bias as a result of non-response, differential recall or conducting the study 
(which may introduce a biased shift in attention). Furthermore, data from EMRs provide 
cases that are diagnosed by a physician, which provides more valid information than 
self-reporting of diseases. Third, major strengths of this dataset compared to other Dutch 
GP registries are the large size and the representativeness for the general population 
and for general practices in the Netherlands. 
 Two characteristics that ensure the representativeness of this dataset for all Dutch 
practices are worth mentioning. The fi rst is that the data derive from general practice 
information systems of fi ve different manufacturers. Although software designers have 
slightly adapted the systems of the LINH practices in order to achieve consistent 
recording,1 the differences in design between these systems remain a largely unknown 
source of variability. An educated guess is that differences in design have a considerable 
impact on the accuracy and completeness of recording.
 The second characteristic is that the dataset consists of a dynamic pool of practices, 
which differs from year to year as some practices leave the network and others join up. 
Although this limits the possibility to conduct longitudinal research, the turnover of the 
participating practices is small; in 2005, 89% of the practices had been participating for 
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more than fi ve years and 27% for more than ten years.1 Hence, the dataset allows for 
longitudinal research based on a limited selection of practices that have participated 
over several years.
 An important limitation inherent to the secondary use of data from EMRs is that 
research of diseases, exposures, and adjustment for confounders is limited to the 
available data. Furthermore, the possibility to control the quality of secondary data from 
EMRs is rather limited compared to quality control in primary data collection. Within 
LINH, much effort is put into ensuring the quality of the database. This requires a 
balance between interventions to control the quality of the data on the one hand and 
the extra workload for the participating GPs on the other. A detailed overview of all the 
quality measures that are taken is provided elsewhere.1 Nevertheless, when we checked 
the data in order to monitor health problems over time, the quality of recording 
appeared to be insufficient for a number of practices. Therefore, we defined clear 
selection criteria for accuracy and completeness, resulting in a considerable loss of 
practices, especially in 2004 and 2005. Furthermore, the selected practices record not 
always 100% completely, which could mean that the calculated rates underestimate the 
true rate to a limited extent.
GENERALIZABILITY
Transportability of EPICON
The fi rst step of the developed strategy for surveillance is the construction of episodes. 
To this end, we designed, built, and evaluated EPICON. The results from the external 
validation indicate that EPICON is transportable to other, similar datasets of diagnoses 
in general practice. In particular, EPICON can be applied to group diagnoses derived 
from contact-oriented EMRs that are coded by the International Classifi cation of Primary 
Care (ICPC)23 and that are characterized as either ‘new’ or ‘ongoing’.
 EPICON is also applicable to the new generation of episode-oriented EMRs.3 These 
EMRs have been developed as a result of the 2005 guideline of the Dutch College of 
General Practitioners, which makes it compulsory that every newly introduced system 
provides the possibility to record episodes.24 This guideline is now being implemented. 
At present, most Dutch practices use contact-oriented EMRs, while some of them use 
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the new episode-oriented EMRs. A possible threat to the validity of morbidity rates 
derived from these episode-oriented EMRs is the unknown variation in the grouping 
rules used by different practices. The fi rst experiences show variation between different 
general practice information systems in the user-friendliness of the possibility to record 
episodes as well as variation between GPs in the actual recording of episodes.25 The 
results of this thesis indicate that rules for grouping diagnoses into episodes may have 
considerable impact on the morbidity rates. A possible application of EPICON in 
episode-oriented EMRs is to discover differences in (handling) the rules used by different 
GPs, i.e. EPICON could serve as a standard to compare with.
 EPICON, which was originally developed using data from 2001, is applicable for the 
coming years. In the long run, however, changing medical insights that affect grouping 
rules may limit the usability of EPICON.
Generalizability of data derived from EMRs in relati on to the health care system
Two characteristics of the Dutch health care system affect the generalizability of the 
data from the EMRs that were used in this study. These characteristics are the presence 
of a gatekeeping system and the availability of patient lists. In a gatekeeping system, 
morbidity rates in general practice provide a good indication of the health status of the 
general population.13;26 In countries where patients have free access to specialist care, 
morbidity rates in general practice still provide an indication of the health status of the 
general population, but there is a higher chance of morbidity ‘leaking’ to other health 
care providers. Furthermore, we used patient lists to determine the size of the population 
at risk in the denominator. These lists are available in countries where every patient is 
registered with a GP,27 which makes it easy to determine the denominator of the 
morbidity rates. Thus, the Netherlands has favorable conditions for surveillance of public 
health based on data from EMRs in general practice, because it utilizes both a gatekeeping 
and a list system.
Generalizability of the developed strategy to other GP registries
When there is a similar database in a country with a gatekeeping and a list system, the 
developed surveillance strategy is directly applicable to another GP registry. Either the 
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strategy or the database could be adapted to accommodate departures from these 
conditions. In countries without a list system, for instance, other methods are available 
to determine the size of the population at risk.28 In addition, when the characterization 
of a diagnosis as either ‘new’ or ‘ongoing’ is lacking, this fi eld could be added to an 
existing EMR system.
Generalizability of the developed strategy to other disciplines
The developed strategy cannot be easily adopted by other disciplines. Compared to 
other health care providers, GPs (at least in the Netherlands) are advanced in the use of 
EMRs. For instance, the Dutch College of General Practitioners develops requirements 
for general practice information systems, produces guidelines for consistent use of these 
systems, and promotes the use of a coding system, i.e. the ICPC.23-25 Such activities are 
not yet common among most other health care providers. Consequently, EMRs in general 
practice are at present and generally speaking more useful for extracting data for epide-
miologic research than EMRs that are used by other disciplines.
 Furthermore, the episode construction within the developed strategy, i.e. the relation 
between diagnoses, is specifi c to general practice. Compared to other medical doctors, 
GPs encounter many patients with a broad range of symptoms, signs and diseases, and 
will often have to make an educated guess about the relations between them. For 
instance, the probability that abdominal pain is caused by an appendicitis (i.e. both 
diagnoses should be grouped into one episode called appendicitis), might be lower in 
a general practice setting than in a hospital setting. The procedures followed to construct 
episodes, however, could be adopted by other disciplines, i.e. using manually grouped 
diagnoses to build another episode constructor or to develop episode-oriented EMRs. 
Once a database with episodes is available, the other steps of the developed strategy 
could be adapted to accommodate surveillance based on EMRs of other health care 
providers.
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IMPLICATIONS FOR PUBLIC HEALTH, GENERAL PRACTICE, AND FUTURE REͳ
SEARCH
Public health
The developed strategy for continuous surveillance of health problems in general 
practice provides policymakers with relevant information that may serve a broad range 
of purposes, such as signaling striking and unusual disease patterns, targeting and 
evaluating interventions, and planning health care services. Overall, this thesis 
illustrates the potential use of data derived from EMRs for monitoring public health. 
Development of methods that disclose and use data from EMRs is an important topic for 
future surveillance of public health.
 In this thesis, we applied the developed strategy to detect striking trends in the 
incidence of health problems in the Netherlands. Some of the results of this study 
merit attention of public health professionals. In particular, attention should be paid to 
the increasing concern about reactions to drugs among middle-aged and elderly 
patients in the Netherlands and the possible relation with the availability of over-
the-counter drugs.16;17 In addition, the increasing incidence of health problems in the 
urogenital area should be monitored closely as it could reflect increases in the 
incidence of sexually transmitted diseases and urinary tract infections.20-22 Finally, the 
results of this thesis show a decrease in the incidence of adenotonsillar problems among 
children, which might be part of an overall decline in upper respiratory tract infections 
in the population.29-32 Further insight into this issue is important for planning health 
care services, because upper respiratory tract infections form a substantial part of the 
workload in general practice, ear, nose, and throat surgery, and pediatrics.
General practice
An essential requirement for surveillance based on EMRs in general practice is 
adequate record keeping, especially accurate and complete recording of ICPC codes. 
An additional requirement for episode-oriented EMRs is the consistent use of uniform 
rules for grouping diagnoses into episodes.
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Adequate medical record keeping is primarily important for the treatment and safety of 
patients. Problems in the transfer of information can jeopardize the quality of patient 
care. Consequences of faults in medical information transfer in curative care include 
wrong medication (44%), no treatment because of a lack of information (25%), and 
wrong operation or treatment (24%).33 The increasing complexity of patient care 
increases the need of health care providers to get a quick overview of the diagnoses and 
treatments of a patient which, in turn, increases the necessity of adequate medical 
record keeping.
 We expect that recent developments within Dutch general practice will further 
enhance the quality of medical record keeping. In order to improve the overview and 
exchangeability of information, the Dutch College of General Practitioners has produced 
a guideline for adequate record keeping within EMRs in general practice that advocates 
the routine use of ICPC codes.34 In addition, the information systems of general practice 
out-of-hours cooperatives will be able to communicate with general practice information 
systems in the near future. The Dutch College of General Practitioners also produced a 
guideline for this exchange of information between the GP and the cooperative.35 ICPC 
codes constitute an essential part of this information exchange, which will further 
enhance accurate and complete recording of these codes. Moreover, to improve 
adherence to these guidelines, a tool has been developed that enables GPs to acquire 
insight into their own recording habits. This tool, the general practice EMR scan, uses a 
set of indicators to assess the quality of recording within EMRs in general practice.36 
Probably, this tool will contribute to further enhancement of the quality of medical 
record keeping within general practice, which will serve both the primary and the 
secondary use of this data.
 The results of this thesis, especially the fi ndings in chapter four, could be used to 
discuss variation in the rules that are used to group diagnoses within episode-oriented 
EMRs. Agreement about those rules would further enhance the quality of medical 
record keeping. We recommend that the Dutch College of General Practitioners start 
this discussion in order to formulate general, uniform grouping rules, which could be 
included in the next update of the guideline for adequate record keeping.
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Future research
EPICON
Future research should aim at a follow-up of the results of the evaluation of EPICON. 
The generalizability of EPICON in cumulative tests across diverse settings needs to be 
confi rmed. Furthermore, the results of the evaluation indicate which aspects of EPICON 
could be improved, i.e. the grouping of unspecifi ed and general diagnoses.
 A fi rst step in the further development of EPICON could be to refi ne this tool. To start 
with, the duration of a disease could be added to the method, which is an important 
criterion in deciding whether or not two diagnoses should be grouped together. The 
actual number of days between each pair of diagnoses in the same patient in the 
DNSGP-2 dataset can be used to make useful categories of disease duration. These 
categories could then be added to the case bases. Duration of disease could also be 
added to the decision table. Furthermore, the decision table could be revised by a 
panel of experts in order to establish broader consensus about the decisions in this 
table. Information about age and sex could also be included in the case bases. However, 
this addition will only be useful when age or sex is relevant for deciding whether or not 
diagnoses should be grouped together. For example, information about sex is not helpful 
when the signs, symptoms, and course of a disease are equal for both sexes.
 A second step could be to add cases. New cases might be derived easily from data 
recorded in episode-oriented EMRs. A basic question that may help to decide whether 
or not new cases should be added is: Will these new cases help to improve the 
performance of EPICON? In particular, will the effect be large enough to have an effect 
on the generated morbidity rates? Which rules were used to group these new cases and 
are they similar to the grouping rules used in the DNSGP-2? The performance will not 
improve by adding cases that are based on different grouping rules. In general, adding 
cases could improve the performance where EPICONs’ decisions are based on a small 
number of cases.
 A third step could be to develop an extension that provides an indication as to 
whether or not a diagnosis represents the start of a new episode from the recorded 
disease history of a patient. This step would depart from the initial requirement for 
developing EPICON, i.e. that it should be in line with the basic methods used in the 
DNSGP-2. However, the suggested extension might produce more valid information 
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about the start of a new episode than the fi eld ‘new’ or ‘ongoing’. Moreover, it would 
enable the inclusion of diagnoses from prescriptions and referrals into the episode 
construction process. These advantages would probably enhance the validity of the 
morbidity rates derived from EMRs in general practice and we therefore advocate the 
development of such an extension.
 EPICON uses only the fi rst two processes of a general case-based reasoning cycle, i.e. 
the retrieve and the reuse process. EPICON could be extended to a learning system by 
building the other two processes, i.e. the revise and the retain process, into the system 
as well. For example, EPICON could suggest an episode for a diagnosis that needs to be 
grouped to a GP (retrieve and reuse) and incorporate the final decision of the GP 
(revise) into the case base for future use (retain). Hence, EPICON could be extended to 
a learning, and interactive decision support system within episode-oriented EMRs, that 
would assist the GP in the construction of episodes.
Epidemiologic surveillance
This thesis shows that data derived from EMRs in general practice are a valuable source 
for epidemiologic surveillance. However, this data is not readily available by pushing a 
single button. The use of this data for the purpose of surveillance requires a special 
strategy for processing, analyzing, and interpreting this information. Further research 
should focus on the development of methods that enable the use of EMRs in general 
practice for epidemiologic surveillance, in particular methods for ensuring the quality 
of this data.
 In addition, more research is needed to examine differences in morbidity rates from 
various computerized GP registries. In the Netherlands, these registries differ in factors 
such as region of residence, patient population, classification system used to code 
diagnoses, measures taken to ensure the quality of the registration, practice software, 
and methods used to calculate morbidity rates.13 All of these factors are potential sources 
of variation in morbidity rates derived from EMRs in general practice. The national public 
health agency in the Netherlands recently started a comprehensive study on the impact 
of these factors on morbidity rates from different GP registries. Gijsen and Poos provide 
various suggestions to improve the comparability of these rates, such as publishing the 
characteristics, rules, and quality procedures of the registries. One of their suggestions 
is to establish a countrywide database that includes data from all GP registries, or even 
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from all GPs in the Netherlands.13 This solution would enable control of relevant 
sources of variation and has the added advantage that consensus on defi nitions, rules, 
and procedures has to be reached, which will be a necessary requirement for such a 
project. We recommend to establish this countrywide GP database as it would enhance 
the validity of morbidity rates derived from EMRs in general practice. 
 Together with advances in informatics, the number of databases containing routinely 
collected (medical) data is growing rapidly. An important advantage of this development 
for epidemiologic surveillance is the possibility to link data from EMRs in general practice 
to other databases with relevant information, such as cause of death statistics. Box 7.1 
presents a picture of a future that would be very advantageous for surveillance based on 
secondary data. An important disadvantage of this development is the threat to privacy 
and the opportunity for misuse. Researchers should be fully cognizant of this heightening 
risk and install advanced procedures to protect security and maintain the trust of the 
public.
Box 7.1 Where are we going?
“Imagine a country where all citi zens are given a personal identi fi cati on number at birth, 
which they keep for the rest of their lives, and where most writt en informati on generated 
by public authoriti es is stored in computers and is identi fi able through this identi fi cati on 
number. Imagine that this informati on includes an electronic medical fi le, all contacts to 
the health care system, all diagnoses made, all prescribed medicines, all social benefi ts, 
all birth defects, all immunizati ons, and more. Image that a similar registrati on system is 
used for income, work history, educati on, social grouping, and residence, and then 
envision a register system that can link family members together and link the members 
of society to huge biobanks that include everyone in the populati on. Image that all this 
informati on is stored and kept over ti me. In this vision, the enti re country is a cohort.” 37
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SUMMARY
Epidemiologic surveillance is defined as ‘the continuous and systematic process of 
collection, analysis, interpretation and dissemination of descriptive information for 
monitoring health problems’. Surveillance is of major importance for various activities 
within public health, such as signaling unusual disease patterns, targeting and evaluating 
prevention and control measures, and planning health care facilities. In this thesis, we 
developed a strategy for continuous surveillance of health problems of the Dutch 
population based on data from Electronic Medical Records (EMRs) in general practice. 
This strategy entails four subsequent steps:
 a. constructing episodes
 b. analyzing the data
 c. interpreting the results
 d. follow-up of detected trends
The studies presented in this thesis encompass both the development and the application 
of this strategy. The thesis includes fi ve studies, which are addressed in separate chapters.
 Chapter 1 is an introduction to the topic. It starts with a description of the background 
and the history of surveillance. We explain two basic concepts from the fi eld of epide-
miology: the prevalence (a measure for existing cases of disease) and the incidence (a 
measure for new cases of disease). These measures are used to monitor the frequency and 
the distribution of health problems. Next, we describe the state-of-the-art of surveillance 
of health problems in the Netherlands based on data from EMRs in general practice. In 
order to calculate prevalence and incidence rates based on these records, the separate 
diagnoses of an individual patient need to be grouped into episodes. An episode 
comprises all diagnoses that refer to the same health problem. For instance, the general 
practitioner (GP) has assigned three separate, subsequent diagnoses to a particular 
patient: coughing, fever, and bronchitis, that together comprise one episode named 
bronchitis. Up until now these episodes were largely manually constructed.
 Chapter 2 describes the development of EPICON, an application that automatically 
groups the diagnoses from EMRs in general practice into episodes. These episodes can 
be used to estimate morbidity rates (prevalence and incidence rates). This study builds 
upon an earlier large-scale investigation among Dutch GPs: the second Dutch National 
Survey of General Practice (DNSGP-2). In this previous study, a semi-computerized 
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method was developed to group diagnoses from EMRs in general practice into episodes. 
Using this latter method, episodes are generated automatically for easy-to-group 
diagnoses, whereas diffi cult-to-group diagnoses are grouped manually. EPICON was 
designed as an extension of this semi-computerized method. Within EPICON, the 
diffi cult-to-group diagnoses are automatically grouped using analogous, or ‘case-based’, 
reasoning, a method derived from the fi eld of artifi cial intelligence. This way of reasoning 
assumes that a new problem can be solved by applying solutions from previous similar 
problems that have been stored in the memory (cases). EPICON uses the manually 
grouped diagnoses from the DNSGP-2 as ‘cases’ to automatically group diagnoses from 
a new dataset into episodes. A preliminary evaluation based on misclassifi cations indi-
cated that EPICON performed suffi ciently well to base morbidity rates upon.
 In order to judge whether this application could actually be brought into use, EPICON 
had to be evaluated for the purpose for which it was to be used: estimating morbidity 
rates based on EMRs in general practice. Therefore, we performed two studies to evaluate 
EPICON at this point. In the fi rst evaluation, described in Chapter 3, we studied the inter-
nal validity of EPICON, i.e., the performance of EPICON was tested using a sample from 
the dataset that was used to develop EPICON (the DNSGP-2 dataset). The results show 
that morbidity rates based on EPICON generally deviate only slightly from the gold 
standard (the DNSGP-2 rates). This allowed us to conclude that the internal validity of 
EPICON is adequate for estimating morbidity rates based on EMRs in general practice.
 Chapter 4 describes the second evaluation: a study on the external validity (general-
izability) of EPICON. In this investigation, the performance of EPICON was examined 
in an independent dataset whose data were recorded by GPs in episode-oriented EMRs. 
Within this new generation of EMRs, GPs manually group the diagnoses of a patient into 
episodes in the EMR of that patient. These episode-oriented EMRs are currently imple-
mented in a number of Dutch general practices. In this study, the manually-grouped 
diagnoses were ungrouped and regrouped by EPICON. Next, we compared the morbidity 
rates based on EPICON with the rates based on the manually-grouped episodes, which 
we considered to be the gold standard in this study. EPICON proved to perform well for 
the great majority of the morbidity rates. However, a small part of the morbidity rates 
(5%) showed structural or large deviations. From this investigation we concluded that 
the external validity of EPICON is suffi cient, but caution is required when EPICON is 
used to estimate morbidity rates of general or unspecifi ed health problems.
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Based on these results, EPICON was applied to construct episodes for a nationally 
representative database using data from EMRs in general practice (the LINH database, 
the Netherlands Information Network of General Practice). This implementation allows 
to routinely monitor health problems of the Dutch population on the basis of data from 
EMRs in general practice. To that end, a general surveillance strategy was needed that 
was useful for the whole dataset. Chapter 5 describes this general strategy that includes 
the construction of episodes, the analyses of data, and the interpretation of the results.
 The fi rst step was the construction of episodes. The national database includes data 
from the usual (contact-oriented) EMRs as well as data from the new episode-oriented 
EMRs. For contact-oriented EMRs, episodes were constructed using EPICON; for 
episode-oriented EMRs, the episodes recorded by the GPs were used.
 The second step was to analyze the data. An important question was how to deal with 
the large quantity of available data. Data were available for about 680 different health 
problems acquired over several years and it was impracticable to set up a separate 
analysis for each health problem. In addition, in the set-up of the analyses, we had to 
take into account the clustering of data within patients and within practices. Therefore, 
we developed a general, statistical model that takes into account clustering, age, and 
sex, and that can be applied to each health problem (a multilevel regression model).
 The third step was to interpret the results emerging from these analyses. To that end, 
we had to consider various factors that could affect the registration of data within EMRs 
in general practice. Therefore, all possible events that could cause a change in morbidity 
rates were listed and grouped into four main categories: changes in recording, changes 
in the demand for care, changes in the supply of care, and ‘real’ changes in the number 
of new cases of disease.
 We applied this general surveillance strategy to monitor health problems in the 
Netherlands over the period 2002-2005. In this study we detected several striking trends 
over time. It emerged that the concern of patients about reactions to drugs had 
increased, especially among patients aged 45 years and older. This might be explained 
by the increased availability and use of over-the-counter-drugs in this period of time. In 
addition, we found an increase in various urogenital problems, including prostate 
problems, fear of veneral diseases, and urination problems. Possible explanations for 
the increase in these types of problems are: the availability of, and campaigns for, new 
drugs for benign prostate hyperplasia, an increase in the number of sexually transmitted 
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diseases, and an increase in the number of urinary tract infections. Another fi nding of 
this study was a decrease in the incidence of hypertrophy and recurrent infections of 
tonsils/adenoid.
 Possible causes for this decrease in hypertrophy/recurrent infections of tonsils/adenoid 
among children were investigated in Chapter 6, which describes a follow-up strategy to 
fi nd clues to possible causes for a detected trend. In this fourth step, we formulated 
specifi c hypotheses based on the list of possible causes for changes in morbidity rates. 
We examined these hypotheses based on the available information in the database, 
including data on consultations, referrals, and prescriptions of medication. Then, 
explanatory variables were constructed that were entered stepwise into the general 
statistical model. This fourth step allows to explore whether a detected trend is caused 
by ‘artefacts’ (like a change in recording) or whether there might be a ‘real’ change in 
the incidence of disease. This follow-up study was conducted among children aged 
0-14 years, i.e., the age group in which hypertrophy and recurrent infections of tonsils/
adenoid occur most frequently. The results show that part of the decline of this health 
problem could be explained by changes in the demand for care (fewer consultations) 
and in the supply of care (fewer referrals and prescriptions). However, no explanation 
was found for the residual decline. This decrease is possibly related to a ‘real’ decline 
in upper respiratory tract infections.
 In Chapter 7, we first summarize the most important findings of this thesis before 
discussing various methodological issues. The surveillance strategy is developed from a 
broad approach that combines elements from different scientifi c fi elds. The drawback of 
this broad approach is that we could not elaborate on all elements in great detail. We 
also discuss the advantages and disadvantages of the particular database that was used. 
Important advantages are the representativeness for the Dutch population, the large 
amount of data, and the fact that the data has already been collected. A disadvantage is 
the limited possibility to control the quality of recording. Next, the applicability of the 
developed surveillance strategy is addressed. Under certain conditions, EPICON can 
be applied to other general practice registries. In addition, EPICON can serve as a 
standard against which to compare other episode constructions. When considering 
the surveillance strategy as a whole, it seems to be particularly suited for application in 
other general practice registries rather than for application in other disciplines. Finally, 
we discuss the implications of this thesis for public health, general practice, and future 
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research. This thesis shows that data derived from EMRs in general practice are valuable 
for surveillance provided that methods are available for disclosing and using this data. 
Future surveillance should focus on the further development of methods for the secondary 
use of data derived from EMRs. For example, methods to enhance the quality of recording 
or the linking of data from EMRs to relevant information from other databases.
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SAMENVATTING
Epidemiologische surveillance is gedefi nieerd als ‘het continue en systematische proces 
van verzameling, analyse, interpretatie en verspreiding van beschrijvende informatie 
voor het monitoren van gezondheidsproblemen’. Surveillance is van groot belang voor 
allerlei activiteiten binnen de volksgezondheidszorg, zoals het signaleren van onver-
wachte ziektepatronen, het instellen en evalueren van maatregelen voor preventie of 
controle van ziekten en het plannen van gezondheidszorgvoorzieningen. Wij hebben 
in dit proefschrift een strategie ontwikkeld voor continue surveillance van gezondheids-
problemen van de Nederlandse bevolking op basis van gegevens uit Elektronische 
Medische Dossiers (EMDs) in de huisartspraktijk. Deze strategie bestaat uit vier opeen-
volgende stappen: 
 a. constructie van episodes
 b. analyse van gegevens
 c. interpretatie van de resultaten
 d. follow-up van ontdekte trends.
De studies in dit proefschrift omvatten zowel de ontwikkeling als de toepassing van 
deze strategie. Het proefschrift bestaat uit vijf studies die in aparte hoofdstukken worden 
behandeld.
 Hoofdstuk 1 is een inleiding op het onderwerp. Het begint met een beschrijving van 
de achtergrond en de geschiedenis van surveillance. We lichten twee basisbegrippen 
uit de epidemiologie toe: de prevalentie (een maat voor bestaande ziektegevallen) en 
de incidentie (een maat voor nieuwe ziektegevallen). Deze maten worden gebruikt om 
de frequentie en de verspreiding van gezondheidsproblemen te monitoren. Daarna 
volgt de stand van zaken omtrent surveillance van gezondheidsproblemen in Nederland 
op basis van gegevens uit EMDs in de huisartspraktijk. Om prevalentie- en incidentie-
cijfers te kunnen berekenen op basis van deze dossiers, moeten de afzonderlijke 
diagnoses van een patiënt gegroepeerd worden in episodes. Een episode omvat alle 
diagnoses die betrekking hebben op hetzelfde gezondheidsprobleem. De huisarts heeft 
bijvoorbeeld drie afzonderlijke, opeenvolgende diagnoses bij een bepaalde patiënt 
gesteld: hoesten, koorts en bronchitis, die samen één episode met de naam bronchitis 
vormen. Tot nu toe werden deze episodes grotendeels handmatig geconstrueerd.
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Hoofdstuk 2 beschrijft de ontwikkeling van EPICON, een applicatie om diagnoses uit 
EMDs in de huisartspraktijk automatisch in episodes te groeperen. Deze episodes kunnen 
gebruikt worden om morbiditeitscijfers (prevalentie- en incidentiecijfers) te berekenen. 
Deze studie bouwt voort op een eerder, grootschalig onderzoek onder Nederlandse 
huisartsen: de Tweede Nationale Studie naar ziekten en verrichtingen in de huisarts-
praktijk (NS2). In dit eerdere onderzoek is een semi-automatische methode ontwikkeld 
om diagnoses uit EMDs in de huisartsenpraktijk in episodes te groeperen. Hierbij worden 
automatisch episodes gegenereerd voor makkelijk te groeperen diagnoses, terwijl moeilijk 
te groeperen diagnoses handmatig worden gegroepeerd. We hebben EPICON ontworpen 
als een uitbreiding van deze semi-automatische methode. De moeilijk te groeperen 
diagnoses worden binnen EPICON automatisch gegroepeerd met behulp van analoog 
ofwel ‘case-based’ redeneren, een methode die afkomstig is uit het vakgebied van 
de kunstmatige intelligentie. Deze vorm van redeneren veronderstelt dat een nieuw 
probleem opgelost kan worden door gebruik te maken van oplossingen voor eerdere, 
soortgelijke problemen, die in het geheugen zijn opgeslagen (cases). EPICON gebruikt 
de handmatig gegroepeerde diagnoses uit NS2 als ‘cases’ om diagnoses uit een nieuwe 
dataset automatisch in episodes te groeperen. Een voorlopige evaluatie op basis van 
misclassifi caties suggereerde dat EPICON voldoende presteerde om morbiditeitscijfers 
op te baseren.
 Om te beoordelen of deze applicatie daadwerkelijk in gebruik genomen kon worden, 
moest EPICON worden geëvalueerd ten aanzien van het doel waar het voor gebruikt 
zou gaan worden: het schatten van morbiditeitscijfers op basis van EMDs in de huisarts-
praktijk. We hebben twee studies uitgevoerd om EPICON op dit punt te evalueren. In 
de eerste evaluatie, beschreven in hoofdstuk 3, bestudeerden we de interne validiteit 
van EPICON, dat wil zeggen dat we de prestatie van EPICON onderzochten in een 
steekproef uit de dataset die gebruikt is om EPICON te ontwikkelen (de NS2-dataset). 
Uit de resultaten bleek dat de morbiditeitscijfers op basis van EPICON over het 
algemeen weinig afweken van de gehanteerde gouden standaard (de NS2-cijfers). 
Hieruit concludeerden we dat de interne validiteit van EPICON voldoende was voor het 
schatten van morbiditeitscijfers op basis van EMDs in de huisartspraktijk.
 Hoofdstuk 4 beschrijft de tweede evaluatie: een studie naar de externe validiteit 
(generaliseerbaarheid) van EPICON. In dit onderzoek bestudeerden we de prestatie 
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van EPICON in een onafhankelijke dataset, waarvan de gegevens door huisartsen 
waren vastgelegd in episode-georiënteerde EMDs. In deze nieuwe generatie van EMDs 
groeperen huisartsen de diagnoses van een patiënt handmatig in episodes in het EMD 
van die patiënt. Deze episode-georiënteerde EMDs wordt momenteel geïmplementeerd 
in een aantal Nederlandse huisartspraktijken. In dit onderzoek werden de handmatig 
gegroepeerde diagnoses ontkoppeld en opnieuw gegroepeerd door EPICON. Vervolgens 
vergeleken we de morbiditeitscijfers op basis van EPICON met de cijfers op basis van 
de handmatig gegroepeerde episodes, die we in deze studie als gouden standaard 
beschouwden. EPICON bleek goed te presteren voor het overgrote deel van de mor-
biditeitscijfers. Een klein deel van de morbiditeitscijfers (5%) liet echter structurele of 
grote afwijkingen zien. Uit dit onderzoek concludeerden we dat de externe validiteit 
van EPICON voldoende is, maar dat voorzichtigheid in acht genomen moet worden 
wanneer EPICON gebruikt zou worden voor morbiditeitscijfers van algemene of van 
weinig specifi eke gezondheidsproblemen.
 Op basis van deze resultaten werd EPICON in gebruik genomen om episodes te 
construeren voor een landelijk representatieve database met gegevens uit EMDs in de 
huisartspraktijk (de database van LINH, het Landelijk Informatie Netwerk Huisartsenzorg). 
Deze implementatie maakte het mogelijk om routinematig gezondheidsproblemen van 
de Nederlandse bevolking te monitoren op basis van gegevens uit EMDs in de huisarts-
praktijk. Hiervoor was een algemene surveillance strategie nodig, die bruikbaar was voor 
de gehele dataset. Hoofdstuk 5 beschrijft deze algemene strategie, die de constructie 
van episodes, de analyse van gegevens en de interpretatie van de resultaten omvat. 
 De eerste stap was het construeren van episodes. De landelijke database bevat zowel 
gegevens uit de gangbare (contact-georiënteerde) EMDs als uit de nieuwe episode- 
georiënteerde EMDs. Voor contact-georienteerde EMDs werden episodes door EPICON 
gemaakt; voor episode-georienteerde EMDs werden de episodes gebruikt die de huisartsen 
geregistreerd hadden. 
 De tweede stap was het analyseren van de gegevens. Een belangrijke vraag was hoe 
de grote hoeveelheid beschikbare data het beste gehanteerd kon worden. Er waren 
gegevens beschikbaar over zo’n 680 verschillende gezondheidsproblemen over meer-
dere jaren en het was praktisch niet haalbaar om voor elk gezondheidsprobleem een 
aparte analyse op te zetten. Bovendien moesten we bij het opzetten van de analyses 
rekening houden met de clustering van gegevens binnen patiënten en binnen praktijken. 
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Daarom hebben we een algemeen, statistisch model ontworpen dat rekening houdt met 
clustering, leeftijd en geslacht en dat toegepast kan worden op elk gezondheidsprobleem 
(een multilevel regressie model).
 De derde stap was het interpreteren van de resultaten uit deze analyses. Hierbij moesten 
we rekening houden met allerlei factoren die van invloed kunnen zijn op het vast -
leggen van gegevens in EMDs van huisartsen. Daarom maakten we een lijst van alle 
mogelijke oorzaken voor veranderingen in morbiditeitscijfers, die we onderverdeelden 
in vier categorieën: veranderingen in registratie, veranderingen in de vraag naar zorg, 
veranderingen in het aanbod van zorg en ‘echte’ veranderingen in het aantal nieuwe 
ziektegevallen.
 We hebben deze algemene surveillance strategie toegepast om gezondheidsproblemen 
in Nederland te monitoren over de periode 2002-2005. In dit onderzoek ontdekten we 
verschillende opvallende trends in de tijd. Zo bleek dat de bezorgdheid van patiënten 
over (bij)werkingen van geneesmiddelen was toegenomen, met name onder patiënten 
van 45 jaar en ouder. Dit zou verklaard kunnen worden door de toegenomen beschik-
baarheid en gebruik van zelfzorgmedicatie in deze periode. Ook vonden we een toename 
van verschillende urogenitale problemen, waaronder prostaatproblemen, angst voor 
geslachtsziektes en plasproblemen. Mogelijke verklaringen voor de gevonden toename 
van urogenitale problemen zijn: de beschikbaarheid van en reclame voor nieuwe 
geneesmiddelen voor goedaardige prostaatvergroting, een toename van het aantal 
geslachtsziektes en een toename van het aantal urineweginfecties. Een andere bevinding 
uit deze studie was dat de incidentie van vergrote en herhaaldelijk ontstoken amandelen 
was afgenomen.
 De mogelijke oorzaken voor deze daling in vergrote/herhaaldelijk ontstoken amandelen 
bij kinderen is nader onderzocht in hoofdstuk 6, waarin we een follow-up strategie 
beschrijven om aanwijzingen te vinden voor mogelijke oorzaken van een ontdekte 
trend. In deze vierde stap formuleerden we specifi eke hypotheses aan de hand van de 
lijst met mogelijke oorzaken voor veranderingen in morbiditeitscijfers. Deze hypotheses 
onderzochten we op basis van de beschikbare informatie in de database, waaronder 
gegevens over consulten, verwijzingen en voorschriften voor geneesmiddelen. We 
construeerden verklarende variabelen, die we stapsgewijs aan het algemene statistische 
model toevoegden. Met deze vierde stap kan onderzocht worden of een gevonden 
trend veroorzaakt wordt door ‘artefacten’ zoals een verandering in registratie of dat er 
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mogelijk sprake is van een ‘echte’ verandering in de incidentie van een ziekte. Dit 
follow-up onderzoek vond plaats onder kinderen van 0 tot 14 jaar: de leeftijdsgroep 
waarin vergrote en herhaaldelijk ontstoken amandelen vaak voorkomt. Uit de resultaten 
bleek dat de daling van dit gezondheidsprobleem deels verklaard kon worden door 
veranderingen in de vraag naar zorg (minder consultaties) en in het aanbod van zorg 
(minder verwijzingen en voorschriften). Voor de resterende daling kon echter geen 
verklaring gevonden worden. Deze afname is mogelijk gerelateerd aan een ’echte’ 
daling in bovenste luchtweginfecties.
 In hoofdstuk 7 geven we eerst een overzicht van de belangrijkste bevindingen van dit 
proefschrift. Vervolgens bespreken we een aantal methodologische kwesties. De 
surveillance strategie is ontwikkeld vanuit een brede aanpak, waarin elementen uit 
verschillende vakgebieden met elkaar gecombineerd worden. De keerzijde van deze 
brede aanpak was dat we niet uitvoerig op alle onderdelen in konden gaan. We bespreken 
ook de voor- en nadelen van de gebruikte database. Belangrijke voordelen zijn de 
representativiteit voor de Nederlandse bevolking, de grote hoeveelheid data en het feit 
dat de gegevens al zijn verzameld. Een nadeel is de beperkte mogelijkheid om controle 
uit te oefenen op de kwaliteit van de verslaglegging. Daarna komen de toepassings-
mogelijkheden van de ontwikkelde surveillance strategie aan de orde. EPICON kan, 
onder bepaalde condities, toegepast worden in andere huisartsregistraties. Ook kan 
EPICON toegepast worden als een standaard waarmee andere episode-constructies 
kunnen worden vergeleken. Wanneer we de totale surveillance strategie beschouwen, 
dan leent deze zich met name voor toepassing in andere huisartsregistraties en niet 
zozeer voor toepassing in andere disciplines. Ten slotte bespreken we de implicaties 
van dit proefschrift voor de volksgezondheidszorg, de huisartspraktijk en toekomstig 
onderzoek. Dit proefschrift laat zien dat gegevens uit EMDs in de huisartspraktijk waarde-
vol zijn voor surveillance op voorwaarde dat er methoden beschikbaar zijn om deze 
gegevens te ontsluiten en te gebruiken. Toekomstige surveillance zou zich moeten richten 
op de verdere ontwikkeling van methoden voor het secundair gebruik van gegevens uit 
EMDs. Hierbij kan bijvoorbeeld gedacht worden aan methoden om de kwaliteit van de 
verslaglegging te verbeteren of aan het koppelen van gegevens uit EMDs aan relevante 
informatie uit andere databases.
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